Methods and Informatics for Gas-Phase Structural Biology and Drug Discovery by Eschweiler, Joseph
Methods and Informatics for Gas-Phase Structural Biology and 
Drug Discovery 
 
by 
 
Joseph D. Eschweiler 
 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
(Chemistry) 
in the University of Michigan 
2017 
 
 
Doctoral Committee:  
 Associate Professor Brandon T. Ruotolo, Chair 
 Professor Phillip C. Andrews 
 Professor Charles L. Brooks III 
 Assistant Professor Daniel R. Southworth 
  
Joseph D. Eschweiler 
joeesch@umich.edu 
ORCID ID: 0000-0002-2486-9726 
 
© Joseph D. Eschweiler 2017 
  
 ii 
 
Dedication 
 
I dedicate this dissertation to my dad, Damian Eschweiler, who I know would 
have loved nothing more than to read it in its entirety. He taught me the value of critical 
thinking, and without his influence this accomplishment would not have been possible.
 iii 
 
Acknowledgements 
 
 I cannot acknowledge my advisor, Professor Brandon Ruotolo enough for his 
sustained support of my scientific growth. His high standards in terms of scientific rigor 
and quality in all forms of scientific communication have shaped me as a scientist and 
will continue to impact my work for many years to come. Not only did Brandon help me 
achieve more than I thought was possible, he did so in a way that made the doctoral 
experience enjoyable, allowing me the freedom to explore new areas and find my own 
internal motivation for my work. 
 I am also incredibly thankful to my doctoral committee members Professors Phil 
Andrews, Charles Brooks, and Dan Southworth. Your standards for scientific rigor and 
insightful questions steered my learning and the direction of my research from my 
candidacy exam all the way through the composition of this manuscript. I extend this 
acknowledgment to the entire UM Chemistry Faculty, who in my experience have been 
incredibly receptive to my questions, and together set an incredible standard for how a 
department should function as educators and scientists.  
 My fellow graduate students have also contributed to an excellent academic 
culture, both in the lab, the department and the entire campus. My Ruotolo lab 
colleagues, both past, and present have been extremely helpful, and give me great 
hope for the future of our research. I started my time in the lab by continuing the 
projects put forth by the first-ever graduate student from our group, Yueyang Zhong. 
 iv 
 
Yueyang’s training, her preliminary data, and her writings formed the foundation for my 
research and I am incredibly grateful for her hard work and patience with me. The same 
can be said for other senior lab members, including Linjie Han, who allowed me to pick 
his brain many late nights in lab, and Russ Bornschein, who knew the answers to any 
instrumental question I could throw at him. The other lab members, whom I spent most 
of my time with over the last 5 years were also of great influence. Special thanks to 
Jessica Gibbons, who kept me on track during my first few years in the lab using 
Pavlovian principles and contributed to the CIUSuite platform that unfortunately only I 
get credit for. I’m confident in leaving the lab in the capable hands of the next most 
senior lab members, Yuwei Tian, Sugyan Dixit, and Dan Polasky. It’s been an honor to 
watch these scientists grow and I know they will take future research in the lab to new 
levels. I also acknowledge the rotators, undergraduates, and junior lab members who I 
have had the privilege of working with, especially Rachel Martini, Chunyi Zhao, Sarah 
Fantin, and Daniel Vallejo, I know that you all will go on to do great things in your 
scientific careers. 
 Importantly, the majority of the science I did throughout graduate school would 
not have been possible without fantastic collaborators. Bob Hausinger and Mark 
Farrugia from Michigan State University set the bar for great collaborative relationships 
early on in my graduate career, and gave me confidence in working with other, more 
experienced scientists. Special thanks to Aaron Sciore, Ajitha Christie-David, Somaye 
Badieyan, Kyle Ferguson, Sang Joon Won, Brent Martin and Neil Marsh for giving me 
the opportunity to work on some of the most interesting biochemical projects I could 
 v 
 
have asked for. I also acknowledge Aaron Frank for his support and mentorship in much 
of my computational modeling work. 
 It would be remiss to not also acknowledge some of my early scientific mentors. 
From UW-Milwaukee, Mary Knasinski, Henry Tomasiewicz, Andy Pacheco, and Matt 
Youngblut were such strong academic and scientific role models for me during my 
college years and I am so thankful they were there to steer me toward my current path. 
From the University of Michigan, I also acknowledge Raoul Kopelman for providing me 
with my first graduate research opportunities during my summer rotation. Brent Martin 
and Jaimeen Mujmadar were also fantastic mentors during my early graduate school 
career, and I thank them for their insights during my most formative scientific years.  
 Last but certainly not least, I would like to thank my family, specifically my mother 
Peggy Eschweiler and my fiancée Katy Robb. My mom has been so supportive of me 
over these last 5 years, and has always been there when I was in a pinch. If it weren’t 
for her, I could never have made it this far in life. Perhaps the greatest thing to come out 
of my Ph.D. years at Michigan was my engagement to the all-around wonderful Katy 
Robb. Katy provided me with the emotional support and motivation to do excellent work 
throughout almost my entire time in graduate school, all while keeping me out of trouble. 
I can’t wait to marry her.
 vi 
 
Table of Contents 
Dedication ...................................................................................................................... ii 
Acknowledgements ...................................................................................................... iii 
List of Figures................................................................................................................ x 
List of Tables .............................................................................................................. xiii 
List of Appendices ..................................................................................................... xiv 
Abstract ........................................................................................................................ xv 
Chapter 1: Introduction ................................................................................................. 1 
1.1 High Resolution Protein Characterization .................................................................. 3 
1.2 Targeted Methods in Structural Biology .................................................................... 5 
1.2.1 Methods for Protein Structure .......................................................................... 5 
1.2.2 Methods for Multiprotein Complexes ............................................................... 6 
1.2.3 Methods for Protein-Ligand Complexes ........................................................... 8 
1.3 Ion Mobility-Mass Spectrometry Instrumentation in Structural Biology ...................... 9 
1.3.1 Ionization and Preservation of Native-like Protein Structure ............................ 9 
1.3.2 Selection, Mass analysis, and Detection of Protein Ions  .............................. 11 
1.3.3 Ion Activation and Tandem Mass Spectrometry  ........................................... 13 
1.3.4 Ion Mobility Spectrometry  ............................................................................. 15 
1.4 Ion Mobility-Mass Spectrometry Methodology in Structural Biology and Drug 
Discovery ...................................................................................................................... 19 
1.4.1 IM-MS Methods for Multiprotein Complex Structure ...................................... 19 
1.4.2 IM-MS Methods for Drug Discovery and Development .................................. 24 
1.5 Summary of the Dissertation  .................................................................................. 26 
1.6 List of Publications  ................................................................................................. 27 
1.7 References  ............................................................................................................. 28 
 vii 
 
Chapter 2: CIUSuite: A Quantitative Analysis Package for Collision Induced 
Unfolding Measurements of Gas-Phase Protein Ions .............................................. 35 
2.1 Abstract ................................................................................................................... 35 
2.2 Introduction ............................................................................................................. 36 
2.3 CIUSuite Overview .................................................................................................. 39 
2.4 CIUSuite Applications .............................................................................................. 44 
2.5 Conclusions ............................................................................................................. 49 
2.6 Acknowlegements ................................................................................................... 50 
2.7 Supporting Information ............................................................................................ 50 
2.8 References .............................................................................................................. 51 
Chapter 3: Chemical Probes and Engineered Constructs Reveal a Detailed 
Unfolding Mechanism for a Solvent-Free Multi-Domain Protein  ............................ 53 
3.1 Abstract ................................................................................................................... 53 
3.2 Introduction ............................................................................................................. 54 
3.3 Experimental Section .............................................................................................. 57 
3.4 Results and Discussion ........................................................................................... 59 
3.5 Conclusions ............................................................................................................. 68 
3.6 Acknowlegements ................................................................................................... 71 
3.7 Supporting Information ............................................................................................ 71 
3.8 References .............................................................................................................. 71 
Chapter 4: Coming to Grips with Ambiguity: Ion Mobility-Mass Spectrometry for 
Protein Quaternary Structure Assignment  .............................................................. 73 
4.1 Abstract ................................................................................................................... 73 
4.2 Introduction ............................................................................................................. 74 
4.3 Assessing Coarse-Graining Errors in Multiprotein Models Generated from IM-MS 
Data............................................................................................................................... 79 
4.4 Benchmarking the Information Content of IM-MS Datasets for Modeling Known 
Protein Complexes  ....................................................................................................... 82 
4.5 Characterizing Ambiguity in the Structural Ensembles Defined by IM-MS  ............. 85 
4.6 Leveraging Symmetry and Modularity to Resolve Ambiguity within IM-MS Model 
Ensembles  ................................................................................................................... 87 
4.7 Conclusions and Future Directions.......................................................................... 91 
 viii 
 
4.8 Supplemental Information ....................................................................................... 94 
4.9 Acknowledgements  ................................................................................................ 94 
4.References  ................................................................................................................ 94 
Chapter 5: Structural Models of the Urease Activation Complex Derived from IM-
MS and Integrative Modeling  ..................................................................................... 97 
5.1 Abstract ................................................................................................................... 97 
5.2 Introduction ............................................................................................................. 98 
5.3 Methods ................................................................................................................ 100 
5.4 Results .................................................................................................................. 102 
5.5 Conclusions ........................................................................................................... 112 
5.6 Supporting Information .......................................................................................... 113 
5.7 References ............................................................................................................ 113 
Chapter 6: Applications of IM-MS for Studying Self-Assembly of Natural and 
Engineered Protein Complexes  .............................................................................. 116 
6.1 Abstract ................................................................................................................. 116 
6.2 IM-MS Evaluates De Novo-Designed Coiled Coils as Off-the-Shelf Components for 
Protein Assembly ........................................................................................................ 117 
6.2.1 Introduction .................................................................................................. 117 
6.2.2 Methods ....................................................................................................... 118 
6.2.3 Results and Discussion ............................................................................... 119 
6.2.4 Conclusions ................................................................................................. 125 
6.3 Elucidating the Structure of Gas-Phase ApoE Tetramers ..................................... 126 
6.3.1 Introduction .................................................................................................. 126 
6.3.2 Materials and Methods ................................................................................ 127 
6.3.3 Results and Discussion ............................................................................... 128 
6.3.4 Conclusions ................................................................................................. 131 
6.4 Acknowledgements ............................................................................................... 132 
6.4 References ............................................................................................................ 132 
Chapter 7: Conclusions and Future Directions  ..................................................... 134 
7.1 Findings and Future Directions for Integrative Modeling of Multiprotein Complexes 
 .................................................................................................................................... 134 
 ix 
 
7.2 Conclusions and Future Directions for CIU as a Structural and Drug Discovery Tool 
 .................................................................................................................................... 136 
7.3 References ............................................................................................................ 140 
Appendices ................................................................................................................ 141 
 x 
 
List of Figures 
Figure 1-1 Electrospray Ionization ................................................................................. 10 
Figure 1-2 Collision-induced Unfolding and Dissociation of Charged Polypeptides  ..... 13 
Figure 1-3 Schematic of the Synapt G-2 Ion Mobility-Mass Spectrometry Platform  ..... 18 
Figure 1-4 Information Content of IM-MS Experiments  ................................................ 20 
Figure 1-5 Integrative Structural Biology Schematic...................................................... 22  
Figure 1-6 Collision-induced Unfolding of Protein-Ligand Complexes........................... 25 
Figure 2-1 Schematic representation of CIUSuite modules ........................................... 39 
Figure 2-2 CIU of Biotherapeutics ................................................................................. 44 
Figure 2-3 Analysis of homologous serum albumins reveals significant differences in 
their CIU fingerprints  .................................................................................................... 47 
Figure 3-1 CIU screen of homologous serum albumins. ............................................... 60 
Figure 3-2 HSA Domain-Specific Chemical Probes of CIU  .......................................... 63 
Figure 3-3 CIU/CID analysis of 15+ noncovalent, reconstituted albumins.  ................... 65 
Figure 3-4 Modular Unfolding Mechanism for 15+ Human Serum Albumin .................. 67 
Figure 4-1 A General Workflow for IM-MS-Based Modeling  ......................................... 76 
Figure 4-2 Coarse-graining Error for domain and subunit-level representations ........... 80 
Figure 4-3 Positive Predictive Values of the IM-MS restraint sets plotted as a function of 
the number of internal CCS-derived restraints. ............................................................. 83 
Figure 4-4 Parsing Structural Ensembles Generated with Ambiguous Restraint Sets .. 85 
Figure 4-5 Modeling the topology of hexameric LTag bound to p53 using the symmetry 
restraint ......................................................................................................................... 88 
Figure 4-6 Docking modules within the ARP2/3 complex using connectivity restraints  90 
 xi 
 
Figure 5-1 IM-MS analysis of (UreABC)3(MBP-DFG)3 and its subcomplexes  ............ 103 
Figure 5-2 IM-MS restraints for building molecular models of (UreABC)3(MBP-DFG)3.
 .................................................................................................................................... 105 
Figure 5-3 Hierarchical clustering reveals ambiguity in under-restrained models.  ..... 107  
Figure 5-4 Resolving ambiguity by integrating new data  ............................................ 109 
Figure 5-5 Comparing IM-MS-derived models with structures from molecular docking.
 .................................................................................................................................... 111 
Figure 6-1 Evaluation of Coiled Coils for Oligomerization of GFP monomers. ............ 120 
Figure 6-2 Evaluation of the effects of coiled-coil fusion on protein structure.  ............ 122 
Figure 6-3 Symmetry-directed Assembly of Protein Cages  ........................................ 124 
Figure 6-4 CCS Distribution of apoE tetramers modeled at subunit resolution ........... 129 
Figure 6-5 Modeling the apoE tetramer at domain resolution from IM-MS data .......... 130 
Figure 7-1 Challenges in Integrative Modeling of Protein Complexes From MS datasets. 
 .................................................................................................................................... 135 
Figure 7-2 Adaptation of the Agilent 6560 IM-MS platform for high throughput, charge 
multiplexed CIU experiments ...................................................................................... 138  
Figure I-1 CIU Fingerprints of All Homologues for 14+, 15+ and 16+ charge states  .. 142  
Figure I-2 Quantitative analysis of CIU Differences across Homologues  ................... 143  
Figure I-3 Correlations between a BSA-based evolutionary distance and the CIU RMSD 
for all albumin homologues ......................................................................................... 146  
Figure I-4 Raw output from CIUSuite_compare, comparing Bovine and Human 
Albumins to other species  .......................................................................................... 147  
Figure I-5 . Quantitation of BSA:HSA Ratio Using Peak Ratio of Unfolded States 
Present at 120V .......................................................................................................... 148  
Figure I-6 A CIU difference plot from CIUSuite, showing that HSA bound to diazepam 
stabilizes late transitions relative to apo HSA .............................................................. 149  
Figure I-7 CIU and CID Datasets for HSA bound to selected Ligands at 14+ and 16+ 
charge state ................................................................................................................ 149  
Figure I-8 A graph of fraction bound versus collision voltage in the ion trap prior to IM 
separation  .................................................................................................................. 150 
Figure I-9 Iodipamide binding causes significant conformational shifts in HSA  .......... 151 
Figure I-10 Lack of correlation between CID energy and traditional biophysical 
properties  ................................................................................................................... 152  
Figure I-11 IM-MS spectra for HSA domain 1 constructs  ........................................... 153  
Figure I-12 IM-MS spectra for HSA domain 2 constructs  ........................................... 153  
Figure I-13 . IM-MS spectra for HSA domain 3 constructs  ......................................... 154  
Figure I-14 IM-MS spectra for HSA domains 1 and 2, covalently linked  ..................... 154  
 xii 
 
Figure I-15 IM-MS spectra for HSA domain 1-2 construct, mixed with domain 3 ........ 155  
Figure I-16 MS/MS spectra for HSA domain 1-2 construct, mixed with domain 3 ....... 155 
Figure I-17 IM-MS and MS/MS data for D12-D1 ......................................................... 156  
Figure I-18 IM-MS and MS/MS data for D12-D2 ......................................................... 156  
Figure I-19 IM-MS and MS/MS data for D12-D3  ........................................................ 157  
Figure I-20 CIU data for WT HSA compared with CIU data for D12-D3, D12-D1 and 
D12-D2  ....................................................................................................................... 158  
Figure I-21 CIU fingerprint data for reconstituted noncovalent HSA constructs  ......... 159  
Figure II-1 Coarse-graining CCS error as a function of Subunit Residues/Sphere  ..... 161  
Figure II-2 CCS restraints increase in selectivity when subunits are similar in size .... 164  
Figure III-1 Solution-phase disruption reveals UreA trimeric subcomplexes  .............. 165  
Figure III-2 UreB knockout yields (UreAC)3 hexamers  ............................................... 166  
Figure III-3 IM-MS of the urease holoenzyme (ureABC)3 ........................................... 166  
Figure III-4 IM-MS of a sample containing all urease accessory components including 
MBP-ureD  .................................................................................................................. 167  
Figure III-5 Fully annotated IM-MS spectrum of the (ureDFG)2 complex and its 
subcomplexes  ............................................................................................................ 167 
 
 xiii 
 
List of Tables 
 
Table I-1 Comparison of Albumins used in the CIU Screen ........................................ 141 
Table I-2 Protein Calibrants used for CCS Calibration ................................................ 141 
Table I-3 Pairwise RMSD matrix for Albumin Homologues Generated by 
CIUSuite_compare  ..................................................................................................... 143 
Table I-4 Pairwise Sequence Identities for Albumin Homologues  .............................. 144 
Table I-5 Pairwise Sequence Similarities for Albumin Homologues  ........................... 144 
Table I-6 Raw numerical output from CIUSuite_Detect  .............................................. 144 
Table I-7 Experimental and Calculated Cross Section Values for Albumin Domains and 
Multidomain Constructs  .............................................................................................. 160 
Table I-8 Measured CCS values for Unfolded Albumin Conformations at 15+  ........... 160 
 xiv 
 
List of Appendices 
 
Appendix I: Supplemental Information for Chapter 3 ................................................... 141 
Appendix II: Supplemental Information for Chapter 4 .................................................. 161 
Appendix III: Supplemental Information for Chapter 5  ................................................ 165 
  
 xv 
 
Abstract 
 
 Methods for rapid interrogation of structure and stability attributes of proteins and 
protein complexes are becoming increasingly important for developing our 
understanding of biology and the development of pharmaceuticals. Gas-phase 
technologies such as mass spectrometry and ion mobility spectrometry have proven 
valuable in these endeavors, as they provide unique perspectives on the solution-phase 
equilibrium of protein complexes and their conformations. Before fully harnessing the 
information derived from these gas-phase techniques, new approaches for data 
analysis and mechanistic understanding of gas-phase protein structure are necessary. 
In this dissertation, we develop ion mobility mass spectrometry methods and informatics 
for the study of gas-phase proteins, multiprotein complexes, and protein-small molecule 
complexes.  
In the first half of the dissertation, novel data analysis tools and experimental 
methodologies are outlined for the study of gas-phase protein unfolding. After providing 
the software tools necessary for robust analysis of gas-phase unfolding trajectories in 
Chapter 2, we turned our attention to understanding the mechanism of unfolding for 
large multidomain proteins. In Chapter 3, we focus on the factors driving changes in 
unfolding trajectories for a variety of serum albumin homologues, and through the use of 
novel unfolding experiments utilizing chemical probes and non-covalent protein 
constructs, a detailed mechanism for solvent-free protein unfolding is provided.  
 xvi 
 
Subsequent chapters in the dissertation focus on the characterization of 
multiprotein complexes, especially through the use of ion mobility-mass spectrometry 
and coarse-grained modeling. In chapter 4, we develop and benchmark new algorithms 
for translating ion mobility and mass spectrometry datasets into coarse grained models. 
These studies outline the limits in current coarse-graining methodologies, and define the 
minimum restraint sets necessary to generate high confidence multiprotein models. 
Additionally, best practices for dealing with ambiguous models resulting from sparse 
datasets are described. In chapter 5, the tools developed in the previous chapter are 
applied to structurally characterize the urease pre-activation complex, a transient 18-
subunit complex that is a target for inhibition of urease-related pathology. When our ion 
mobility-mass spectrometry datasets are combined with previously published chemical 
crosslinking and x-ray scattering data, a discrete population of conformations for the 
urease pre-activation complex emerges which compares favorably to previous models 
generated using computational techniques.  
In Chapter 6, I highlight more applications of ion mobility-mass spectrometry to 
engineered and naturally occurring protein complexes. These applications highlight the 
power of ion mobility mass-mass spectrometry datasets for rapid analysis of protein 
oligomerization state and structure, providing a basis for further integration of the 
technology into pharmaceutical and structural biology workflows. 
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Chapter 1: Introduction 
Elements of this chapter are taken from: 
Eschweiler J.D.; Rabuck-Gibbons, J. N.; Kerr, R.; Ruotolo, B.T.: Sizing Up 
Protein–Ligand Complexes: The Rise of Structural Mass Spectrometry 
Approaches in the Pharmaceutical Sciences, Annu. Rev. Anal. Chem. 10 (2017) 
 
The study of biochemical processes is imperative for continued advances in 
medicine, psychology, human health, food production, and environmental conservation. 
In an era where full genomic datasets are available for many important species, 
including thousands of human genomes,1 it has become clear that the richness of 
biological complexity is not contained solely in nucleic acid sequences, but in the 
downstream chemical  and physical processes that occur when gene products interact 
with each other and with the environment.2-4 These gene products, proteins, are the 
biochemical machinery of life, each having unique structures and propensities for 
interaction with other biomolecules and their environments.5 It has been the goal of 
structural biologists to understand the conformations and functions of proteins for nearly 
100 years,6 and these structural insights have been crucial for the discovery of 
pathological mechanisms and therapeutics. 
Throughout history, most drugs have been small molecules that modulate the 
activity of a protein or protein class.7 Though this remains true today, the fastest 
growing class of FDA-approved drugs are now proteins themselves, specifically 
monoclonal antibodies similar to those produced by the mammalian immune system.8 
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The development of new drugs, of both classical and biologic nature continues to 
hinge on the structural elucidation of proteins.9,10  
Since the first studies of protein tertiary structure by X-ray crystallography in 
1958,11 over 119,785 high-resolution protein structures have been deposited in the 
protein data bank (PDB) to date.12 Despite continued growth in PDB entries every year, 
the number of structures for new protein folds has been stagnant since 2008. This 
stagnation is due in part to physical and practical limitations of “gold standard” structural 
biology techniques for characterizing highly dynamic or unstructured proteins, as well as 
proteins that exist in low quantities in cells or with low solubility.13 The ability to fully 
characterize the structural space of proteins is further complicated by the fact that most 
proteins are involved in dynamic interactions with other proteins,14 nucleic acids,15 or 
small molecules16 that result in heterogeneous populations of protein conformation and 
stoichiometry that complicate analysis. In order to characterize these highly complex 
biological mixtures, it is necessary that we construct technologies that merge cutting-
edge separation science into next-generation structure analysis tools.17 One such 
intersection occurs in the gas-phase, where ion mobility-mass spectrometry (IM-MS) is 
emerging as a robust tool for the simultaneous separation and determination of protein 
stoichiometries and conformations, allowing access to highly-specific structural 
information within complex mixtures.18,19 In this dissertation, we explore the application 
of IM-MS for gas-phase structural biology and drug discovery. 
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1.1 High-resolution Protein Characterization 
Although the 3D structure of a protein is dictated by its amino acid sequence 
under a given set of conditions,20 methods for predicting protein structure from 
sequence information de novo are still unreliable.21 While template-based modeling is 
much more robust,22 these methods are limited to proteins that share well-defined 
structural elements with proteins that have already been experimentally characterized at 
high resolution.23 Thus, direct determination of protein structure by experiment remains 
the predominant approach in most structural biology and drug discovery laboratories. Of 
the experimental techniques for determination of protein structure, X-ray diffraction 
(XRD)24 and nuclear magnetic resonance spectroscopy (NMR)25 remain among the 
highest resolution approaches available currently, and thus make up the majority of 
structures deposited in the PDB. XRD experiments characterize crystals of individual 
proteins,26 multiprotein complexes,27,28 and protein-ligand complexes,29 with resolution 
values often under 3 Å. After over 80 years of development, collecting diffraction data 
and appropriately processing these signals is now often routine; however, our ability to 
generate high-quality crystals for proteins of high mass, disordered structure, low 
solubility or concentration in an expedient fashion is still a limiting factor for such 
approaches.30,31, Moreover, the inability of XRD to capture protein dynamics and deal 
with heterogeneous populations has limited its use for many complex systems.32 
NMR, on the other hand, is well-suited to capturing protein dynamics, often at 
resolutions rivaling that of XRD.33 Additionally, NMR captures proteins in solution rather 
than a crystalline phase, increasing confidence in structural assignments especially 
when studying interactions with other proteins or small molecules.34 Despite these 
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advantages, NMR typically requires large amounts of soluble protein, and has 
limitations associated with protein mass due, in part, to line broadening and the 
increasing number of distance restraints needed to restrain large numbers of atoms.13 
Although many reports have overcome major challenges in NMR analysis,33,35-39 these 
methods often require large amounts of optimization, purified protein, and custom data 
analysis techniques for each system.  
To fill the gap in characterization of large proteins and protein complexes, cryo-
electron microscopy (CEM) has emerged as a powerful tool capable of resolution 
generally around 4.5 Å, with recent examples demonstrating resolution in the 2 Å 
range40-42. Advantages of cryo-EM include its ability to capture snapshots of even the 
largest protein complexes in a variety of dynamic states in solution.43 Despite great 
promise for this technology, reconstructing 3D images from a series of 2D micrographs 
remains challenging, especially when heterogeneous samples make identification of 
particles challenging.44 
Although the requirements of each of these techniques vary, one common theme 
is the need for homogenous samples in order to achieve high resolution analysis. In the 
case of multiprotein or protein-ligand complexes, this requirement is severely limiting, as 
in many cases an equilibrium distribution of structural states and stoichiometry exists 
within a sample.45 Currently, it is not possible to simultaneously characterize all of the 
components in such a complex sample with high-resolution technologies, as it is 
necessary to artificially push the equilibrium toward forming a particular species before 
analysis.46 Moreover, in the context of drug discovery, crystallization or NMR analysis of 
large libraries of drug variants is both expensive and time consuming, making high 
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resolution technology amenable to very few drug leads in any development 
pipeline.47,48  In many cases, however, lower resolution technologies can be utilized to 
answer more targeted questions about protein structure and interactions, and do so on 
much faster timescales than high resolution structural efforts. 
 
1.2 Targeted Methods in Structural Biology 
 Targeted methods are technologies that lack the ability to produce high-
resolution 3D structures of proteins and protein complexes, but have specific 
advantages in speed, sensitivity, or specific information content over high resolution 
methods. Targeted methods are often used in the context of drug discovery or 
integrative structural biology, as will be discussed below.   Discussion of targeted 
methods in structural biology could conceivably cover hundreds of molecular biology, 
biochemistry, and analytical chemistry experiments. For brevity, only the most 
commonly used and integral methods with be highlighted here, with a focus on 
analytical technologies rather than those tools that are primarily genetic or biochemical 
in nature. 
 
1.2.1 Methods for protein structure 
 The first step in studying protein structure is often mass and sequence analysis 
by mass spectrometry.49,50 For intact mass analysis, proteins may be denatured and 
analyzed most commonly by electrospray50 or matrix assisted laser desporption 
ionization (MALDI)51 and  time of flight mass spectrometry instruments. Alternatively, 
proteins may be digested with specific proteases before the resulting peptides are 
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separated and analyzed by liquid chromatography and tandem mass spectrometry to 
recapitulate the protein sequence.52 These techniques, although powerful, do not 
provide information about 3D protein structure. Optical methods are available for 
detecting secondary structure elements within proteins, such as circular dichroism (CD) 
which can monitor the relative amounts of alpha helices, beta sheets, and unstructured 
regions within a protein sample.53,54 Alternatively, small angle x-ray scattering (SAXS) 
profiles provide information on the overall topology of a protein that can aid in structural 
modeling when combined with mass and secondary structure information.55-57 If more 
detailed hypotheses for protein structure are available, the use of engineered Förster 
resonance energy transfer (FRET) tags into the amino acid sequence of a protein 
provide the opportunity for distance measurements to be made between the tags at 
given positions using fluorescence spectroscopy.58,59 
 Akin to this distance-based experiment, chemical crosslinking (CXL) of lysine 
and other residues within a protein is often used to provide information about the 
proximity of certain residues.60,61 These chemical crosslinkers have known length, so 
mass spectrometric analysis of crosslinked peptides may provide information on the 
maximum distance between crosslinked residues. Additionally, new chemical labeling 
strategies such as fast photochemical oxidation of proteins (FPOP)62,63 and hydrogen 
deuterium exchange (HDX)64,65 are emerging as reliable methods for determining the 
solvent accessible residues of proteins.  
  
1.2.2. Methods for Multiprotein Complexes 
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Genome-wide mapping of protein-protein interactions has provided the scientific 
community with detailed maps of modular networks of protein interactions with cells.14,66 
These maps are largely the result of yeast two hybrid experiments that utilize gene 
regulation machinery to report on the presence of given protein-protein interactions. 
Although these maps are crucial for identifying interacting networks of proteins, they do 
not provide information on the stoichometry, composition, or structure of individual 
complexes.67  
 Due to the noncovalent nature of multiprotein complexes, it is not always trivial to 
determine the intact mass, composition or structure of these analytes .13 Classically, 
size exclusion chromatography (SEC) combined with multiangle light scattering68 has 
been used for absolute determination of protein molecular weight and size, however this 
family of techniques only provides rough estimates of assembly mass, maximally 
precise to about 1 kDa. Some methodologies from the previous section have been 
extended to analyze multiprotein complexes, including SAXS,56,57,69 HDX,70-73 and 
FPOP,74 but in all of these cases the presence of heterogeneous populations of protein 
complexes presents significant challenges in data analysis. CXL has proven to be 
particularly useful in mapping the topology of multiprotein complexes. When CXL is 
applied, even highly labile multiprotein complexes become tethered together and can 
survive separations in SEC or denaturing gels.75,76 When this technology is combined 
with analysis of crosslinked peptides by mass spectrometry, CXL provides information 
on the pairwise interactions between crosslinked peptides, providing critical structural 
insights.77,78  
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 In the last 20 years, native mass spectrometry and ion mobility mass 
spectrometry have also emerged as important methods for studying multiprotein 
complexes. The details of these technologies will be discussed in in section 1.3 
 
1.2.3 Methods for Protein-Ligand Complexes 
 As the basis of modern enzymology and much of the pharmaceutical sciences, 
protein-ligand interactions are some of the most well-studied phenomena in 
biochemistry.79 A large portion of the work in these fields revolves around measuring 
interaction strengths between proteins and small molecules, which can range from 
extremely strong nanomolar (nM)-range dissociation constants (kD) to nearly 
undetectable fleeting interactions in the millimolar (mM) kD range.
80 Technologies for the 
measurement of interactions strengths rely largely on optical spectroscopy, the most 
commonly employed being fluorescence anisotropy and surface-plasmon resonance 
techniques.80,81 Although recognized as gold standard approaches for characterization 
of binding strength, these tools provide little to no structural information concerning 
protein-ligand complexes studied. Short of high-resolution 3D structural 
characterization, there are very few technologies capable of routinely localizing ligand 
binding to proteins with multiple or unknown binding sites. In some cases, hypothesis-
driven mutation experiments provide the best evidence for a ligand binding pocket, 
however, these experiments are time consuming and require advanced molecular 
biology techniques.82,83  Chemical labeling strategies coupled to MS, like HDX and 
FPOP, have recently been shown to provide structural insights into protein-ligand 
binding;65,84-86 however these technologies are also relatively time consuming and may 
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not always be sensitive to all ligand binding events. As with multiprotein complexes, 
gas-phase technologies have recently been developed for ligand localization, especially 
those relying on tandem MS technology, which will be discussed in subsequent sections 
in this chapter.  
 
1.3 Ion Mobility - Mass Spectrometry Instrumentation in Structural Biology 
 In the current structural biology landscape, mass spectrometry-based techniques 
have become indispensable for analysis of proteins or protein complexes that are 
refractory to high-resolution techniques. Structural mass spectrometry has evolved from 
its origins in fragmentation and sequencing of digested peptides to new areas that 
include intact mass measurement of noncovalent complexes,87 ion mobility analysis of 
native-like ions,17 and gas-phase calorimetry.88 To understand these new applications, 
an overview of the fundamentals of native mass spectrometry and ion mobility 
spectrometry is necessary.  
 
1.3.1 Ionization and Preservation of Native-like Proteins 
 Since 1989, electrospray ionization (ESI) has been used to ionize large 
biomolecules once thought to be too labile to survive the harsh transition from solution 
to gas-phase.50 This method, in contrast to other techniques that involve the 
bombardment of samples with ions, electrons, or photons, utilizes an electrokinetic 
spray to more gently ionize biomolecules through charged solvent droplets .  The 
droplets generated in this fashion undergo fission and eventual evaporation as they 
cross the potential and pressure gradients on their path into the mass spectrometer.89 
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This process produces a distribution of multiply charged ions that, for large proteins, 
depends largely on the surface area of the protein in the final stages of the electrospray 
process.90,91 Further refinements to the electrospray process involved decreasing flow 
rates and potential gradients to yield increasingly smaller droplets which serve to 
increase overall ionization efficiency. The modern implementation of ESI used for 
structural MS operates at nL/min flow rates and utilizes a conductive capillary with an 
orifice on the order of 1 μm in diameter. This technology, deemed nanoelectrospray 
ionization (nESI) tolerates 100% aqueous buffers having a relatively wide range of ionic 
strengths, allowing for proteins to be electrosprayed from native buffers at room 
temperature.92 In contrast to early ESI measurements of intact proteins made from 
acidified and partially organic 
solutions, nESI from native 
buffer results in a distribution of 
charge states both considerably 
lower and narrower, indicating 
that nESI is capable of 
generating more compact ions 
with memory of their solution-
phase structure.93 
 Much research has been 
conducted into the mechanism 
of electrospray ionization,89 and 
there are currently several 
Figure 1 - 1 Electrospray Ionization. A.) Schematic of the 
electrospray source, including the ESI or nESI emitter on the left, 
and the path of analyte droplets to the MS inlet on the right. B.) 
depicts the evaporation of analyte-containing droplets as they 
travel towards and into the mass spectrometer described in the 
Charged Residue Mechanism of ESI.   
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theories available to explain various electrospray phenomenon. Notably, the charge-
residue model (CRM) explains most of the ionization behavior of proteins in nESI, 
accounting for charge state distributions and IM-derived collision cross sections (CCSs), 
as well as other phenomena such as charge reduction and amplification.94-97 (Figure 1-
1) It has been well established that evaporation of solvent molecules in ESI droplets 
produces droplet fission governed by the Rayleigh limit for charge density.98,99 The CRM 
states that a droplet containing a macromolecule, after undergoing Rayleigh fission may 
continue evaporation to completion, leaving a “naked” macromolecular ion solvated only 
by residual, unevaporated charged particles, where the net charge generally 
approaches 90% of the Rayleigh limit. As a result of CRM-like behavior, the transition 
from solution to gas-phase is often slow and gentle enough to preserve noncovalent 
interactions in the gas phase.100,101 Once in the gas-phase, noncovalent protein 
interactions can be maintained at least on the millisecond timescale if they are not 
activated by collisions with neutral gas or other ions.102 Other models, such as the ion 
evaporation  and the chain ejection models, account for the ionization of small 
molecules and highly unstructured proteins, respectively.103-105 
 
1.3.2 Selection, Mass analysis, and Detection of Protein Ions 
To date, the majority of structural MS research has utilized TOF mass analyzers. 
The TOF mass analyzer measures the mass to charge ratio (m/z) of an ion by 
measuring the flight time of the ion pulsed with a given amount of kinetic energy through 
a fixed distance to a detector, usually either a multichannel plate or a collision 
dynode.106 Reflectron TOFs, the state of the art  TOF technology, utilize a V shaped 
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flight path with a reflectron at the vertex for two reasons: the use of the reflector corrects 
for differences in the initial kinetic energy of ions, and the V shape effectively doubles 
the flight path for an ion; both factors contribute to significant increases in resolution.107 
Commercial TOF analyzers now routinely offer mass resolution values > 40,000, which 
allows for isotopic resolution of small proteins.108 Compared with dedicated high 
resolution mass analyzers such as Fourier transform ion cyclotron resonance (FT-ICR) 
and Orbitraps, which routinely achieve resolutions greater than 130,000, TOF analyzers 
are extremely fast, able to complete scan in 50 us, at least 10 fold faster than higher 
resolution instruments.109 This increase in scan time allows for greater signal 
accumulation and averaging, and higher duty cycle considering the continuous stream 
of ions generated using ESI methods.  
 Another mass analyzer commonly utilized in structural MS experiments is the 
quadrupole.110 Although quadrupoles can function as stand-alone mass analyzers, they 
are generally employed in conjunction with TOF analysis (Q-TOF) in structural MS due 
to their ability to act as an m/z filter.111 Quadrupoles are comprised of 4 conductive rods, 
of which opposing rods are electrically paired and direct (DC) and alternating current 
(AC) is applied. Specific combinations of DC and AC currents applied to each pair of 
rods act as high and low m/z filters for ions, as higher m/z ions are less sensitive to high 
radio frequency (RF) fields than low m/z ions. By setting the quadrupole to a specific set 
of DC and AC amplitudes, the quadrupole will act as a filter, usually with unit m/z 
resolution. In other cases, the quadrupole can act as a low mass filter, high mass filter, 
or allow all ions to pass through in an RF-only mode. Notably, for transmission and 
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selection of high m/z ions in such devices it is necessary to utilize low-frequency RF 
generators.112  
 
1.3.3 Ion Activation and Tandem Mass Spectrometry 
 Despite the high accuracy 
and resolution of common mass 
analyzers, it is often necessary to 
perform tandem mass 
spectrometry experiments to 
confirm the identity of an 
unknown signal. This is 
especially true in the case of 
intact proteins analyzed by 
Native MS, where peak 
broadening can result from the 
combination of large isotopic clusters and heterogeneous water, buffer, or salt 
adducts.113,114 Tandem mass spectrometry utilizes two mass analyzers and some mode 
of ion activation to dissociate an ion selected by the first analyzer into several 
components that can be analyzed by the second analyzer. In most structural MS 
applications, the configuration of choice is the Q-TOF with a collision-induced 
dissociation (CID) cell located between the two mass analyzers.112 In CID, ions are 
accelerated from vacuum into a cell pressurized to around 10-2 mbar of neutral gas, 
resulting in ion-neutral collisions which increase the internal energy of the ion.115 The 
Figure 1 - 2 Collision-induced Unfolding and Dissociation of 
Charged Polypeptides. The fate of polypeptides at different 
size regimes under different amounts of collisional activation is 
depicted. Peptides easily fragment into smaller B and Y ions, 
proteins undergo unfolding to extended structures before 
fragmentation. In the case of multiprotein complexes, unfolding 
and dissociation of a subunit is the predominant mechanism, 
while further activation of unfolded subunits leads to 
fragmentation as is described above.   
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fate of peptides, proteins, and protein complexes in CID is depicted in Figure 1-2. At low 
collision energies, protein ions usually undergo unfolding to realize a series of 
intermediate structures prior to complete unfolding,116 but may in some cases compact 
upon collisional heating.117 If significant energy is imparted to an ion, covalent 
fragmentation or noncovalent dissociation may occur resulting in ejection of protein 
subunits, small molecule binders, or fragmented peptides.115,116 Typical CID behavior for 
protein complexes involves unfolding and dissociation of a disproportionately charged 
monomeric subunit, leaving behind a charge-reduced protein complex which may 
undergo structural compaction.118,119 This asymmetric charge partitioning phenomena 
has puzzled the field for many years, however recent molecular dynamics studies have 
provided mechanistic details for CID of protein complexes that are broadly in line with 
experimental evidence.120  
CID of protein-small molecule complexes, on the other hand, proceeds by a more 
intuitive mechanism that involves ejection of singly-charged or neutral small molecules 
concomitant with local unfolding of the binding site.121,122 In the case of peptide bond 
fragmentation at high CID energies, collision energy is distributed roughly evenly 
through the polypeptide chain, resulting in preferential fragmentation of the weakest 
peptide bonds giving rise to b and y ions with amine and carboxy termini resembling a 
new polypeptide.49 
 Other fragmentation techniques can also be utilized for interrogating proteins or 
protein complexes in the gas-phase. Surface-induced Dissociation (SID) is a thermal 
activation technique akin to CID, however it utilizes a single collision against a surface 
to impart energy on the ion rather than multiple collisions with gas molecules.123 The 
 15 
 
result of this change is that energy transfer occurs much faster, and thus can 
sometimes result in more symmetric charge partitioning between precursor and product 
ions, as well as a variety of other fragment ions not typically found in CID. Infrared 
multiphoton dissociation (IRMPD)124 and blackbody infrared dissociation (BIRD)125 are 
other thermal techniques which use IR radiation to directly heat the analyte ion, 
removing the need for collisions. Energy can also be imparted directly to ions through 
electron transfer using techniques like electron transfer dissociation (ETD)126 and 
electron capture dissociation (ECD),127 as well as some forms of ultraviolet 
photodissociation (UVPD).128 Many of these technoloigies are capable of fragmenting 
peptide bonds without necessarily perturbing the global structure of the protein or 
protein complex ion undergoing activation. These methods, still under investigation for 
their utility in analysis of protein complexes, may provide unique capabilities in terms of 
identifying flexible regions, interfaces, and ligand binding sites in difficult to analyze 
protein systems.129  
 
1.3.4 Ion Mobility Spectrometry 
 Ion mobility spectrometry (IMS) is an integral tool for gas-phase structural 
biology.17 In nearly all modern implementations IMS is combined with mass 
spectrometry equipment to form a hybrid instrument, an ion mobility-mass spectrometer 
(IM-MS).130 IMS separates ions based on their propensity to collide and interact with 
neutral gas molecules at a given temperature and pressure.131 In most cases, a weak 
electric field is used to force ions through a pressurized drift cell, and the drift time over 
the fixed distance of the cell is measured and related back to the CCS of the ion.132 In 
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this type of experiment, ion CCS is an orientationally averaged size parameter which 
describes the probability of ion interactions with the buffer gas: Ions with larger CCS will 
have more interactions with buffer gas, and will therefore have longer drift times 
compared to an ion of identical charge but lower CCS. Many IMS devices have been 
developed over the years which can routinely be operated with low enough field 
strengths to avoid activation and disruption of protein structure.133 For brevity, the 
sections below focus on two commonly-used IMS devices in gas-phase structural 
biology research: Drift tubes and traveling wave separators.  
 Drift tube IMS (DTIMS) devices represent the modern incarnation of the earliest 
reported form of ion mobility separation .132 For protein analysis, these devices can 
range from centimeters to meters in length and in general utilize a stacked-ring 
electrode geometry to establish a uniform potential gradient across the drift length. For 
continuous ion sources,  an ion trap is necessary prior to the DTIMS device in order to 
accumulate ions into packets that can be released into the cell at a given start time. 
Most IMS measurements of protein ions using any device are performed in Helium, 
Nitrogen, or a mixture of the two gases using pressures that range from 1-4 mBar.133 
Early DTIMS devices operated without any RF focusing of ions across the drift tube, 
however some implementations have successfully utilized RF focusing to increase 
transmission efficiency in these devices without increasing the temperature of the ions 
substantially.134-136 Because the physical principles surrounding of ion transport in gases 
are well understood,131 the drift time of an ion in DTIMS under given conditions can be 
used to directly calculate an ions CCS. Importantly, IMS separations for proteins occur 
on the millisecond timescale, meaning that the ions exiting the drift cell can be easily 
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sampled by a TOF mass analyzer, which can operate at approximately 200 times the 
frequency of the IMS separation.137 
 Despite simplicity of the DTIMS device, the first IMS device to be commercialized 
and hence the most widely currently used, is the traveling-wave IMS (TWIMS) 
implemented in the Synapt and Vion IM-MS platforms from Waters Corporation.130,138 
Like the DTIMS, the TWIMS device utilizes a stacked-ring electrode geometry to guide 
ions through the mobility cell, however in this case a non-uniform, dynamic field is 
applied. To create this field, a DC voltage is applied to a combination of electrodes to 
create a waveform, which is then propagated through the device as the DC voltage is 
moved to adjacent electrodes at a given velocity. Since the mechanism of separation in 
this device depends on the ability of an ion to be propelled forward by a wave rather 
than be passed by the wave due to drag by the buffer gas, tuning of TWIMS wave 
amplitude and wave velocity allows for optimization of IMS separations for a variety of 
different systems. Although TWIMS is a versatile separation device, the use of a 
nonuniform field makes direct calculation of the CCS challenging, and therefore 
calibration of ion drift times based on drift tube datasets is necessary for extraction of 
CCS values.136,139,140  
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Figure 1 - 3 Schematic of the Synapt G-2 Ion Mobility-Mass Spectrometry Platform. A.) Ions are 
generated using nESI and can be mass-selected by the high m/z quadrupole for subsequent 
experiments. B.) In the Tri-wave region of the instrument, the first cell is operated as a trap 
where CIU or CID can be used to interrogate the ions. This trap also functions as a gate for the 
ion mobility separation. The TWIMS cell is operated at much higher pressure, and the transfer 
of ions to 4mBar nitrogen is facilitated by the helium cell. After IM separation is preformed, the 
pressure is rapidly dropped in the transfer cell before ions are released into the TOF mass 
analyzer for high resolution mass analysis.   
 Currently, variations of the Synapt HDMS (Waters Corp.) are by far the most 
commonly used instruments for studying the structure of proteins and protein 
complexes in the gas-phase. The Synapt platform features a nESI-Q-TWIMS-TOF 
configuration with two CID cells located before and after the TWIMS.138,141 (Figure 1-3) 
Variants of this instrument include replacement of the TWIMS with drift tube IMS,135 or 
replacement of one or more CID cells with SID,142 ETD,143 or UVPD.144  Other IMS 
instruments have recently come to market, however these instruments have yet to find 
unique applications in protein structural studies.145,146 
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1.4 Ion Mobility - Mass Spectrometry Methodology in Structural Biology and Drug 
Discovery 
 Since the first proteins were observed in the gas-phase, the question of whether 
any elements of solution-phase structure could be maintained within the vacuum of a 
mass spectrometer has been investigated using a variety of techniques.101 The first 
evidence for conservation of solution-phase structural elements was presented by 
Chowdhury in 1990,147 when it was shown that the charge-state distribution of 
cytochrome C from various pH solutions correlated with known pH-dependent structural 
changes. Subsequent reports noted similar correlations between charge state 
distributions and structures perturbed by addition or organic solvent,148 and reduction of 
disulfide bonds.149 Since this early work, the field of protein structural studies using MS 
and IMS methods has matured substantially. Large surveys of CCS measurements by 
IMS have revealed strong agreement between experimental CCS measurements and 
CCS values calculated for solutions structures by highly accurate computational 
methods.150 Further support for conservation of protein structure in the gas-phase has 
come from gas-phase HDX,151 and a variety of nonergodic tandem MS 
experiments.128,143,152,153  
 
1.4.1 IM-MS Methods for Multiprotein Complex Structure 
The field of multiprotein complex studies by IM-MS is perhaps the most 
successful, as IM-MS offers unique advantages over other technologies. Early 
observations of multiprotein complexes in the gas-phase lead to a flurry of studies 
interrogating the stoichiometry of homomeric154-156 and heteromeric complexes.157-160. In 
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1999, Rostom detected intact 800 kDa tetradecameric groEL,154 and in the next 5 years 
methods for detection of other massive particles including ribosomes,161 
proteasomes,162 and virus particles has been developed.163 It wasn’t until 2005, 
however, the first rigorous structural analysis of multiprotein complex structure in the 
gas-phase using IM-MS, showing that the 
ring structure of trp RNA binding 
attenuation protein could be maintained in 
the gas-phase.117 This study was impactful 
not only for the observation of native-like 
topologies, but for the new take on coarse-
grained molecular modeling that allowed 
the authors to visualize collapsed 
structures resulting from collision activation. 
By 2008, robust protocols for CCS analysis 
of multiprotein complexes had emerged,140 
and CCS analysis could be used to 
determine the topologies of homomeric 
complexes using relatively simple 
informatics.164 More recent studies 
targeting large heteromeric complexes 
highlight the strengths and challenges of 
defining protein connectivity and topology 
by IM-MS.165,166 Although IM-MS is capable 
Figure 1 - 4 Information Content of IM-MS 
Experiments. A.) The information content of the IM-
MS experiment can be greatly increased by the 
generation of subcomplexes in solution. B.) 
Simultaneous analysis of subcomplex mass and 
CCS allows for identification of complex connectivity 
and geometry. Moreover, the 3D plot of IM Drift time 
vs Mass to charge allows for facile deconvolution of 
the mass spectra.  
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of identifying the composition of subcomplexes resulting from intact protein species, 
tandem MS using CID is limited to generation of only minimal numbers of subcomplexes 
and is generally not informative enough for detailed connectivity assignment.116 Thus, it 
is often necessary to use complementary tandem MS methods or solution-phase 
disruption with chaotropic agents to generate enough subcomplexes to build a useful 
model of the complex;167 (Figure 1-4) New methods for generation of subcomplexes in 
the gas123,168 and solution phase169,170 are currently under development by several 
groups.  
In addition to experimental challenges, informatics approaches for modeling 
heteromeric complexes from IM-MS data sets are currently underexplored. Clearly, for 
complexes with masses over 100 kDa, all-atom modeling is not an option due to the 
computing power necessary to dynamically restrain many thousands of atoms. Various 
coarse-graining approaches have been utilized with some success, however the utility 
and accuracy of highly coarse-grained models is still of some debate. One popular 
approach for coarse-graining large multiprotein complexes is the representation of each 
protein subunit as a sphere with CCS corresponding to an experimental or calculated 
measurement. For trimeric complexes, the CCS information necessary for restraining 
the topology in this case is well-defined, however for larger subunit numbers the amount 
of experimental CCS measurements for sub complexes needed to fully restrain a model 
increases linearly.165 Hall explored this problem in 2012 and had success restraining 
tetrameric complexes using biophysical and limited CCS datasets, however the sample 
of protein complex space studied was small.171 
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Figure 1 - 5 Integrative Structural Biology. Many challenging structural targets are refractory to 
high-resolution characterization by a single technique. Integrative structural biology seeks to 
incorporate information from multiple experimental datasets into a single model. These datasets 
are integrated by way of spatial restraints in a computational platform that analyzes structures 
consistent with all of the experimental data. The resolution of the output structures depends on the 
information input into the model, where new information can be added to resolve specific 
ambiguities. 
Although the ability of IM-MS to accurately measure protein complex mass, 
composition, stoichiometry, and CCS have provided invaluable insight to the structural 
biology of several complexes, it is clear that IM-MS is not a stand-alone tool for those 
seeking atomic-level insights into multiprotein complexes. Instead, IM-MS is viewed as 
an emerging tool for integrative structural biology.87 Integrative structural biology was 
popularized by Alber’s comprehensive structure of the 456-subunit, 50 MDa nuclear 
pore complex in 2008,172,173 despite the foundations for this platform being developed 
much earlier.13,174 In essence, the integrative approach integrates data from multiple 
experimental types into a single model by way of a scoring function. The only limitation 
on data integration is spatial representation as a restraint on individual or groups of 
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particles within the model. This field has moved forward substantially in recent years 
thanks to integrative modeling software,175,176 and the work of experimentalists to define 
what specific data types mean in the context of an integrative model. In Alber’s model of 
the nuclear pore complex, datasets from ultracentrifugation, quantitative 
immunoblotting, affinity purification, overlay assays, electron microscopy, membrane 
fractionation and bioinformatics were integrated. These diverse datasets were used to 
restrain the shapes and sizes of each protein subunit, pairwise or subcomplex 
connectivities, membrane contacts, and overall shape of the complex. These 
restraintswere encoded into a complex scoring function that was optimized 200,000 
times to generate an ensemble of 1000 structures satisfying the experimental data. The 
ensemble was then analyzed for commonalities and ambiguities that form the bases for 
new hypotheses and experiments. 
 Alber’s integrative modeling work provides a workflow for structural biologists 
seeking to understand complex multiprotein systems: 1) gather experimental data 2) 
express data as spatial restraints in a scoring function 3) optimize the scoring function 
to sample all possible structures and 4) Analyze the ensemble of possible structures to 
form new hypotheses and repeat the process. Within this context, MS methodologies 
including IM-MS are emerging as powerful tools for assignment of size, shape, and 
connectivity information for various units within large complexes.165,177,178 (Figure 1-5) 
Several reports have integrated IM-MS datasets as restraints on the connectivity and 
size of protein complexes alongside chemical crosslinking,179-182 oxidative labeling,183  
and electron microscopy184,185 datasets. Although all of these studies are foundational to 
our ability to use IM-MS data in conjunction with other data types, the current literature 
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falls short when assessing the error introduced into integrative models from the coarse-
graining procedures and ambiguity in the structures refined by experimental CCS.  
1.4.2 IM-MS Methods for Drug Discovery and Development 
MS has proven a powerful tool for screening and measuring Protein:Ligand (P:L) 
interactions, including the capability to measure binding affinities, in addition to 
elucidating many of the structural details of such complexes. Coupled to IM, MS 
methods gain an enhanced structural dimension that can be leveraged to detect shifts in 
protein conformation and changes in protein complex stability upon ligand binding. In 
the early 1990s, the first reports of noncovalent complexes emerged.186-188 Notably, the 
first experiments observing FK506 binding protein bound to FK506 and rapamycin also 
implemented control experiments with decoy ligands or denatured protein to rule out the 
possibility of nonspecific adduction, setting the stage for rigorous examination of 
protein-ligand binding constants. Since these early reports, the field of studying protein-
ligand interactions with mass spectrometry has matured largely through the efforts of 
John Klassen and Renato Zenobi, who have developed robust methods for kD 
measurement using ESI189-194 and MALDI MS,195,196 and provided methods for high 
throughput identification of small molecule binders from compound libraries from difficult 
classes including carbohydrates and glycolipids.197-199 Additionally, tandem MS 
technologies have evolved for rapid identification of small molecule binders,200,201 
measurement of gas-phase dissociation constants,121,202,203 and even localization of 
binding sites.127,153,204  
A suite of IMS-based tools also exist for examining protein-ligand binding 
properties. Notably, the ion mobility shift assay has been successfully used to detect 
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conformational shifts as a result of ligand binding, which may be correlated with 
biologically relevant solution-phase processes.205-207 
 
Figure 1 - 6. Collision-induced Unfolding Analysis of Protein-Ligand Complexes. A) apo-protein ions are 
selected and activated to produce unfolded ions (B). Measurement of ion CCS (size) as a function of 
Collision voltage results in a unique unfolding fingerprint for the ion (C). Unfolding fingerprints can be 
compared with those from proteins bound to ligands (D-F) resulting in a difference plot that represents 
changes in stability induced by the ligand (G).  
In many cases, conformational shifts resulting from ligand binding may be too small to 
resolve via CCS measurement alone, even with high resolution IMS instruments. For 
these cases, collision induced unfolding (CIU) technologies are being developed by 
multiple laboratories, which are highly sensitive to subtle conformational shifts 
unobservable by traditional IMS.208 (Figure 1-6) Despite success in extracting useful 
empirical information from these experiments, the physics involved in gas-phase protein 
unfolding, ligand stabilization, and ejection during these processes are largely unknown. 
In order for the field to move toward high-throughput drug discovery applications of CIU, 
our understanding of the fundamental processes in gas-phase activation needs to be 
improved.  
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1.5 Summary of the Dissertation 
This dissertation represents my work in the areas of gas-phase structural biology 
and drug discovery. The 2nd and 3rd chapters focus on collision induced unfolding 
technology for protein structure and drug discovery applications. In chapter 2, I discuss 
my contributions to an informatics platform for analysis of CIU of proteins. This work has 
been previously published as Eschweiler J.D.; Rabuck-Gibbons, J. N.; Tian, Y.;Ruotolo, 
B.T. CIUSuite: A Quantitative Analysis Package for Collision Induced Unfolding 
Measurements of Gas-Phase Protein Ions., Anal. Chem., 2015, 87 (22), pp 11516–11522 
In chapter 3, I presentmechanistic studies of CIU using a series of albumins as a model 
system. In this chapter, I also discuss future applications of CIU technology in drug 
discovery. This work has been previously published as Eschweiler J.D.; Martini, R.M.; 
Ruotolo, B.T. Chemical Probes and Engineered Constructs Reveal a Detailed Unfolding 
Mechanism for a Solvent-Free Multidomain Protein. J. Am. Chem. Soc., 2017, 139 (1), pp 
534–540. 
The 4th and 5th and 6th chapters focus on my work developing IM-MS and 
informatics methods for building structures of multiprotein complexes. In Chapter 4, I 
present data relating to the information content of IM-MS datasets in modeling 
multiprotein complexes, and outlines best practices for reporting ambiguities in 
modeling results. This paper is under review as Coming to Grips with Ambiguity: Ion 
Mobility-Mass Spectrometry for Protein Quaternary Structure Assignment. In 
Chapter 5, I use IM-MS and the informatics tools outlined in chapter 4 to characterize 
the structure of the urease activation complex, a 610 kDa octadecamer. This manuscript 
is awaiting submission. In Chapter 6, I highlight my contributions to several studies 
focused on structural determination of protein complexes. Stoichiometry assessment of 
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engineered multiprotein complexes in collaboration with the Neil Marsh group, including 
results from Flexible, symmetry-directed approach to assembling protein cages209 
and Evaluation of de novo-designed coiled coils as off-the-shelf components for 
protein assembly210. I also present further application of IM-MS based modeling to the 
ApoE Tetramer, for which I present the first structural model of this species. 
 To conclude, I provide a comprehensive list of my published work for the 
interested reader, which includes as its first entry a recent review article.  
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2.1 Abstract 
Ion mobility-mass spectrometry (IM-MS) is a technology of growing importance 
for structural biology, providing complementary 3D structure information for 
biomolecules within samples that are difficult to analyze using conventional analytical 
tools through the near-simultaneous acquisition of ion collision cross sections (CCSs) 
and masses. Despite recent advances in IM-MS instrumentation, the resolution of 
closely related protein conformations remains challenging. Collision induced unfolding 
(CIU) has been demonstrated as a useful tool for resolving isocrossectional protein 
ions, as they often follow distinct unfolding pathways when subjected to collisional 
heating in the gas phase. CIU has been used for a variety of applications, from 
differentiating binding modes of activation state-selective kinase inhibitors to 
characterizing the domain structure of multidomain proteins. With the growing utilization 
of CIU as a tool for structural biology, significant challenges have emerged in data 
analysis and interpretation, specifically the normalization and comparison of CIU data 
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sets. Here, we present CIUSuite, a suite of software modules designed for the 
rapid processing, analysis, comparison, and classification of CIU data. We demonstrate 
these tools as part of a series of workflows for applications in comparative structural 
biology, biotherapeutic analysis, and high throughput screening of kinase inhibitors. 
These examples illustrate both the potential for CIU in general protein analysis as well 
as a demonstration of best practices in the interpretation of CIU data. 
2.2 Introduction 
Native mass spectrometry (MS) is now a widespread technique in the structural 
biology community due to its ability to study the stoichiometry and connectivity of 
heterogeneous biomolecules while having lesser requirements on concentration and 
purity of such samples than other common techniques.1,2 Coupling native MS with ion 
mobility spectrometry (IM-MS) allows for simultaneous interrogation of the mass, 
charge, and size of biological macromolecules, which has proven invaluable in the 
structural analysis of complex biological systems.3 Recently, IM-MS has been 
successfully utilized to solve the structures of important macromolecular complexes,4-7 
probe structural changes upon ligand binding,8,9 examine the polydispersity of protein 
complexes,10,11 and study the effects of small molecules on amyloid formation in 
disease models.12-14  
 A key feature of IM-MS for structural and pharmaceutical applications is the 
ability to measure the orientationally averaged collision cross section (CCS) of an ion in 
addition to its mass and charge.  The CCS is a coarse-grained size parameter that is 
limited in information content when viewed alone, but can become information rich when 
measured as a function of stoichiometry,15 ligand binding,16 or ion activation.2,17 
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Additionally, the experimental CCS is an extremely important scoring metric for 
modeling complex systems, as it can be compared to CCSs calculated from other 
known or inferred structures.18   
 A long-term challenge for IM-MS has been the resolution of closely-related 
protein conformations, commonly observed by X-ray and NMR analyses. Despite recent 
enhancements to IM resolving power, IMS still faces significant challenges when 
attempting separating protein conformations that differ by less than 2% in CCS. The 
information content of an IM-MS experiment can be greatly enriched by the addition of 
gas-phase ion activation, as some structural differences in protein structure are too 
subtle to be detected by classical IM separations. Early experiments that utilized gas-
phase protein unfolding to both study and differentiate protein structures focused on 
small, single domain proteins and detected stability difference for proteins as a function 
of charge state, and for those with intact disulfide bonds.19 Subsequent experiments 
extended these observations to the ligand-bound forms of wild-type (WT) and disease-
associated variants of tetrameric transthyretin (TTR).2 In this study, a 3D contour plot of 
ion intensity as a function of activation voltage and drift time, termed a collision induced 
unfolding (CIU) fingerprint, was used to perform an in-depth analysis of subtle 
differences in the unfolding and dissociation pathways of TTR variants, identifying 
additional ligand-based protein stabilization in mutant TTR forms not detectable by IM-
MS alone.  
 Since these earlier experiments, CIU fingerprints have been used in the context 
of various applications. These efforts include: studying the influence of bound anions 
and cations on gas-phase protein stability,20,21  distinguishing between inhibitors that 
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stabilize either the active or the inactive form of the Abelson protein tyrosine kinase 
(Abl),22 measuring stability enhancements and cooperativity effects in proteins upon 
ligand-binding,17,23  probing the selectivity of lipid binding in membrane proteins,24 
determining the domain structures for 16 proteins with varying molecular weights and 
domain structures,25 and differentiating between disulfide binding isoforms in 
antibodies.26 
 Despite these varied and potentially impactful applications, CIU has not reached 
its full potential as a tool for structural biology and drug discovery.  Key challenges for 
the technique include the general underutilization of structural information content of 
CIU data, as well as a lack of high throughput experimental frameworks and data 
analysis tools.  Recent advances have been made in analysis and interpretation of other 
IM-MS data types, including deconvolution algorithms,26,27 and an array of methods for 
prediction of CCSs from experimental or model structures,28-30, but thus far CIU data 
has not been the focus of any such data analysis packages. 
 In order to move forward in the use of CIU as a tool for general structural biology, 
as well as for high-throughput pharmaceutical applications specifically, data analysis 
tools and strategies for handling the large amount of data that is produced by CIU 
fingerprints must be developed and implemented. In this report, we describe such 
software tools, collectively named CIUSuite, designed to ameliorate many of the 
challenges described above. Additionally, through detailed discussions of three diverse 
applications of the CIU technique, we illustrate workflows and best practices for 
extracting maximal information content from CIU data.  
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2.3 CIUSuite Overview 
 To facilitate interpretation of 
CIU data for a variety of applications, 
we designed CIUSuite, a series of 
Python31 modules for generation and 
manipulation of CIU fingerprints. 
CIUSuite consists of six modules that 
allow the user to readily access 
statistical and structural information 
from CIU experiments by designing 
user-defined CIUSuite workflows. 
The main data structure in CIUSuite 
is the three dimensional size, 
activation energy, and intensity 
matrix that forms the CIU fingerprint. 
The size axis is IM-MS drift time (ms) 
by default, however the user is able 
to substitute CCS values when available. The activation energy axis can be expressed 
in volts, laboratory–frame energy, or center-of-mass frame energy. In an attempt to 
obviate potential problems arising from signal intensity variation between samples, the 
intensities for each activation energy are normalized to a maximum value of 1 and 
smoothed using a Savitsky-Golay filter with a window length of three and polynomial 
order of two, however these parameters can also be easily adjusted by the user.  
Figure 2-1 Schematic representation of CIUSuite 
modules. All modules (shown as white boxes) take 
as input raw data in the form of a 2D matrix (purple) 
formatted such that ion intensity is collected a 
function of drift time and trap collision voltage. 
Additionally, modules can accept outputs from 
CIU_stats for groupwise comparisons using average 
and standard deviation measurements. Example 
outputs from each of these modules are also shown 
(blue). Both the modules and their outputs are 
discussed in detail in the text. 
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CIUSuite_plot forms the basis of the CIUSuite. CIUSuite_plot batch processes any CIU 
data in its working directory tagged with the suffix “_raw.csv” and writes the 
corresponding contour plot to a .png file. 
CIUSuite_stats outputs both visual information that can be interpreted by the user and 
numerical matrices that can be used for downstream analysis. The current 
implementation of CIU_stats calculates the average and standard deviation of all of the 
CIU data in a directory with the “_raw.csv” tag. This calculation is performed for every 
data point in the CIU fingerprint, and both the average and standard deviation matrices 
are output as a .csv matrix as well as a .png figure in the same fashion as CIU_plot. 
This module requires at least 3 datasets to calculate the standard deviation fingerprint  
CIUSuite_compare allows for facile comparison of CIU fingerprints by matrix 
subtraction and visualization of the difference matrix. Inputs for CIUSuite_compare can 
be raw data matrices or the average matrices output from CIUSuite_stats. 
CIUSuite_compare also utilizes the root mean square deviation (RMSD) parameter to 
report the absolute  .  
 difference between two matrices and prints the RMSD on the difference plot. Here, 
RMSD is defined in Equation 1 as:  
𝑅𝑀𝑆𝐷 = √
∑(𝐴−𝐵)2
𝑚×𝑛
  × 100%  (1) 
where A and B are both m x n CIU matrices. The module operates in three modes: 
Basic Mode: Outputs the difference plot and RSMD for two user defined inputs. 
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Batch Mode: Outputs the difference plot and RMSD for a reference dataset compared 
to all other _raw.csv files in the directory. Here, RMSDs are also saved to a .csv file for 
future reference.  
Cluster Mode: Calculates pairwise RMSDs for all _raw.csv files in the directory and 
utilizes K-medoids clustering to form a user-defined number of clusters. Cluster mode 
outputs a .csv file with the optimal clustering, where each file is assigned a cluster 
number corresponding to the file that is the medoid of the cluster. Additionally, the 
pairwise RMSD matrix (distance matrix) is output as a .csv if the user desires to utilize 
other clustering algorithms.  
CIUSuite_detect is a simple feature detection algorithm that allows for quantitative 
analysis of CIU data. The algorithm utilizes the first derivative test to identify local 
maxima in the data, before refining the shape of the feature using user-defined data 
scaling and intensity thresholds. After features are identified and refined, their stabilities 
in collision voltage space as well as their centroid drift times (or CCSs) are output to a 
file summarizing the dataset. CIUSuite_detect works in a batch processing mode that 
allows for detailed quantitative comparisons of CIU datasets beyond the absolute 
difference output from CIUSuite_compare. Because CIUSuite_detect may require 
tuning of data scaling and intensity thresholding parameters, we also output 
reconstructed CIU fingerprint plots showing only the features used in the analysis.  
CIUSuite_analysis was developed as a tool for adaptation of CIU fingerprinting for high 
throughput ligand screening and structural biology. CIU_analysis allows the user to 
identify areas within the CIU fingerprint that are useful for categorizing datasets into 
groups, such as type I or type II kinase inhibitors (vide infra).  The current 
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implementation of CIU_analysis takes as input a training dataset, where each file is 
annotated as either a type I (_typeI_raw.csv) or type II (_typeII_raw.csv) fingerprint. 
CIU_analysis utilizes a scaled deviation score where each fingerprint in the dataset is 
compared to the average fingerprints for both the type I and type II groups. Here, the 
type I scaled deviation score (SDS) is defined in Equation 2: 
𝑆𝐷𝑆𝑖 = ∑
(𝑋𝑖𝑗−𝐴𝑖𝑗
1 )×𝐴𝑖𝑗
1
𝑆𝑖𝑗
1
𝑗=𝑚
𝑗=0                   (2) 
Where X is a CIU matrix, A1 is the average type I matrix, S1 is the type I standard 
deviation matrix, i is a given collision energy, j a given drift time, and m is the total 
number of drift time bins.  The primary outputs are two plots of SDS vs Collision 
Voltage, one corresponding to the type I average SDS value, the other corresponding to 
the type II average SDS value. These plots display the average SDS value (with 2 
standard deviations as the error bars) for both type I and type II fingerprints compared 
to the corresponding average value. The information contained in these two plots is 
extremely valuable for the accurate classification of unknown fingerprints as well as 
targeting CIU workflows toward optimal regions of dissimilarity between the two data 
classes, increasing the throughput of the experiment. CIUSuite_analysis also outputs a 
plot of SDS vs Collision Voltage for each component of the training dataset, allowing the 
user to identify outliers or other anomalies that may bias the analysis.  
CIUSuite_score is predicated on data from CIUSuite_analysis. CIUSuite_score accepts 
as input a training data set and “unknown” data that is tagged with “_uk_raw.csv.” 
Previous analyses of CIU fingerprint data22  have shown that focusing on specific 
collision voltages, rather than using the entire CIU fingerprint, can increase the 
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throughput and robustness of the resulting screen. After identifying the voltage ranges 
or drift times in the CIU fingerprints that yield significant group-wise deviation values 
using CIUSuite_analysis, the user can enter these values into the scoring module to 
calculate classification scores based only on these regions. Each training data set is 
grouped according to a user-defined tag, and corresponding SDS values are calculated. 
SDS values are then summed over all of the collision energies to be scored, assigning a 
single scaled deviation value for each fingerprint. For example, type I fingerprints should 
have low overall deviation relative to the type I average, whereas they should have 
higher deviation scores relative to the type II average. The type I z-score with respect to 
the type I training data for an unknown fingerprint is simply the z-score of its SDS 
compared to the average SDS for a type I compared to the type I average, as described 
in Equation 3: 
𝑧 𝑠𝑐𝑜𝑟𝑒1 =
𝑆𝐷𝑆1−?̅?  1 
𝑠1
   (3) 
Where SDS1 is the SDS of the unknown compared to the type I average, ?̅?  1 is the 
average SDS of a type I compared to the type I average, and s1 is the standard 
deviation of SDS values around ?̅? 1.The output for CIUSuite_score comprises of a .csv 
file that contains the type I and type II z-scores for each dataset and a graph showing 
the type II classification-score vs type I classification-score. The resulting plot displays 
type I training data in blue, type II training data in red, and unknown scores in cyan. A 
blue and red box around the data sets indicates two standard deviations from the type I 
and type II training data, respectively.  
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2.4 CIUSuite Applications 
Assessing the reproducibility of CIU for intact antibody analysis 
Monoclonal antibodies (mAbs) are among the fastest growing class of 
therapeutics due to their high specificity and low incidence of side effects. Unlike most 
drugs, mAbs are complex macromolecules (~150 kDa), leading to a host of quality 
control and characterization challenges inherent in their development.32 We have 
developed a CIU method capable of  differentiating human IgG subtypes which mainly 
differ by inter-chain disulfide bonding 
numbers and patterns.26 Our CIU 
method was validated by 
reproducibility tests enabled by 
CIUSuite, where large numbers of 
replicates were collected and 
analyzed. 
In order to illustrate the function 
of CIUSuite_stats, we analyzed the 
CIU profiles for four IgG4 samples 
from four different suppliers (Sigma-
Aldrich Co., St. Louis, Mo; 
MyBioSource Inc., San Diego, Ca; 
Abcam, Cambridge, UK; and 
Fitzgerald Industries International, 
Acton, Ma.), denoted as IgG4-1 (Lot 
Figure 2-2. CIU of Biotherapeutics. (A) CIU 
fingerprints for Human IgG4 samples are plotted 
using CIUSuite_plot and display almost identical 
unfolding pathways. (B) Standard deviation plots are 
generated using CIUSuite_stats for CIU replicates of 
a single lot of IgG4 purchased from Sigma-Aldrich 
(Left) and CIU fingerprints of IgG4 samples from 
various suppliers (Right). 
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#1), IgG4-2 (Lot #2), IgG4-3 (Lot #3), and IgG4-4 (Lot #4) respectively.  
For the CIU experiments, each sample was provided from the manufacturer in a 
20 mM phosphate buffer that contained 150 mM NaCl, pH 7.4, with 0.05% sodium azide 
as a preservative except for the Sigma sample, which was provided in 20 mM Tris 
buffered saline, pH 8.0. All samples were purchased at a concentration of 1 mg/ml (~6.7 
µM) and buffer exchanged into 100 mM ammonium acetate buffer using Micro Bio-Spin 
30 columns (Bio-Rad, Hercules, CA) without further purification. ~7 µl aliquotes were 
introduced to a nano-electrospray ionization-quadrupole-ion mobility-time-of-flight mass 
spectrometer (Synapt G2, Milford, MA). Capillary voltages were set to 1.5-1.7kV, and 
the sampling cone was operated at 60V. The trap traveling wave ion guide was set to a 
pressure of 3.4 × 10-2 mbar of argon gas, and the traveling wave ion mobility separator 
was set to 3.5 mbar. The wave height and wave velocity was set to 40V and 600 m/s, 
respectively, to maintain ion mobility separation. The time-of-flight (ToF) was operated 
at a pressure of 1.7 × 10-6 mbar over a m/z range of 1,000-10,000. Collision energy was 
added to the ions in the trap traveling wave ion guide before the IM separator to unfold 
the antibodies. The 23+ charge state was isolated in the quadrupole and the collision 
voltage was ramped from 5-200V in 5V increments to unfold the ions, collecting IM-MS 
spectra at each voltage.   
 As shown in Figure 2-2 A, the 23+ charge state of intact IgG4 ions exhibit 
identical initial drift times prior to activation and highly similar unfolding pathways. For 
example, as the collision voltage is increased to the region of 70V – 100V, all IgG4 ions 
exhibit a gradual transition from an initial compact state, to an elongated unfolded state, 
resulting in an increase in recorded IM drift time. This unfolded species dominates the 
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CIU fingerprint for all species tested, until a larger unfolded protein ions are produced 
between  120V and 160V. At voltage values higher than 160V, two unfolded IgG4 forms 
are universally observed, at nearly equal intensities. 
While small variations between replicate CIU fingerprints are apparent, a 
CIUSuite statistical analysis of the data reveals that these variations are insignificant, 
leading to the conclusion that the four IgG4 samples can be treated as ‘identical’. The 
workflow for this analysis first involves the acquisition of multiple CIU data replicates for 
a single IgG4-1 lot. These CIU fingerprint replicates are then plotted and analyzed using 
CIUSuite_plot and CIUSuite_stats functions and their standard deviations 
comprehensively assessed (Figure 2-2B, left). Near-zero deviations are observed 
across the whole collision voltage range, consistent with previous observations.26 With 
these “baseline” standard deviation values established, we can further evaluate CIU 
reproducibility by investigating variations between samples. To perform such an 
assessment, a standard deviation plot is generated using CIUSuite that compares CIU 
fingerprints acquired for IgG4-1, IgG4-2, IgG4-3, and IgG4-4 (Figure 2-2B, right). 
Standard deviations equal to or smaller than the baseline values are observed, further 
illustrating the excellent reproducibility of the CIU method.  Taken together, the data 
shown in Figure 2-2 illustrate the capabilities of CIUsuite to evaluate CIU data for 
potential applications in biopharmaceutical characterization and quality control. 
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Quantifying Differences in the 
Unfolding Pathways of Homologous 
Albumins 
 We evaluated the use of the 
CIU fingerprint experiment for 
differentiation of homologous serum 
albumins for both analytical 
separations and comparative biology. 
Using albumins from bovine (BSA, 
66,463Da) and human (HSA, 
66,437Da) serum (both from Sigma 
Aldrich Co., St. Louis, MO,  10uM, 
buffer exchanged into 100mM 
ammonium acetate using a Biospin 6 
column(Bio-Rad, Hercules, CA)), we 
isolated the 15+ charge state and 
subjected it to collisional activation 
over a voltage range of 26 to 188V, 
using instrument conditions similar to 
those published previously.25 Bovine 
and human albumin are both three-
domain proteins that share 76% 
Figure 2-3. Analysis of homologous serum albumins 
reveals significant differences in their CIU fingerprints. 
A) Comparison of bovine (BSA) and human (HSA) 
serum albumin fingerprints using CIUSuite_plot reveals 
similar unfolding pathways, each having four CCS 
features present over the entire voltage range probed. 
B) A product of CIUSuite_compare, difference plots are 
shown where features that identify most strongly with 
one fingerprint are shown on a red intensity scale, and 
the other is shown in blue. The evaluation of technical 
BSA CIU replicates reveals a 5% RMSD, whereas a 
similar BSA-HAS comparison results in nearly 15%. C) 
Using feature detection and extraction from 
CIUSuite_detect, we quantified the cross section (A
2
), 
centroid stability (V), and stability range (V) of each 
feature, finding that across homologous, the CCS of the 
unfolding intermediates vary negligibly, with most of the 
variability coming from the different CIU stabilities of the 
features observed. 
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sequence identity, and are indistinguishable in both m/z and ground state CCS in the 
context of a native mass spectrometry experiment. In Figure 2-3A, we first observe that 
both homologues produce four prominent CIU features, in agreement with our previous 
report noting the correlation between native protein domain structure and CIU.25 Our 
previous data showed that at for low charge states, the number of CIU transitions 
observed should equal the number of domains, indicating uncoupling and unfolding of 
individual domains as a major source of CCS transitions in CIU.   
Despite these similarities, we also observe qualitative differences in the 
fingerprints that require further investigation. To assess the reproducibility of the 
experiment and the significance of these differences, we used CIU_compare to assign 
RMSD values to BSA and HSA replicates, comparing these values with RMSDs 
obtained by  
comparing BSA directly to HSA(Figure 2-3B). We find that in proteins such as BSA and 
HSA, the RMSDs observed for technical replicates are low, under 5% for all cases with 
satisfactory (>3) signal intensities. In contrast, the RMSD computed between BSA and 
HSA was found to be 14.7%, indicating significant differences in the unfolding process 
between homologues. The difference plot shown in Figure 2-3 allows us indicates a few 
major regions of the fingerprint where deviation occurs, specifically subtle changes in 
the region between 40V and 60V, and much more pronounced changes in the region 
from 120V to 150V.  
 To gain a more quantitative understanding of the changes in CIU between BSA 
and HSA, we extracted and characterized the most intense features from each 
fingerprint using CIU_detect (Figure 2-3C). The results of this analysis show that the 
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centroid drift time of each feature varies by only ~1% across homologues, whereas the 
centroid position of these features in the collision voltage dimension, and the stability of 
the feature, exhibit larger average variations, 9% and 20%, respectively. We interpret 
these results as support for our previous work that initially linked the native domain 
structure of proteins to their respective CIU pathways at low charge states.25 
Additionally, the differences in the stability of CIU features between homologous 
proteins may indicate potential for domain or interface-specific stability measurements 
to be used in biopharmaceutical or protein engineering applications.  
 
2.5 Conclusions 
Analysis of CIU data is an emerging challenge for those seeking to expand the 
information content of typical IM-MS experiments. Rapid and robust procedures for CIU 
fingerprint analysis are necessary for the continued development and application of 
such gas-phase unfolding experiments. Emerging applications, such as protein 
engineering and high throughput screening, which involve the rapid analysis of large 
numbers of samples, require streamlined quantitative analysis, provided by CIUSuite, in 
order to achieve realistic analysis capacities. Forthcoming challenges in this field may 
include the integration of CIU fingerprint data into databases, allowing for analysis of 
variability across instruments as well as the comparison of CIU data for quality control 
applications. Although the CIU analysis workflows contained herein overcome major 
bottle necks in experiment and analysis time, hurdles still exist in making CIU ready for 
diverse high throughput applications.  One exciting area of exploration will surely be the 
integration of adaptive, data-dependent algorithms for optimization of signal and 
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analysis time in high throughput screens. Important features of these algorithms will be 
the ability to adaptively focus on collision voltages that are the most information-rich, 
and to rapidly tune instrumental conditions and acquisition times to ensure that 
adequate signal-to-noise is achieved for each measurement.  
This software and the mathematical procedures contained within CIUSuite 
represent a framework for the continued study of gas-phase protein unfolding, and we 
anticipate that its application will lead to further discoveries regarding the basic 
biophysics of proteins in the absence of bulk solvent.  In addition, as the study of protein 
unfolding analysis in the gas-phase is a relatively new area, the authors encourage 
modification and expansion of CIUSuite capabilities, so that the base approaches 
described here can be applied to data structures not yet conceived.   
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3.1 Abstract 
Despite the growing application of gas-phase measurements in structural biology 
and drug discovery, the factors that govern protein stabilities and structures in a solvent-
free environment are still poorly understood. Here, we examine the solvent-free 
unfolding pathway for a group of homologous serum albumins. Utilizing a combination 
of chemical probes and non-covalent reconstructions, we draw new specific conclusions 
regarding the unfolding of albumins in the gas-phase, as well as more-general 
inferences regarding the sensitivity of collision induced unfolding to changes in protein 
primary and tertiary structure. Our findings suggest that the general unfolding pathway 
of low charge state albumin ions is largely unaffected by changes in primary structure; 
however, the stabilities of intermediates along these pathways vary widely as 
sequences diverge. Additionally, we find that human albumin follows a domain 
associated unfolding pathway, and are able to assign each unfolded form observed in 
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our gas-phase dataset to the disruption of specific domains within the protein. 
The totality of our data informs the first detailed mechanism for multi-domain protein 
unfolding in the gas phase, and highlights key similarities and differences from the 
known the solution-phase pathway. 
 
3.2 Introduction 
A detailed understanding of protein structure is centrally-important in the post-genomic 
era, especially in the context of human disease.1  Despite nearly sixty years of 
molecular-level observations, and an online repository of nearly 120,000 structural 
datasets, our ability to predict the three-dimensional fold of an amino acid sequence ab 
initio is mainly limited to small, single domain proteins.2  In contrast, the successes of 
template-based methods of protein structure prediction, relying upon previously-
captured structural data, can extend to much larger sequences.3 Currently, such 
datasets are limited primarily to those gathered through X-ray diffraction, nuclear 
magnetic resonance (NMR) spectroscopy, or electron microscopy (EM).4  While all 
highly enabling, high-resolution technologies in their own right, these techniques also 
bear significant limitations in terms of their throughput and their ability to access 
mixtures, thus rendering significant regions of the proteome absent from our current 
structural databases and refractory to rational drug design efforts.5 Therefore, it is clear 
that in order to move forward our fundamental understanding of the forces that drive 
environment-dependent protein folding reactions, protein structure data from other 
experimental methods must be considered. 
 55 
 
Beginning with the introduction of electrospray ionization (ESI)6 and matrix-assisted 
laser desorption ionization (MALDI)7,8 over twenty-five years ago, solvent-free 
biomolecular structure has been targeted in an effort to resolve some of the mysteries 
surrounding native protein folding.  In the gas phase, a simplified state of biological 
matter can be accessed, free from its native environment and accessible to high 
resolution spectrometric techniques.  Surprisingly, many aspects of native protein 
structure can be retained in vacuo, including protein complex binding stoichiometry and 
topology.9 In addition, the locations of bound substrates10,11 and overall protein folds12,13 
can exhibit a strong memory of their native forms when observed in the gas phase.  
Technologies including gas-phase hydrogen-deuterium exchange mass 
spectrometry,14,15 action spectroscopy,16 and ion mobility-mass spectrometry (IM-MS)17 
have revealed that gas-phase proteins are not ‘inside-out’ as originally surmised,18 but 
are instead largely charge solvated, existing in multiple iso-energetic states, and can 
strongly resemble their native-like forms.19  
A key observation from such gas-phase structural biology measurements is that 
solvent-free proteins can undergo unfolding following sufficient collisional heating, and 
that unfolding pathways can be monitored by IM-MS and mined for detailed structural 
information.20 Generally, these experiments involve sequentially increasing the kinetic 
energy of ions as they enter a pressurized ion trap, and thereby collisionally heating 
them. Subsequent analysis of IM drift time distributions for ion populations post-
activation generally reveal increases in ion collision cross sections as in a manner 
correlated with their increased internal energies. Although generalized correlations 
between gas-phase and native state protein stabilities are not yet available, gas-phase 
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protein unfolding has already demonstrated substantial promise as a fingerprinting 
technology in biomolecular analysis.21 Early IM-MS measurements revealed that single 
domain protein ions containing disulfide bonds resist collision induced unfolding (CIU) 
more so than those that lack such bonding.22 Subsequent CIU experiments targeted 
protein-protein and protein-ligand complexes, and highlighted the ability of gas-phase 
unfolding to detect minor differences in protein stability connected to changes in both 
local and global protein structure.23-27  More recent experiments have discerned the 
ability of CIU to detect conformationally-selective ligand binding,28 the cooperative 
stabilization upon ligand binding in multiprotein complexes,29 the details of disulfide 
bond structure within intact antibodies,30 and a domain-correlated mechanism of gas-
phase unfolding overall.31  Despite these insights, we still lack a clear, detailed picture of 
protein CIU. Information regarding the extent to which gas phase unfolding mimics such 
processes in solution, as well as a detailed view of domain-correlated unfolding events 
achieved in the absence of bulk solvent, could be transformative for both CIU as an 
analytical tool and our ability to predict protein structure.   
In this report, we use a variety of homologous serum albumins to study the sensitivity 
of CIU to changes in primary structure. Additionally, we utilize domain-specific chemical 
probes and novel noncovalent constructs to assign CIU transitions to specific regions of 
Human Serum Albumin (HSA). Taken together, our results demonstrate, for the first 
time, a detailed mechanism of gas-phase protein unfolding that links individual 
increases in ion size to unfolding events within specific regions of a multi-domain 
protein.  In addition, by comparing our gas-phase results with well-known mechanisms 
of HSA unfolding in solution32 we are able to determine that elements of albumin CIU 
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strongly resembles albumin unfolding in solution, adding further evidence of solution-
phase memory in gas-phase proteins and allowing us to point toward future applications 
of CIU in protein stability analyses.   
 
3.3 Experimental Section 
Sample Preparation. Wild type (WT) bovine, hominian, ovine, leporine, caprine, 
murine, and porcine serum albumin were purchased from Sigma Aldrich (St. Louis, MO) 
as lyophilized powders at purities greater than 97%. (Table S1)  The lyophilized proteins 
were diluted to 100µM in 100mM Ammonium Acetate and stored at -80⁰C. 8-Anilino-1-
naphthalenesulfonic acid (ANS) ammonium salt hydrate (97%),  Warfarin (WRF, 
analytical grade), indomethacin (IDM, 99%), L-thyroxine (98%), Bilirubin (98%), and 
Hemin (HMN, 98%) were also purchased from Sigma Aldrich, 10mM DMSO stocks 
were prepared prior to each experiment. A stock solution of 1mg/mL Diazepam (DZP) 
was generously provided by the Kennedy Group at the University of Michigan. 
Recombinant albumin domains 1, 2, and 3, as well as the domain 1-2 fusion protein, 
were purchased from Albumin Biosciences (Huntsville, AL) as lyophilized powders. 
Recombinant albumin domains were diluted to 90 or 180µM in 100mM ammonium 
acetate and stored at -80⁰C.  
IM-MS Data Collection. CIU fingerprints were obtained on a Synapt G2 IM-MS 
instrument (Waters Corp, Manchester, UK) as described previously.31 Briefly, albumin 
samples were diluted to 10µM and loaded into homemade, gold coated borosilicate 
needles. The cone voltage was maintained at 1.5kV with the sampling and extraction 
cones set to 30V and 2V, respectively. The source pressure was set to 50mbar and the 
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source backing pressure was adjusted to 9 mbar.  For all measurements, the 
quadrupole was set to isolate the 15+ charge state between 4420 and 4450 m/z. The IM 
T-wave ion guide was operated at 4mBar with wave height and wave velocity values of 
15V and 150m/s, respectively.  Mass spectra and drift time distributions were obtained 
for the ions at multiple trap collision energies in steps of 2V from 20V to 188V. All 
collision cross-section (CCS) values, which relate IM drift times directly to ion size and 
shape, were calibrated using ions of known CCS as described previously and detailed 
in table S2.33 
Chemical Probe CID Analysis. HSA was incubated with chemical probes at a ratio 
of 10uM protein to 100uM probe with a DMSO content of less than 5%. Experiments 
were performed as described above, although the quadrupole was adjusted to isolate 
either singly-bound and apo protein. Selected measurements were chosen for 
replication and their variabilities were found to be +/- 2 V, much lower than what is 
needed for our data analysis.   
CIU/CID analysis of Reconstituted HSA. Noncovalent reconstitutions of HSA were 
prepared by mixing component domains and incubating on ice for 10 min. The domain 
1-2 fusion protein was incubated with domains 1, 2 and 3 at concentrations of 45uM to 
provide  noncovalent complexes. These complexes were then  subjected to CIU and 
CID analysis without quadrupole selection . We similarly analyzed nonspecific trimers 
comprised of domains 1, 2 and 3, as well as the specific trimer of domains 1, 2 and 3.  
IM-MS Data Analysis. CIU fingerprints, subsequent RMSD calculations, and feature 
analysis were carried out using CIUSuite.34 CID analysis of both chemical probes and 
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reconstituted HSA complexes were carried out using Masslynx (Waters Corp. 
Manchester, UK) 
 
3.4 Results and Discussion 
Effects of Protein Primary Structure on CIU.  
Previous studies from our group have indicated that the CIU behavior of proteins is 
sensitive to their domain structure.31 To further understand the effects of intermolecular 
interactions governed by primary structure on the global CIU process, we undertook 
analysis of 7 homologous serum albumins. Each SA studied is a single polypeptide 
chain composed of three homologous domains (D1, D2, and D3), all of which share 
near-identical tertiary structure while differing significantly in primary structure from 70 to 
90% sequence identity.  Previous work has revealed that the CIU fingerprint of an ion is 
dependent on its charge-state.31 Figure 3-1A shows the average unfolding pathway for 
7 homologous albumins for the 14, 15, and 16+ charge states. The  standard deviation 
plots to the right characterize the variability between these structures caused by subtle 
changes to primary structure. As expected, the lowest charge state, 14+, requires higher 
voltages to unfold and generally accesses fewer intermediate structures along the 
unfolding pathway. For the 15+ and 16+ ions, the average behavior of the 7 homologues 
is quite similar, giving rise to a plurality of intermediate conformer families during CIU. 
Interestingly, analysis of the standard deviation plots reveals significant differences in 
CIU response caused by small changes to primary structure. We identified the 15+ ion 
not only as having the highest total deviation from the mean, but also as exhibiting 
significant deviations across the largest area of the unfolding fingerprint. We note that 
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standard deviation values between replicates of the same protein are generally at least 
5 times lower than those reported here across homologues. Due to this potential 
richness of information, we choose to focus on this charge state for further analysis and 
discussion. The reader is directed to Figure I-1 for CIU fingerprints for individual 14+ and 
16+ homologues.  
Analysis of the resulting fingerprints for 15+ serum albumins (Figures 3-1G-L, I-2) 
reveals clear similarities. For example, all albumins appear to undergo the same 
structural transitions upon collisional activation, resulting in a total of N+1 conformer 
families, where N is the number of domains in the native structure (labelled 1-4 in Figure 
Figure 3-1. CIU screen of homologous serum albumins. Average and standard deviation CIU fingerprints 
of 7 homologous serum albumins at charge states 14
+
 (A, B), 15
+
 (C, D) and 16
+
 (E, F).  Examples of 
albumin CIU fingerprints from various species acquired for 15
+
 ions (G-L as indicated on the figure). Four 
main conformer families (1-4, highlighted in G) are detected throughout.  
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3-1G). This behavior is predicted from our previous work, which describes a method for 
predicting optimal charge-states for CIU analysis.31 It should be noted that transitions 
and conformer families are assigned based on their stabilities, signal intensities, and 
resolution in CCS/energy space (See Appendix I for more details on CIU feature 
assignments).   
Further analysis using the feature extraction and characterization functions of 
CIUSuite revealed additional information regarding the gas-phase unfolding pathways of 
homologues (Tables I-3-6, Figures I-3 and I-4).  We characterized each CIU conformer 
family in terms of its centroid drift time, the range of voltages over which the conformer 
family is stable, and the centroid collision voltage value for the conformer family in order 
to determine the main factors that drive the absolute deviations observed in CIU 
fingerprints. Our results indicate that nearly all the albumin homologues tested access 
virtually identical unfolded conformer families, as defined by their centroid collision 
voltage and drift time values, when subjected to CIU. Critically, however, these same 
conformer families differ substantially in terms of their stability values. Based on this 
data, we draw two major conclusions: 1) The stabilities of CIU features are sensitive to 
small changes in protein primary structure, and 2) The number of CIU features 
observed, centroid IM drift times, and activation voltage values are conserved across 
different protein homologues and are instead linked to native protein domain structure. 
These results, therefore, indicate potential future applications for CIU in the context 
structure predictions for large proteins of unknown folds based on CIU data, as well as 
high-throughput local stability measurements of domains within larger protein or 
multiprotein constructs. Furthermore, we anticipate future CIU-based separations of iso-
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mass, iso-CCS proteoforms for the purposes of protein identification and quantitation 
(Figure I-5) based on the principles outlined in Figure 3-1. 
Domain-Specific Chemical Probes for the Structural Interpretation of CIU 
Fingerprints.   
Our data linking the conformational families accessed by CIU and native protein domain 
structure motivated us to develop a mechanistic understanding of serum albumin 
unfolding in the gas phase. For this series of experiments we chose to focus on the 
human variant of serum albumin (HSA), as it is arguably the most well studied and is 
supported by a large amount of crystallographic data associated with ligand binding.35 
Our approach involves correlating ligand dissociation energies with CIU features, where 
the binding location of the ligand is known from robust experimental data. First, we 
chose hemin as a marker for domain 1(D1), as many datasets, including an x-ray 
structure, indicate a highly-specific hemin binding site in this region for the HSA 
sequence.35,36 Results from 15+ ions (Figure 3-2)  indicated that the hemin binding 
pocket on D1 is preserved through at least the first two CIU structural transitions we 
observe, and the ligand is finally dissociated from conformer family 3 as it begins to 
transition to family 4. Surprisingly, the third albumin domain, D3, positioned on the 
opposite end of the polypeptide chain from D1, shows similar results, indicating the 
preservation of the D3 drug binding site for both ANS31 and Diazepam32,35 through the 
first two albumin conformer families observed. In contrast, ligands such as 
Indomethacin and Warfarin1 that bind to a site on D2, are rapidly dissociated during the 
initial HSA CIU events observed at low collision voltages, despite similar overall binding 
affinities to the D1 and D3 binders described above. Of the ligands presented in Figure 
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Figure 3-2. HSA Domain-Specific Chemical 
Probes of CIU. A) Surface representation of HSA 
based on PDB ID: 4K2C with ligand binding sites 
indicated. CID breakdown curves for HSA-ligand 
complexes, fitted to sigmoid functions. Datasets 
are shown for binders associated with domain 1 
(B), 2 (C), and 3 (D). See text for abbreviation 
definitions. Overlaid on all plots is a color scale 
indicating the voltage ranges where different CIU 
conformer families are observed (see legend, top).  
 
3-2, we found no significant differences in 
the CIU fingerprints of ligand  bound and 
apo species, with the exception of 
diazepam complexes, for which we observe 
large CID thresholds and stabilization of 
conformer family 3 (Figure I-6). To validate 
these results, we examined ligand 
dissociation behavior of hemin, warfarin, 
and diazepam from the 14+ and 16+ HSA 
ions. (Figure I-7) These datasets reinforced 
our hypotheses, as nearly identical 
behavior to the 15+ ions described above 
were observed for 16+ ions, and only minor 
deviations were detected in the 14+ case.  
Additionally, we examined the behavior of 
two larger molecules, Iodipamide35 and 
Thyroxine37 (Figure I-8) that are known to 
bind in two and four locations within the 
HSA structure respectively. Data acquired 
for these ligands also support the 
hypothesis that the D2 binding site is 
affected early in collisional activation, 
however structural interpretation of the 
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CID data from these ligands proved to be difficult as it was clear that both displayed 
evidence of significant cooperative stabilization. (Figure I-9).  
In addition to the above-noted correlations between CID and CIU data, we interpret 
our HSA chemical probe data in the context of previous experiments correlating protein-
ligand interactions with CID energies.38-41 These early studies employing native ESI and 
CID demonstrated a strong correlation between the polar surface binding area of a 
ligand and the corresponding threshold collision energy required for ligand CID, 
although no similar correlation could be found for nonpolar binders.(Figure I-10) For 
each ligand in our study, we calculated the total polar surface area42 as well as the total 
number of polar contacts for each albumin-ligand complex from available X-ray 
datasets.43 We observe no correlation between our observed CID threshold energies for 
HSA-ligand complexes and any description of the native contacts formed between 
ligands and their respective protein binding pockets (Figure I-10). This result, taken in 
context with the CIU/CID correlations observed in Figure 3-2, strongly indicates that that 
the collisional ejection of a ligand from a multi-domain protein system, such as HSA, is 
most strongly correlated with the structural cohesion of its resident domain, rather than 
the number of local contacts developed within a protein-ligand binding site.   
Noncovalent Albumin Constructs Further Reveal the CIU Mechanism of HSA. 
 To build on our understanding of the unfolding of HSA we designed a series of 
CIU/CID experiments utilizing HSA constructs built as noncovalent complexes 
comprised of individual HSA domains (Figures I-11- I-19). First, we incubated covalently 
attached albumin domains 1 and 2 (D12) with D3 to generate a noncovalent dimer that 
mimics full length HSA, (D12-D3). These results were compared with nonspecific dimers 
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where D3 was replaced with either D1 
or D2, creating D12-D1 and D12-D2 
respectively. Surprisingly, we were 
able to generate stable, noncovalent 
albumin mimics that had ground state 
drift time values nearly identical to 
their covalently-bound, native 
counterparts. CID analysis of these 
complexes (Figure 3-3 A) revealed 
that the two mismatched dimers 
showed nearly identical CID behavior, 
both possessing increased stability 
relative to D12-D3. Specifically, D12-
D1 and D12-D2 begin to dissociate at 
around 80V, similar to D12-D3, 
however neither achieves the 
expected sigmoidal trend between 
intact dimer intensity and collision 
voltage, and instead both proceed to 
dissociate along an apparently 
frustrated, near-linear trend-line. A comparison of the CIU fingerprints for these mis-
matched dimers (Figure I-20) reveals that D12-D1 and D12-D2 are unable to access 
CIU conformer family 3, which we find is necessary for the efficient dissociation of D3 
Figure 3-3. CIU/CID analysis of 15
+
 noncovalent, 
reconstituted albumins. A) CID breakdown curves 
representing the dissociation of a noncovalently-
bound D3 domain from the covalent D12 fusion 
protein. B) CID breakdown curves representing the 
dissociation of a noncovalent subunit from a 
noncovalent homo-trimer of albumin domains. C) 
CIU comparison of WT HSA with the noncovalent 
D12-D3 construct. Dashed lines indicate strong 
correlation between the first three CIU features 
observed. D) CIU Difference plot between WT and 
D12-D3 HSA. RMSD values are calculated for 
before and after the transition to non-sigmoidal CID 
behavior (black line). E) Correlation between the 
structural transition from CIU conformer 2 to 3 and 
the CID behavior of D12-D3.  
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from the D12-D3 dimer.  Next, we used individual HSA domains to construct both all the 
possible homotrimers and a heterotrimer of native-like composition for CIU and CID 
analysis. CID data shown in Figure 3-3B illustrates that homotrimers constructed 
entirely from D2 are least stable, and those comprised of D1 are most stable, with D3 
and D1-D2-D3 trimers presenting intermediate, and nearly identical, stabilities (Figure 3-
3E).   
Figure 3-3C compares the CIU fingerprint for native-like HSA (left) with the D12-D3 
construct (right) discussed above. We find a striking correlation in the positions of CIU 
features and transitions for these two constructs at collision voltages lower than the CID 
threshold for D3 ejection from the D12-D3 dimer. In order to quantify the similarity of the 
CIU data shown in figure 3-3C, we computed two RMSD values the datasets: one for all 
CIU data collected at collision voltages lesser than 100 V (at which CID has depleted 
D12-D3 by 50%), and another for all CIU data collected above that value (Figure 3-3D). 
Aside from some additional stability imparted in the noncovalent complex, a difference 
analysis shows that these fingerprints are nearly identical at lower collision voltages, as 
evidenced by a relatively low CIU RMSD value of 8.29. In contrast, the RMSD value 
computed for CIU data acquired above 100 V is 22.28, strongly indicating that D12-D3 
can neither efficiently access conformer family 3, nor any of conformer family 4. Instead, 
D12-D3 appears to access a new final unfolded state for CIU/CID above 100 V. 
Surprisingly, CIU fingerprints of both D1 and D3 homotrimers, as well as for the D1-D2-
D3 heterotrimer, showed similar levels of correlation with native HSA CIU prior to their 
respective CID thresholds (Figure I-21). In Figure 3-3E, we compare the transition from 
conformer family 2 to 3 in both native and D12-D3 albumins with the CID breakdown 
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curve that tracks D3 ejection from the D12-D3 dimer. The same non-sigmoidal trends 
are observed in all three datasets, indicating a mechanistic connection between the 
appearance of CIU conformer family 3 in 
both WT HSA and D12-D3, as well as 
the ejection of D3 from D12-D3. We 
observe an average charge state for 
dissociated D3 of ~8+, which amounts to 
53% of the parent ion charge, thus 
strongly indicating D3 is unfolded prior to 
ejection from the D12-D3 complex.44 
Mechanism of Gas-Phase Albumin 
Unfolding.  
Taken together, our data allows us to 
generate the first detailed unfolding 
model for a solvent-free multi-domain 
protein. Our chemical probe studies 
indicate that ligands bound to D2 
generally dissociate iso-energetically 
with the transition from conformer family 
1 to 2, leading us to assign CIU 
conformer family 2 to a D2 unfolding 
event. Supporting this assignment is our 
CID/CIU data for D2 non-covalent trimer ions, indicating that D2 forms the least stable 
Figure 3-4. A Modular Unfolding Mechanism for 
15
+
 Human Serum Albumin. Proposed structural 
transitions that agree with experimental evidence 
are depicted in a cartoon. Domains are indicated 
in Red for D1, Green for D2, and Blue for D3. (A) 
Albumin compacts upon entry to the gas-phase, 
and all three domains are in a native like 
conformation (represented by circles). (B) As ion 
energy is increased, D2 undergoes unfolding, 
leaving the other two domains in a relatively 
native-like state. (C) Partial unfolding of D3 
(indicated by the dashed ellipse) is achieved only 
at higher ion energies. (D) At the highest ion 
energies access in our experiment, all native-like 
protein structure is lost, including D1.     
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homotrimer out of all those studied here. Next, our CID data for D12-D3 inform our 
assignment of CIU conformer family 3 as related to unfolding of D3. Interestingly, our 
ligand binding studies indicate that D3-bound ligands can survive activation past this 
transition despite relying upon a relatively low number of polar contacts to remain within 
the D3 binding site. Taking this into account, we assign this transition to the partial 
unfolding of D3 in a manner that leaves its diazepam binding site intact. Finally based 
on both the large stabilities of D1-based constructs and D1/D3 chemical probe data, we 
assign CIU conformer family 4 to a coupled unfolding event involving both D1 and the 
remainder of D3.  
By combining WT HSA CIU data with CID data from D12-D3, we can also infer a role 
for charge migration in the unfolding of large multi-domain proteins. The dissociation 
products of D12-D3 are those expected from multi-protein CID: highly charged, unfolded 
D3, and charge stripped, compact D12.44 Although such results have been observed in 
CID data for many multi-protein complexes, the finding takes on new meaning in the 
context of understanding the CIU of a single protein chain. Considering the remarkable 
similarities between the measured unfolding data for HSA and D12-D3, we argue that 
the CIU of WT HSA must involve asymmetric charge migration during the first unfolding 
steps, and that the charge is likely redistributed evenly across newly-revealed protein 
surfaces as unfolding continues.  
 
3.5 Conclusions 
This work presents the most thorough investigation to date of the gas-phase 
unfolding of a multidomain protein. While the scope of our study is limited to albumins, a 
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careful analysis of our data indicates trends that may be generalizable across many 
classes of proteins and protein complexes. Our results indicate the sensitivity of CIU 
experiments to subtle changes in primary structure, where the tertiary structure remains 
essentially unchanged. Stated more specifically, we show that the conformational 
intermediates accessed during unfolding are dictated entirely by the tertiary structure of 
the protein, whereas the stability of those intermediates is determined by the underlying 
primary structure.  
In addition to the insights above, our dataset reveals previously unknown correlations 
between gas-phase protein dissociation and unfolding.  For example, our data show a 
clear correlation between the CIU of individual domains within a protein and the 
threshold voltage associated with CID-based ligand ejection. Interestingly, we did not 
find any correlation between our CID data and ligand-protein polar contacts/surface 
areas, in contrast to previous literature for smaller, single-domain protein systems. 
Additionally, a comparison of our CIU and CID data from noncovalent models of HSA 
strongly indicates that surface charges are re-distributed during the CIU of multi-domain 
proteins, similar to the mechanism proposed to describe multi-protein CID.44 
A comparison of the mechanism shown in figure 3-4 with previously reported solution-
phase measurements 32,35-37 indicates key similarities between solvent-free and solvated 
albumin unfolding. Guanidine hydrochloride-based denaturation of albumin bound to 
many of the probes used in our studies has identified the unfolding of D3 as a relatively 
early participant in the overall albumin unfolding process, and D1 has the most stable 
albumin domain. Additionally, these studies describe a modular, domain-centric 
unfolding pathway for albumin in solution, in agreement with our gas-phase studies. In 
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contrast, solution-phase studies do no capture large conformational shifts, like those 
that we attribute to D2 unfolding. While it is not surprising that gas-phase CIU does not 
precisely mimic protein denaturation in solution, the level of correlation that we observe 
projects a tantalizing future for CIU measurements in understanding the fundamental 
forces that drive native protein stability and predicting domain organization.  
Although the experimental data presented in this report provides our most detailed 
insights into gas-phase protein unfolding to date, the resolution of our model is certainly 
limited. In order to improve our understanding of both CIU and protein structure in 
general, it is clear that improvements in both gas-phase molecular dynamics simulations 
and experimental IM-MS techniques will be required. For example, tandem IM 
technologies,45 capable of both assessing the direct connectivity between CIU 
conformer families and revealing the fine structure within such families, will undoubtedly 
prove useful in achieving CIU models of greater detail than shown here.  In addition, the 
synergy between CIU datasets and recent advancements that combine charge 
migration algorithms with atomistic molecular dynamics simulations of large proteins46 is 
clear.   Future efforts in both theory and experiment will likely build on the insights 
discussed here, along with accumulated CCS data from these studies (Tables S7 and 
S8), in order to move our understanding of solvent-free protein folding forward, acquire 
structural data for refractory regions of the proteome, and access canonically 
challenging targets for the discovery of next-generation therapeutics.  
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Chapter 4: Coming to Grips with Ambiguity: Ion 
Mobility-Mass Spectrometry for Protein 
Quaternary Structure Assignment 
Joseph D. Eschweiler, Aaron T. Frank, and Brandon T. Ruotolo  
Supplemental Information can be found in Appendix II 
 
4.1 Abstract 
Multiprotein complexes are central to our understanding of cellular biology, as 
they play critical roles in nearly every biological process. Despite many impressive 
advances in structural characterization techniques, large and highly-dynamic protein 
complexes are too often refractory to analysis by conventional, high-resolution 
approaches. To fill this gap, ion mobility-mass spectrometry (IM-MS) methods have 
emerged as a  promising approach for characterizing challenging structural targets due 
in large part to the ability of these methods to characterize the composition, 
connectivity, and topology of large, labile complexes. In this Critical Insight, we present 
a series of bioinformatics studies aimed at assessing the information content of IM-MS 
datasets for building models of multiprotein structure. Our computational data highlights 
the limits of current coarse-graining approaches, and compelled us to develop an 
improved workflow for multiprotein topology modeling, which we benchmark against a 
subset of the multiprotein complexes within the PDB. This improved workflow has 
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allowed us to ascertain both the minimal experimental restraint sets required for 
generation of high-confidence multiprotein topologies, and quantify the ambiguity in 
models where insufficient IM-MS information is available. We conclude by projecting the 
future of IM-MS in the context of protein quaternary structure assignment, where we 
predict that a more complete knowledge of the ultimate information content and 
ambiguity within such models will undoubtedly lead to applications for a broader array of 
challenging structural targets. 
 
4.2 Introduction 
Structural characterization of the multicomponent complexes that form the functional 
units of the “interactome”, specifically protein complexes, represents a major challenge 
for structural biology.1,2 Due to their large size, low copy numbers, and intrinsic 
heterogeneity and lability, important targets are too often refractory to analysis by 
traditional techniques such as X-ray crystallography, nuclear magnetic resonance 
(NMR) spectroscopy, or electron microscopy, despite impressive advances in these 
fields.3,4 Alternative approaches for characterizing difficult multicomponent structures 
may result in low-resolution or sparse datasets, such as those generated from small-
angle scattering5 or covalent labeling/crosslinking methodologies.6 Circumventing the 
limitations of a single technique, integration of datasets from multiple experiments has 
been shown to be a potent approach for characterizing multiprotein complexes,7 as 
often times these datasets provide complementary information. This family of methods, 
commonly referred to as integrative structural biology, have progressed rapidly due 
largely to advances in computational techniques that have made it possible to encode 
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different types of experimental datasets as spatial restraints in a single modeling 
workflow.8 
Generally, an integrative modeling workflow is an iterative process described by 
four major steps: 1) the gathering of experimental data, 2) the translation of such 
data into spatial restraints, 3) the generation of an ensemble of putative structures 
that satisfy the experimentally-defined restraints, and 4) the characterization of the 
ensembles generated, where ambiguities are identified and used to refine structural 
hypotheses. This process may then be iterated as necessary in order to resolve 
ambiguities to the extent allowed by the experimental restraints utilized.8  MS-
based methods such as chemical crosslinking,9-11 native-MS,12,13 and ion mobility-
MS14 have garnered much attention as valuable experiments within such integrative 
structural biology frameworks. Of these MS-based technologies, ion-mobility-mass 
spectrometry (IM-MS) is uniquely positioned for interrogating multiprotein structure.15 
Unlike solution-phase measurements which may report on the average of an 
ensemble of proteoforms, conformers, or oligomerization states, IM-MS datasets can 
be used to discern the relative proportions of these species within mixtures, and 
interrogate their composition, connectivity, and collision cross sections individually.16 
Due to its unique capabilities in protein structure analysis, IM-MS is often deployed 
to determine coarse-grained (CG) protein topology models for assemblies that have 
resisted previous characterization attempts, often in combination with other forms of 
biophysical data.17,18  
Figure 4-1A illustrates the potential information content often derived from native MS 
datasets. While direct analysis of the masses of intact complexes can often provide 
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unambiguous information about the 
protein composition and 
stoichiometry,19 it is also useful to 
interrogate solution or gas-phase 
disassembly products to further 
elucidate connectivity and structural 
modularity. To this end, methods for 
solution20,21 and gas-phase22-24 
disruption of multiprotein complexes 
are actively being developed to 
increase the number of observable 
sub-complexes, and therefore the 
overall information content of the 
experiment. In addition to the 
composition and connectivity 
information garnered by MS, IM-MS 
(Figure 4-1B) provides 3D structural 
information on both monomeric and 
oligomeric protein ions in the form of 
collision cross sections (CCSs).25,26 
Since multiple methods are available for the accurate calculation of CCS values from in 
silico models,27-29 it is possible to assign putative structures to the signals observed in 
the IM-MS experiment.  
Figure 4- 1 A general workflow for IM-MS-based 
modeling. A) native-MS, tandem-MS, and solution-phase 
disruption-MS yield increasing amounts of composition 
and connectivity information for a multiprotein complex. 
This information can be encoded with varying levels of 
ambiguity based on the information available. B) IM-MS 
data can be included to build a 3D topology mode. 
Individual subunits or domains can be encoded as 
spheres with radius derived from their measured CCS, 
while exact distances between subunits can be derived 
from CCS measurements of dimeric and trimeric species. 
C) Optimization of the experimentally-defined scoring 
function using a Monte Carlo method provides unbiased 
sampling of potential structures for high-stoichiometry 
complexes. These structures form an ensemble which is 
subjected to clustering analysis to mine for predominant 
structural families D) Structural families detected by 
clustering can be characterized in aggregate using kernel 
density functions, mean structures and standard 
deviations, or individual structures can be identified as 
representative of the family. 
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Despite being used to restrain rigorous dynamics experiments for peptides 
30 and small proteins 31 for decades, our ability to extract structural information 
from CCS measurements of large proteins and multiprotein complexes is still 
evolving.  A recent comprehensive analysis of the PDB revealed that the general 
amount of CCS variance exhibited by proteins increases for high mass and 
stoichiometry protein complexes, indicating increased information content from 
CCS measurements in this regime.28 These observations corroborate earlier 
experimental results showing that the oligomerization patterns of homomeric 
protein complexes can be discerned in many cases based on CCS trends as a 
function of complex stoichiometry.32  
Methods for extracting topological information for large, heteromeric protein complexes 
are, however, less developed. Early procedures for optimizing pairwise and trimeric 
subunit interactions were based on a linear search for conformations, using spherical 
subunit representations that satisfied experimental CCS restraints.33 Although the 
spherical representation of protein subunits possesses obvious limitations when 
modeling highly aspherical subunits such as multidomain proteins, spheres still 
represent the primary component in IM-MS based modeling due to their trivial geometric 
relationship to the CCS parameter, their ease of implementation in computational 
workflows, and their facile relationship to protein-protein interaction geometries.  
Subsequently described IM-MS workflows aimed at the generation of protein quaternary 
structure models (Figure 4-1C) utilized a Monte Carlo approach for sampling 
orientations of spheres that satisfied excluded volume, symmetry, connectivity, and 
CCS restraints in order to yield an ensemble of structures that can be interrogated via 
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hierarchical clustering methodologies.33-35 Such IM-MS derived models have been 
favorably compared to structures produced using more mature workflows, indicating a 
promising level of cooperativity between CCS measurements and other biophysical 
parameters commonly used in protein complex model generation.34 This general 
approach has been used to elucidate the topological features of the DNA replisome,33,36 
ribosomal initiation factor complexes,37 and ATPases,38 all providing critical structural 
insights as well as methodological enhancements. More recently, surface induced 
dissociation (SID) coupled to IM-MS and covalent labeling has been applied to build a 
complete model of the toyocamycin nitrile hydratase complex39 by leveraging the sub-
complexes produced both through controlled disruption in solution and SID. 
Despite these promising examples, many questions remain about the ability to 
unambiguously assign protein topology using IM-MS datasets (Figure 4-1D). Most of 
these questions surround the potential errors introduced when high levels of coarse 
graining is applied, the interpretation of structural ensembles generated from IM-MS 
modeling approaches, and the confidence levels associated with IM-MS structures in a 
general sense.40 Additionally, questions remain regarding the extent of structural 
rearrangement apparent in some proteins and complexes in the gas-phase; a topic that 
has been investigated in detail elsewhere.35,41 In this Critical Insight, we seek to critically 
evaluate the information content of IM-MS for protein quaternary structure assignment 
in cases where we can assume a strong memory of solution-phase structure.  Based on 
many of the challenges described above, we develop a new generalized algorithm for 
translating IM-MS datasets into structural models and benchmark our new method 
against many known topologies present in the PDB. We continue by quantifying, for the 
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first time, the ambiguity present in under-restrained models, and suggest approaches 
mitigating such effects.  We conclude by projecting the future of IM-MS derived models 
of protein quaternary structure. 
4.3 Assessing Coarse-Graining Errors in Multiprotein Models Generated from IM-
MS Data  
In workflows that utilize IM-MS data to restrain models of protein quaternary structure, it 
is typically assumed that the protein components of the assembly can be accurately 
represented by spheres defined by either their measured or estimated CCS. Although 
many reports have demonstrated a strong correlation between experimental CCS 
measurements and CCS values extracted from solution-phase protein models, the 
strength of this correlation can depend on the domain structure and globularity of the 
protein analyte in question.42,43 Moreover, the magnitude and nature of the errors 
incorporated into IM-MS multiprotein models through the coarse-graining process are 
currently unknown. In order to investigate such coarse-graining errors, we extracted a 
non-redundant set of 191 high-resolution protein complex structures from the 3D 
complex set database,44 and developed a method for the rapid generation of CG 
structures based on these entries where the extent of coarser graining can be treated 
as a variable. The first step in our protocol involves extracting coordinates and center-
of-mass values for each subunit within the protein complex. Next, the CCS values are 
calculated for each subunit using the projection approximation function within the 
IMPACT library.28 To generate the initial CG model at subunit resolution, we placed 
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Figure 4- 2 Coarse-graining Error for domain and subunit-level 
representations. A) An example high resolution reference 
structure PDB ID 4MXW with subunits color coded. B.) A coarse-
grained model of 4MXW at the subunit level. C) A coarse-grained 
model of 4MXW at the domain-level. D) 191 non-redundant 
protein topologies were coarse grained at the subunit-level. The 
coarse-graining error distribution for this level of coarse-graining is 
shown. E) Subunit-level coarse graining introduced significant 
CCS errors for 28% of the complexes in our set. F) The coarse-
graining error distribution for the same set of protein topologies 
coarse-grained at the domain level. G) When coarse-grained at 
the domain level, only 2% of topologies had significant coarse-
graining errors introduced. 
spheres having radii 
corresponding to the projected 
area of the subunits at the 
center of mass for each subunit 
in the complex. To evaluate the 
model, the projected area of 
the high-resolution structure 
was compared to that 
calculated from the CG model.  
 Our results suggest that 
a significant number of the 
protein complexes currently 
available within the PDB 
contain subunits that are not 
accurately represented when 
subunit-level coarse-graining 
is applied. As shown in Figure 4-2A-C, subunit-level coarse-graining very often results 
in large deviations in CCS compared to the reference. We define CG error as the total 
percent of atoms found within the high-resolution structure that fit within an average of 
CG representations determined by our workflow (see Appendix II for Details).  We used 
a 5% deviation in the CCS values obtained for CG models when compared to reference 
CCSs for the corresponding all-atom reference structure to define a ‘significant’ error 
threshold in our analysis, as such defects reflect, in our view, both the maximum error 
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that can be introduced into a model before losing significant topology information, as 
well as the maximum error value carried by experimental restraint information recovered 
for large protein complexes by IM-MS.45  Specifically, over 28% of the protein 
complexes studied here contained significant errors (greater than 5%) when this level of 
coarse graining was applied.  We also note that the error distribution associated with 
this level of coarse graining is highly asymmetric, containing many structures having CG 
errors greater than 10%.  
A more detailed analysis of the structures within the survey reveals that proteins with 
multiple domains are most susceptible to high CG errors, especially those proteins 
having domains connected by long linker regions. Interestingly, however, we found no 
correlation between the CCS/mass ratio of individual subunits and their propensity to 
introduce error into the model, indicating that the overall packing density of the protein 
does not play a major role in the CG errors on display in Figures 4-2D and 4-2E. Based 
on this data we hypothesized that coarse-graining at the domain level should eliminate 
the majority of the errors we observed from our subunit-resolution CG modeling 
experiments. To investigate this, we implemented a k-means clustering method46 in 
SciPy47 to heuristically detect protein domain structure over a range of thresholds 
associated with protein and domain mass (See Appendix II for Details). The results 
associated with these higher-resolution CG structures are shown in Figures 4-2F and 
2G, and reveal a strong relationship between the resolution of the CG structures and 
the propensity for CG error we record during our analysis. Figure 4-2G, for example, 
shows that the fraction of protein complexes with significant errors drops to ~2% when 
domain-level CG is applied to the same pool of structures analyzed in Figure 4-2E.  
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4.4 Benchmarking the Information Content of IM-MS Datasets for Modeling 
Known Protein Complexes 
To generate ensembles of putative structures based on IM-MS-derived data, we 
developed a program for interpretation and optimization of diverse MS and/or IMS-
derived restraint sets. This program, referred to as IMMS_modeler, was built using 
connectivity and distance restraints from the Integrated Modeling Platform (IMP)8, some 
of which were implemented previously.34 Novel aspects of our approach include: 1) the 
use of a restraint file for facile input of new data, 2) the ability to use new functional 
forms within the scoring function, and 3) a new Monte Carlo algorithm that enables a 
significantly broader sampling restraint space. By default, IMMS_modeler generates 
ensembles of 1000 structures that satisfy all of the declared restraints. We found this 
amount of structures to be a representative sample of structural space for most 
complexes, and have based the following experiments on these ensembles. All CCS 
calculations were performed offline using the projected area function in the IMPACT 
library (See Appendix II for Details).   
In order to thoroughly evaluate our method as a general approach for modeling 
multiprotein complexes, we set out to benchmark IM-MS modeler against known protein 
complex topologies with varying levels of restraint information. In these experiments, we 
generated CG models at the resolution of individual protein subunits for a small subset 
of complex topologies used in the previous experiment. For simplicity, we focused this 
stage of our analysis only on those protein complexes that did not show significant CG 
error, as described in the above section (Figure 4-2). Despite these limitations in the 
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scope of our benchmarking, the geometric principles described here are transferrable to 
models created at higher levels of CG resolution.  
On the Positive Predictive Power of IM-MS datasets 
 In order to characterize the information content associated with CCS 
measurements of intact protein complexes and sub-complexes when used to define 
inter-protein distances and geometry in the context of a search of potential quaternary 
structures (which we define as 
‘internal restraints’), we 
simulated IM-MS datasets for at 
least five non-redundant 
complex topologies for protein 
trimers, tetramers, pentamers, 
and hexamers (Figure 4-3). 
Although some of the complexes 
used to generate the analysis 
shown in Figure 4-3 contain 
symmetric elements, no 
symmetry restraints were 
implemented to avoid bias. All restraint sets contained detailed information regarding 
the connectivity of the complex, as well as the CCS of the intact assembly. In addition to 
this information, restraint sets contained varying numbers of the ‘internal restraints’ 
described above, which correspond to the  pair-wise distance restraints that are 
commonly obtained from native IM-MS datasets.21,32  We note that although 3D systems 
Figure 4- 3 Positive Predictive Values of the IM-MS restraint sets 
plotted as a function of the number of internal CCS-derived 
restraints. At least 5 non-redundant topologies from the PDB 
were considered for each number of subunits, A) Trimers B) 
Tetramers C) Pentamers and D) Hexamers. Each restraint set 
was manually curated to ensure the data reflected data that could 
be reasonably generated through existing IM-MS technologies. 
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are generally restrained by a minimum of 3N-6 restraints (where N is number of bodies), 
our restraint sets attempt to simulate restraints from real IM-MS datasets with built in 
errors, often causing producing predictive values less than predicted by the precise 
distance geometry. For purposes of this analysis, the structures generated using our 
method were defined as true positives (native-like topologies) if they had an RMSD 
values of less than 5Å relative to the reference structure; and we defined a positive 
predictive value (PPV) as the fraction of true positive structures within the ensemble of 
structures sampled using a given restraint set.  
 As expected, our results reveal a positive relationship between the number of 
internal CCS restraints available for a complex and the positive predictive value for a 
given modeling effort. For trimeric protein complexes (Figure 4-3A), the ensemble is 
enriched for true positives with the addition of internal distance restraints between 
subunits. Here, due to the trivial relationship between the CCS and the angle of 
subunits within the complex, the model should be fully restrained by the global CCS 
plus any two IM-derived distance restraints.33 Notably, there is one outlier structure that 
seemingly refutes this general conclusion; however, our analysis also suggests that the 
CCS restraint becomes less sensitive when large disparities exist in the CCS of each 
component, allowing us to rationalize all of the results shown. (Figure II-2)  Higher 
stoichiometry complexes (Figure 4-3B-D), exhibit similarly strong increases in PPV in a 
manner correlated with the number of internal restraints included.  We note that the 
number of restraints necessary to reach a PPV > 0.8, where 80% of the structures 
identified in the ensemble are within 5Å of the ‘true’ structure, increases rapidly as the 
number of subunits increases, further motivating the need to develop  new methods and 
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technologies for the comprehensive generation of native-like sub-complexes for IM-MS 
analysis.20,23,24  
4.5 Characterizing Ambiguity in the Structural Ensembles Defined by IM-MS 
Although the PPV is a valuable metric 
for comparing the information content 
of multiple restraint sets, interpretation 
of PPV values for individual datasets 
can be challenging. This is due to the 
fact that members of a structural 
ensemble generated by the IMMS-
modeling approach described here are 
not randomly distributed, and in many 
cases can be clustered into distinct 
sub distributions, or structural families. 
Pairwise relationships between 
structures within an ensemble can be 
described by a pairwise RMSD matrix, 
which can in turn be interrogated using hierarchical clustering to determine groups of 
highly related structures, and the relationships between those groups. Alternatively, 
other similarity measures can be implemented to describe structural relationships 
between models, including the ultrafast similarity score,48 or distance matrix RMSD,49 
which each may have their own advantages depending on the geometries present in the 
ensemble. For the computational data described in this Critical Insight, a detailed 
Figure 4- 4 Parsing Structural Ensembles Generated with 
Ambiguous Restraint Sets. A) A restraint set was 
generated for 2AFH, a nitrogenase heterotetramer 
(purple and grey) bound to the dimeric nucleotide switch 
protein (green). The binding location and pose for the 
nucleotide switch protein is not defined in the restraint set 
and a CCS-filtered structural ensemble contains many 
putative structures. B) Hierarchical clustering of the 
ensemble reveals three distinct structural families within 
the ensemble, greatly simplifying the analysis. C) Plotting 
the kernel density function of each structural family 
reveals high resolution within all families. 
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analysis of the structural ensemble produced from an IM-MS restrained search of 
protein topology space regularly reveals useful information, in addition to what is 
provided by the PPV value analysis shown in Figure 4-3 alone. In the sections below, 
we discuss the interpretation of hierarchical clustering da tasets in the context of 
such IM-MS restrained models, focusing on our recent efforts to define and quantify the 
ambiguity and resolution within the IM-MS data.  
A hierarchical clustering dendrogram (as shown in Figure 4-4) illustrates the relationship 
between all structures within an ensemble. The number of clusters depends on the ‘cut 
point’ chosen during dendrogram analysis, a value that is typically a user defined 
parameter. For example, our algorithm automatically defaults to a dendrogram cut point 
that generates clusters at linkages that exhibit greater than 70% of the maximum RMSD 
in the entire matrix analyzed.  Our ensemble analysis workflow evaluates the in-cluster 
RMSD as it compares to the average RMSD of the ensemble, as well as the cross-
cluster RMSD, revealing distinct structural families that define the identified clusters 
(Figure4- 4).  It is worth noting that the application of IM-MS restraints often leads to the 
type of model ambiguity shown in Figure4- 4 for large hetero-protein targets.34  Indeed, 
such ambiguity may, in some cases, represent the native ensemble of protein complex 
structures associated with function.38,50  Commonly, however, such uncertainty is due to 
incomplete structural information and can be resolved either through the application of 
additional restraints 18,51 (see below for examples).  
 As mentioned above, the in-cluster RMSD can be a valuable metric for 
quantitatively expressing the ambiguity within a cluster. However, when evaluating 
biomolecular structures, qualitative and visual expression of ambiguity is often more 
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facile to interpret. In order to fill this gap for IM-MS derived models, we developed a new 
method for visualizing the ambiguity within a structural family using kernel density 
functions.47,52 In this method, the coordinates within a structural family or ensemble are 
aligned, and each subunit coordinate is uniformly populated with protein density as a 
sphere corresponding to its collision cross section. Next, the Gaussian kernel function is 
estimated for this volume of coordinates, and then visualized. For the workflow 
described here, we utilize the Mayavi Library53 in Python to visualize the kernel 
densities. As illustrated in Figure 4-4C, this kernel density function approach allows for 
the visualization of structural ambiguity present within an ensemble; information that is 
likely vital for the detailed interpretation of structural ensembles defined by sparse sets 
of restraints.   
4.6 Leveraging Symmetry and Modularity to Resolve Ambiguity within IM-MS 
Model Ensembles 
To further evaluate IM-MS based quaternary structure assignments in a general sense, 
as well as the newly-developed methods described here, we chose two case studies 
that illustrate real-world examples of challenging modeling targets. As shown in Figure 
4-3, the number of restraints needed to accurately recapitulate the topology of a 
multiprotein complex with greater than 5 subunits increases exponentially, creating 
challenges for integrative modeling of these complexes. However, in the data shown 
below, we demonstrate that by leveraging modularity and symmetry within high-
stoichiometry complexes, it is possible to circumvent these limitations. 
 As an example of a symmetry restraint applied in order to resolve ambiguity 
within an IM-MS restrained ensemble of protein quaternary structures, we built models 
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of the Large T-antigen (LTag) complex 
bound to p53. LTag is a hexameric ring 
structure that binds p53 monomers in a 
stoichiometric and symmetric fashion 
around the ring.54 Assuming a 
comprehensive protein-protein 
connectivity dataset from Native MS, we 
searched for a minimal IM-MS restraint 
set to recapitulate the known topology of 
LTag-p53 with C6 symmetry. Our first 
attempt utilized only connectivity and 
global CCS information to generate a 
structural ensemble. (Figure 4-5A) For 
this ensemble, we observe three 
structural families, with relatively little resolution between them. Each family is 
represented by a very broad distribution of RMSD values relative to the reference 
structure, indicating that both the accuracy and effective resolution of the structural 
models created in this search are low. The kernel density function estimated for each 
structural family also illustrates the poor resolution generated from this restraint set.  
 In order to resolve the above ambiguity, we add restraints associated with the 
CCS of the LTag hexamer and the overall C6 symmetry of the complex, a likely result 
given the interface structure known for this assembly.54 The resulting IM-MS restrained 
ensemble is homogenous and gives rise exclusively to highly accurate models (Figure 
Figure 4- 5 Modeling the topology of hexameric LTag 
bound to p53 using the symmetry restraint.  Two 
restraint sets (left panels, A and B) were used to 
generate structural ensembles that were evaluated 
using hierarchical clustering, kernel density functions, 
and RMSD distributions. (Right panels). 
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4-5B). This monomodal ensemble of structures is characterized by a significantly 
narrower distribution of RMSD values when compared with the distributions observed in 
Figure 4-5A, and is centered at an RMSD of 6Å relative to the reference. Such RMSD 
values are typically achieved by our modeling workflow for structures where additional 
symmetry restraints can be coupled to the distances mined from IM-MS data.   
For our second example, we sought to apply our method to a large, asymmetric protein 
complex that has been interrogated using MS methods previously.55 The Actin-Related 
Protein 2/3 (ARP2/3) complex structure was recently solved by X-ray crystallography 
(PDB ID 1K8K).56 In addition, a previous native mass spectrometry study identified two 
modules within the heptameric complex, the trimeric Actin Localization Module (ALM) 
and the tetrameric Nucleating Module (NM). Extrapolating from the data shown in 
Figure 4-3, we predict that the heptameric ARP2/3 requires between 16 and 19 internal 
CCS restraints to reach a PPV value of 80%. When modeling the ALM and NM 
individually, we find that even minimal simulated IM-MS restraint sets lead to highly 
accurate models.  We generated high-confidence models for the trimeric ALM using 2 
IM-derived distance restraints and a global CCS restraint. In parallel, the correct 
structure was readily found for the NM using 3 IM-derived distance restraints plus the 
global CCS restraint. These results agree well with data shown in Figure 4-3 for trimeric 
and tetrameric protein complexes. 
 Next, we attempted to find the minimal IM-MS restraint sets necessary for 
localization of ALM binding to NM, leading to a precise assignment of ALM-NM 
topology. We started by attempting to model this complex without providing any 
information about points of connectivity between ALM and NM, and filtered the resulting 
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ensemble based on global CCS alone. 
(Figure 4-6A) The resulting ensemble 
features two structural families, a 
larger population family with an RMSD 
distribution centered on 15 Å from the 
reference structure, and a less 
populated cluster with a very broad 
RMSD distribution centered on 28 Å. 
Interestingly, although the resolution 
within both families is poor, the major 
family appears to correctly localize the 
general ALM binding site on the NM 
surface. To reduce the ambiguity in the 
models, we then added two restraints 
that enforced connectivity between the 
p20 subunit of the ALM and the p34 
and arp3 subunits of the NM (Figure 4-
6B). This new connectivity information, 
along with the global CCS restraint 
gives rise to a new ensemble of potential structures. The new restraint set acts to 
eliminate the majority of the incorrect structures found in Figure 4-6A; however, it gives 
rise to a new, more highly-resolved distribution of structures centered on 25 Å from the 
reference.  Interestingly, we note that the major structural family identified for this 
Figure 4- 6 Docking modules within the ARP2/3 complex 
using connectivity restraints. After encoding the 
structures of the nucleating module (NM) and the actin 
localization module (ALM), we tested the global CCS in 
conjunction with various sets of connectivity restraints 
(left panels, A, B, and C) for their ability to restraint the 
docking location and pose of NM on ALM.  Structural 
ensembles were evaluated by hierarchical clustering and 
the structural families, kernel density functions, and 
RMSD distributions from the reference are provided. 
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restraint set remains essentially unchanged from the one identified in Figure 4-6A, 
where the correct localization of ALM is determined, but having a broad RMSD 
distribution centered on ~15 Å from the reference structure 
 Finally, we applied a new restraint set with 4 total connectivity restraints linking 
p20 from the ALM with p34, arp2, and arp3 from the NM; and linking p40 from the ALM 
with arp2 from the NM. (Figure 4-6C) These restraints represent the full complement of 
protein connectivity information accessible through MS methods.57 When combined with 
sufficient connectivity information, we find that the global CCS restraint can define not 
only the location of ALM on the surface of NM, but also the relative orientation of the 
two sub-complexes. We observe a single, well-resolved family of structures centered 
around and RMSD value of 9 Å relative to the reference structure. Furthermore, when 
structures within this family are averaged, the resulting mean structure has an RMSD of 
only 2 Å from the reference, indicating that in this example, the mean structure is in 
much closer agreement with the reference than any individual structure in the 
ensemble. Combining the connectivity restraints used here with the distance and 
internal CCS restraints used to build models for each module, we recapitulated the 
correct topology using only 11 internal restraints, one third fewer internal restraints than 
that the number of restraints one would predict based on PPV alone (extrapolated from 
Figure 4-3). 
4.7 Conclusions and Future Directions 
In this report we explored several questions related to the generation of CG multi-
protein topology models restrained using IM-MS data. We outlined a workflow based on 
integrative modeling principles that allows for facile translation of IM-MS data into 
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ensembles of putative structures for hypothesis refinement or integration with high 
resolution docking tools. We explored the limits of coarse-grained modeling, and 
demonstrated that many protein topologies found in the PDB are not amenable to 
coarse-graining at the subunit-level, mostly due to their intricate domain architectures. 
However, when sufficient data is available, domain-level coarse-graining is high fidelity, 
resulting in significant errors in only 2% of cases.   
 We benchmarked our CG modeling workflow against protein topologies extracted 
from the PDB, exploring the ambiguity in IM-MS derived structural ensembles as a 
function of the information content contained in restraint sets. Our results indicated a 
predictable relationship between the PPV of an ensemble, and the number of internal 
IM-MS restraints used to generate it. Although the estimated PPV may be used as a 
benchmark to predict the ambiguity within a CG modeling ensemble, in many cases it 
underestimates the total possible information content of the IM-MS experiment, as such 
an analysis does not account for the structural relationships between members of an 
ensemble. We found that applying hierarchical clustering yields, in many cases, highly 
resolved conformational families that can inform future experiments, or be reported as 
likely structures based on available data.   Additionally, we undertook two case studies 
that showed that highly symmetric or modular complexes can be modeled with high 
fidelity using smaller numbers of internal restraints than those predicted by a PPV 
analysis. 
 Although the computational results presented in this Critical Insight are 
encouraging, there are still many challenges ahead in fully harnessing the information 
content available in IM-MS datasets.  Our CG error analysis (Figure 4-2) clearly 
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motivates the development of domain-level IM-MS models of protein quaternary 
structure, and a move away from CG at the intact subunit level.  The development of 
IM-MS tools for the generation of such information on protein tertiary structure, such as 
collision induced unfolding (CIU),58,59 as well as efforts to integrate IM-MS data with 
other sources of experimental data sensitive to local protein structure51,60,61 and 
computational domain assignment algorithms62 will, therefore, become increasingly 
important in future protein topology modeling efforts.  Similarly, our analysis of 
ambiguity in IM-MS models of protein quaternary structure strongly points to the need 
for improved methodologies capable of detecting protein complex connectivity and 
symmetry. As such, the development of technologies that produce a comprehensive 
population of protein sub-complexes, either in the gas-phase or in solution, will prove 
highly valuable.20,23,24  Finally, the ability of our IMMS-Modeler algorithm to assess, for 
the first time, the ambiguity present within IM-MS restrained models of protein complex 
structure will likely lead to a greater ability to integrate such datasets with other forms of 
structural restraints, derived both from MS and other forms of data. Future iterations of 
IMMS-Modeler will incorporate the ability to build models based on custom shapes, 
interface directly with domain-prediction software, and utilize next-generation scoring 
functions that enable multi-factorial assessments of model fitness.  Although not 
discussed in detail here, it is also clear that increases in CCS precision will drive 
concomitant increases in the PPV of IM-MS restraints.63-65 On the other hand, our data 
demonstrate that much can be accomplished using current IM-MS capabilities and that 
the proper application of restraints can be used to build high-confidence models of 
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multi-protein complexes with both full knowledge of their precisions and informed 
estimates of their accuracies.    
 
 
4.8 Supplemental Information 
All of the software used in this work for modeling and analysis will be made freely 
available at: https://sites.lsa.umich.edu/ruotolo/software/IMMS_Modeler 
 
Supplemental Information can be found in Appendix II.  
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Chapter 5: A Structural Model of the Urease 
Activation Complex Derived from IM-MSIon 
Mobility-Mass Spectrometry and Integrative 
Modeling 
 
Joseph D. Eschweiler, Mark. A. Farrugia, Robert P. Hausinger, Brandon T. Ruotolo 
Supporting information can be found in Appendix III 
 
5.1 Abstract 
The activation of K. aerogenes urease via an 18-subunit enzyme-accessory protein 
complex has been well-studied biochemically, but thus far this complex has remained 
refractory to direct structural characterization.  Using ion mobility-mass spectrometry,we 
characterized several protein complexes between the core urease enzyme and its 
accessory proteins, including the 610 kDa (ureABC)3(ureDFG)3 complex. Using our 
recently-developed computational modeling workflow, we generated ensembles of 
putative (ureABC)3(ureDFG)3 consistent with experimental restraints and characterized 
the structural ambiguity present in these models. By integrating structural information 
from previous studies, we increased the resolution of the ion mobility-mass 
spectrometry derived models substantially, and we observe a discrete population of 
structures consistent with all of the available data for this complex.
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5.2 Introduction 
 Protein-protein interactions are critical to nearly all complex cellular processes, 
making structural characterization of such interactions imperative to our understanding 
of biology.[1,2] These interactions are diverse, however, ranging from discrete protein 
dimers and other small oligomers [3] to large, labile interaction networks comprised of 
dozens of protein chains.[4] One such multiprotein system, the urease activation 
complex, features a wide range of protein subunit sizes, interaction strengths, and 
stable subcomplexes within a putative 21-subunit network that has been the focus of 
diverse structural biology efforts.[5-7] Despite the presence of numerous structural 
datasets for this system, few direct measurements of its higher-order complexes have 
been made, and thus relatively little is known about the structure of the urease 
activation complex or its mode of action in vivo. 
 Ureases are an important class of bacterial enzymes responsible for the 
hydrolysis of urea to ammonia and carbamate.[5] Significant attention has been paid to 
this class of enzymes due to their impacts on human health,[8] and agriculture.[9] K. 
aerogenes urease, the subject of this study, is composed of three protein chains, UreA, 
UreB and UreC which form a trimer of trimers, (UreABC)3 with molecular weight around 
250 kDa.[7] Although X-ray crystallography has elucidated the details of the quaternary 
and tertiary structure for this urease, including details about its dinuclear Ni2+ active site 
featuring a carbamylated lysine,[10] much less is known about the GTP and CO2-
dependent assembly of the urease active site by the urease accessory proteins UreD, 
UreE, UreF, and UreG which are co-expressed in K. aerogenes.[7] Biochemical studies 
of these accessory proteins have provided insight into their specific roles in urease 
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activation. Briefly, UreD is a relatively insoluble protein in aqueous environments that 
been found to bind directly to urease, but is not competent for urease activation without 
the other accessory proteins.[11] Recent studies have provided experimental evidence 
for a Ni2+ channel through UreD, indicating a unique ability to provide Ni2+ to urease 
specifically.[12] UreF, a similarly insoluble protein in aqueous solvent, has been found 
to act as a GTPase modulator to the GTPase UreG,[13] a dimeric protein known to bind 
Ni2+ ions[14,15] and UreE is a known nickel chaperone with known interactions with 
ureG.[16] Early hypotheses for urease activation proposed sequential binding of ureD, 
ureF, and ureG to the three urease active sites to form an octadecameric pre-activation 
complex, (ureABC)3(ureDFG)3, that could accept Ni
2+ ions from ureE before performing 
a GTP-dependent Ni insertion event.[6,7] More recently, our group and others observed 
a soluble, stable complex of (ureDFG)2 that accepts Ni
2+ from ureE prior to formation of 
the (ureABC)3(ureDFG)3 complex.[17,18]  
 Despite its importance, the (ureABC)3(ureDFG)3 pre-activation complex has 
eluded detailed structural characterization. One factor precluding such a structural 
characterization for this complex is its lability, which results in multiple coexisting 
subcomplexes that make interpretation of any dataset that doesn’t include a high-
resolution separation step extremely difficult. Importantly, several subcomplexes have 
been identified by native mass spectrometry (MS)[17] and chemical crosslinking[17,19] 
including (UreABC)3(ureDFG) and (UreABC)3(ureDFG)2, (ureABC)3(UreD)3, and 
(ureABC)3(ureDFF). Detailed analysis of crosslinked peptides by tandem MS revealed 
putative interaction sites of urease with UreD,[19] which have also been supported by 
SAXs datasets for samples containing (ureABC)3(ureD)3.[20] These datasets were 
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recently integrated with molecular docking to provide the most comprehensive picture of 
the (ureABC)3(ureDFG)3 structure to date,[21] however without direct observation of the 
complex it is difficult to assign a confidence level to the model produced.  
 In this study, we use ion mobility-mass spectrometry (IM-MS) to characterize 
complex samples relating to the (ureDFG)2 complex as well as complexes formed 
between UreDFG and urease. IM-MS is a tandem methodology that separates proteins 
and protein complex ions produced using nano-electrospray ionization (nESI) under 
native conditions first by size by IM and then by m/z using MS.  IM-based size 
separations can be calibrated to produce orientiationally-averaged collision cross 
section (CCS) values that can be used, along with connectivity information recovered 
from native MS to restrain modeling efforts. We utilize a previously-reported maltose-
binding-protein:ureD fusion protein to increase the solubility of the system, while still 
allowing for formation of key protein complexes that are competent activators of 
urease.[11] Furthermore, we report the first observations of the fully assembled 
(ureABC)3(ureDFG)3 complex, and using IM-derived CCS  information[22] we develop a 
method for coarse-grained modeling[23,24] of (ureABC)3(ureDFG)3 and its 
subcomplexes that allows us to characterize the conformational space of 
(ureABC)3(DFG)3 consistent with our data.  
5.3 METHODS 
Sample preparation. (UreDFG)2 (UreAC)3 and (UreABC)3 were expressed and 
purified as reported previously.[17,11,25] (UreABC)3(ureDFG)x samples were prepared 
by incubating (ureABC)3 with (ureDFG)2 for 30m before flash freezing and storage at -
80C. 
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Ion mobility-mass spectrometry. Samples were buffer exchanged into 200mM 
ammonium acetate using Micro Bio-Spin P-30 columns (Bio-Rad, Hercules, CA) at an 
initial concentration of ~1uM. The final concentrations of the samples were unknown, 
however likely range from 100 to 900 nM based on expected losses during exchange. 
IM-MS Experiments were performed on a Synapt G2 ion mobility-mass spectrometry 
platform (Waters Corp., Milford, MA) with a nano-electrospray ionization source 
equipped. Briefly, the capillary voltage was set to 1.5 kV, with sampling and extraction 
cone voltages set to 0 V to preserve noncovalent interactions. The trap and transfer 
collision energies were both set to 4V. Optimal IMS parameters were as previously 
published,[26] IMS gas pressure approximately ~4 mBar with a wave height and wave 
velocity set to 15 V and 150 m/s, respectively. Data was processed using Masslynx and 
Driftscope (Waters Corp., Milford, MA). Mass assignments were calculated using the 
maximum entropy method as implemented in ESIprot.[27]  
CCS Calibration. CCS values were determined as previously described.[22,28] 
cytochrome C, avidin, alcohol dehydrogenase, and glutamate dehydrogenase were 
used as calibrants for the wide range of CCS values observed. Typical calibration 
curves produced correlation coefficients of greater than 0.99.  
Coarse-grained Modeling. Our general method for coarse-grained modeling is 
similar to previously described protocols[23,29] and more specific details on our method 
are provided in an accompanying manuscript (Chapter 4). Briefly, individual protein 
subunits are represented as spheres with radii corresponding to their experimental or 
calculated CCS. Higher order complexes are restrained by specific geometric 
constraints or more ambiguous connectivity restraints as defined by the experimental 
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data acquired. An ensemble of putative models is generated by repeated optimization of 
a scoring function built from the above restraints. Typical ensembles ranged from 1000 
to 25,000 structures but were drastically reduced in size by filtering these model pools 
using experimental and biophysical restraints not included in the original scoring 
function.[23] CCS for each model were determined using the projection approximation 
function in IMPACT,[30] and CCS values with an uncertainty of +/- 3% were used as an 
experimental filter for the ensemble. After CCS filtering, models that agree with 
biophysical and experimental data are analyzed using hierarchical clustering to 
determine the predominant structural families present in the ensemble. Ensembles or 
subsets thereof are then represented by kernel-density functions,[31] with the median 
structure shown for reference. These same groups were also characterized by the 
average RMSD from the mean, which provides an estimate of the relative resolutions 
between ensembles.  
5.4 RESULTS 
IM-MS of (MBP-UreDFG)2 and (UreABC)3(MBP-ureDFG)3 containing samples 
IM-MS analysis of samples containing the fusion protein MBP-UreD, UreF, and 
UreG revealed the predicted (MBP-UreDFG)2 complex plus a number of subcomplexes 
consistent with our previous study.[17] Analysis of the CCSs of these subcomplexes 
revealed values consistent with those predicted from a homologous urease accessory 
complex, (hypHFG)2, for which a crystal structure exists,[18] indicating a degree of 
topological agreement between these two complexes. After evaluation of the complexes 
derived from (MBP-UreDFG)2, we incubated this complex with (UreABC)3 before 
subsequent IM-MS analysis. (Figure 5-1) The resulting dataset featured many of the 
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Figure 5-1 IM-MS analysis of (UreABC)3(MBP-DFG)3 and its subcomplexes. IM-MS analysis of 
(UreABC)3(MBP-DFG)3 is presented as a plot of drift time vs m/z, with the standard m/z dimension 
projected on top of the figure. This data reveals the masses and collision cross sections of many 
subunits, and subcomplexes that comprise the 610 kDa (UreABC)3(MBP-DFG)3 octadecamer. 
subcomplexes found in the (MBP-UreDFG)2 sample, plus a host of complexes derived 
from interactions between MBP-UreDFG and (UreABC)3. Notably, in this dataset we a 
observe a new complex, the linear (MPB-UreDF)2, which was not observed in the 
absence of urease, which has been observed in the H. pylori urease activation 
pathway.[18] In contrast to our previous study, these new datasets also contain signals 
from the fully assembled (UreABC)3(MBP-DFG)3 complex, as well as the subcomplexes 
(UreABC)3(MBP-DFG)2 and (UreABC)3(MBP-DFG). These results provide further 
evidence for modular addition of MBP-UreDFG to urease to form the pre-activation 
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complex, and provide the first direct observation of the long-hypothesized 
(UreABC)3(MBP-DFG)3 complex.  
IM-MS-based Modeling of (UreABC)3(MBP-DFG)3 
After calculating CCS values for (UreABC)3(MBP-DFG)3 and its subcomplexes, 
as well as incorporating other datasets that provided CCS data for the urease core and 
other subcomplexes, specifically (ureA)3, (UreAC)3, (UreABC)3, and (ureABC)3-(MBP-
ureD), (Figure 5-2A and figures III-1 – III-5) we hypothesized that the data would be 
sufficient to restrain a coarse-grained model of the (UreABC)3(MBP-DFG)3 
complex.  We started by translating each protein within the complex into a sphere with 
radius corresponding to its measured or calculated CCS. Specifically, CCS values for 
UreA, UreC, UreF, and UreD were derived from the trajectory method approximation in 
IMPACT, while values for ureB, UreG, and MBP were derived from calibrated 
experimental drift times. In terms of the urease core complex (ureABC)3, our 
experimental CCS values were in close agreement with trajectory method 
approximations from IMPACT, with an error of -1.4%. We leveraged this data, as well as 
experimental data for (ureA)3 and (UreAC)3 to build a coarse-grained model of the 
urease core that matched our experimental dataset with errors <1%.(Figure 5-2 B and 
5-2 C) Importantly, we found it was necessary to model ureC as two spheres 
representing each domain within the protein chain, as it was impossible to accurately 
recapitulate the shape and CCS of the complex otherwise. 
 Once an accurate model of the urease core was developed using gas-phase 
restraints, we developed a restraint-based scoring function for a Monte-Carlo search for 
a representative sample of structures for the complete pre-activation complex that agree 
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Figure 5-2 IM-MS restraints for building molecular 
models of (UreABC)3(MBP-DFG)3.. A) left panel: CCS 
restraints used to build the urease core scaffold 
(UreABC)3, and to restrain the interaction between 
maltose binding protein (MBP) and ureD. Right panel: 
CCS restraints for target complexes used to filter large 
ensembles of structures generated using a Monte Carlo 
search in IM-MS_modeler. Comparison of the X-ray 
structure of (UreABC)3 (B) with a coarse-grained model 
generated with IM-MS data (C) that is used as a scaffold 
to for modeling of (UreABC)3(MBP-DFG)3. D) Results of 
filtering an ensemble of 25,000 putative structures of 
(UreABC)3(MBP-DFG)3 based on biophysical and 
experimental data. “0” restraints filters only by general 
biophysical parameters related to the interaction 
geometries of proteins, “1”, “2”, and “3” restraints 
incorporate filters for the experimental CCS values +/- 
3% for (UreABC)3(MBP-ureD), (UreABC)3(MBP-DFG)2, 
and (UreABC)3(MBP-ureDFG)3, respectively.  
with our experimental IM-MS data. The 
restraints in our initial scoring function 
included a rigidly restrained model of 
MBP-UreD, however all other restraints 
were defined simply by connectivity, 
which allows subunits to adopt a range 
of distances and orientations as long as 
they remain in contact. Some of these 
connectivity restraints were derived from 
previous studies which demonstrated 
connectivity between UreC:UreD, 
UreB:UreD, UreD:UreF, and 
UreF:UreG.[19,13] Although detailed 
structural information is available for the 
UreD:UreF and UreF:UreG found in 
homologous complexes,[18] we chose to 
only assign connectivity rather than rigid 
distance restraints to avoid biasing the 
model toward interactions that may not 
be present in the (UreABC)3(MBP-DFG)3 
structure. We generated 25,000 possible 
conformations for the complex of MBP, 
UreD, UreF, and UreG with respect to the urease core structure, with the same C3 
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symmetry enforced as found in the core.[12] In the next step, we filtered models based 
on biophysical restraints that govern maximum and minimum levels of inter-digitation 
observed for protein-protein interfaces, which manifests as an overlap between the 
spheres representing single-domain protein subunits in our models.[24] This filter 
brought the ensemble down to 13,317 models, which were subjected to the next round 
of filtering based on agreement with experimental CCS data. In this step, we used 
IMPACT to calculate CCS values for each model, as well as subcomplexes within a 
given model. Models were passed into the filtered ensemble if they agreed with the 
experimental CCS value for (UreABC)3(MBP-DFG)3,  (UreABC)3(MBP-DFG)2, 
and  (UreABC)3(MBP-D) within +/- 3%. In Figure 5-2 D, each CCS restraint decreases 
the size of the ensemble, indicating that each adds unique information about the 
structure of the pre-activation complex. The structures in the resulting ensemble, 
matching all biophysical and experimental CCS restraints, were then subjected to 
structural analysis by hierarchical clustering. The resulting dendrogram (Figure 5-3 A) 
reveals strong clustering of structures within the final ensemble into 3 families, denoted 
as cluster 1, cluster 2, and cluster 3. In Figure 5-3 B, each cluster is visualized by 
plotting the median structure of each cluster plus the kernel density function that 
represents probability density of structures around the median. Visual analysis of these 
clusters reveals key ambiguities present in our data. First, the position of the MBP 
(brown) cannot be resolved, which is not surprising because it can adopt many 
orientations around UreD (blue) within the model. Next, the position of ureD itself is 
changed substantially between clusters, anchoring the ureDFG assembly to the right of 
UreB (red) in cluster 1, forward of ureB in cluster 2, and to the left of ureB in cluster 3. 
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Figure 5-3 Hierarchical clustering reveals ambiguity in 
under-restrained models. A) An ensemble of 252 
structures that agreed with all experimental restraints was 
subjected to hierarchical clustering analysis to identify 
structural families within the group. In this example, the 
ensemble clustered strongly into 3 structural families. B) 
Each structural family is represented by the median 
structure and the kernel density function estimated from 
the structural ensemble. Using this technique, we 
qualitatively assess the resolution and structure of each 
family. 
Our models suggest this positioning 
plays a role in the possible 
configurations for ureF (purple) and 
ureG (green) within the ensemble, 
where the clusters with ureD in 
plane with ureB and UreC (clusters 
0 and 2) adopt similar 
configurations for UreF and UreG, 
and are in contrast to the out-of-
plane conformations found in 
cluster1.  
 Although significant 
ambiguity was present in these 
models, we were encouraged by 
the strong clustering of the 
ensemble into distinct groups 
having structural differences that 
were easily assessed qualitatively. 
Since the major sources of 
ambiguity for non-MBP urease accessory proteins hinged on the positioning of ureD 
relative to ureB and ureC, we sought to incorporate data from other sources into our 
model improve the confidence in our structure assignment for the pre-activation urease 
complex.  
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Integration of Additional Structural Data for Improved Structural Resolution 
To resolve structural ambiguity within our IM-MS-derived models, we looked to 
previously reported structural data to incorporate into our model. Ligabue-Braun and 
colleagues have previously reported a model for the (UreABC)3(MBP-DFG)3 complex 
based on molecular docking that broadly agrees with existing crosslinking[19] and 
SAXS[20] datasets relating to the (ureABC)3(ureD)3 complex.[21] Specifically, the 
positioning of the UreD subunit in the LigaBue-Braun (UreABCD)3 model is broadly 
consistent with chemical crosslinks between ureC K401 and the UreD N-terminus, UreB 
K76 and UreD N-terminus, and the deactivation of UreC 515 crosslinking upon binding 
of UreD.[19] The simulated SAXS profile for the this (ureABC)3(ureD)3 conformation is 
also in agreement with experimental data. In light of this broad agreement with other 
experimental sources, we used the (UreABCD)3 structure put forth by Ligabue-Braun to 
restrain the position of UreD in our coarse-grained model. Although Ligabue-Braun and 
colleagues in provided a model for the fully assembled  (UreABC)3(MBP-DFG)3 
complex, we chose not include any restraints related to higher order complexes into our 
model, as we could find little experimental support for the positioning of ureF and ureG 
within the (UreABC)3(MBP-DFG)3 complex. When we implement these new restraints 
for the (ureABC)3(ureD)3 subcomplex, the resulting structures are largely in agreement 
with the ureB:ureC:ureD configuration in cluster 2 from our initial modeling effort (Figure 
5-3B), where MBP-UreD is found proximal to the active site, on the left side of UreB and 
oriented toward the back of the urease complex. (Figure 5-4 A-B)  
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Using this new model as a 
scaffold, we repeated our Monte-Carlo 
search for 50,000 possible structures 
that represent the conformational space 
available to UreF and UreG within this 
model. Filtering this ensemble by the 
previously discussed biophysical 
restraints resulted in 16,308 candidate 
structures, which were then filtered by 
agreement with experimental CCS to 
yield a population of 443 structures. 
Remarkably, upon clustering of these 
structures, only weak clustering was 
observed, indicating two closely-related 
structural families. (Figure 5-4 C; note 
that spheres corresponding to MBP have 
been removed for clarity) Indeed, the 
standard deviation of this pre-clustering 
ensemble was consistent with the post-
clustering standard deviation from the 
previous modeling output, indicating that 
restraining UreD resulted in a 
significantly narrowed ensemble of 
models for the pre-activation complex. 
(Figure 5-4B). Visualization of these 
Figure 5-4 Resolving ambiguity by integrating new data. A) 
A previously published all-atom model of (UreABC)3(ureD)3 
was used to restrain the position of ureD in our coarse-
grained scaffold structure. B) Additional restraints 
significantly increase the resolution of the model as 
measured by the standard deviation within the ensemble. 
Blue bars indicate IM-MS data only, red bars indicate IM-
MS data plus restraints on ureD from a previous model. 
The standard deviations of the entire ensemble and each 
cluster are reported.  C) Hierarchal clustering of the new 
ensemble reveals weak clustering into two structural 
families, indicating a more homogenous population of 
structures. D) Median structures and kernel density 
estimates for the two structural families identified.  
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structural families reveal that the experimental data define a discrete structural space that lies 
between a largely planar and extended structure, and a slightly more compact structure 
featuring ureDFG modules directed toward the back of (ureABC)3 (Figure 5-4D). 
 Comparison with previous models. Although our coarse-grained model 
incorporated some elements of the model put forward by Ligabue-Braun,[21] a detailed 
analysis of our IM-MS-derived structural models reveals significant differences in the 
expected conformations for the urease (UreABC)3(MBP-DFG)3 complex. Figure 5-5A 
shows the RMSD distributions for two structural ensembles derived from the coarse-
grained version of the Ligabue-Braun model. The first ensemble, represented by a blue 
histogram with a black Gaussian fit, incorporates no experimental CCS data, and 
represents the entirety of conformational space that can be adopted by UreF and UreG 
on a scaffold of (UreABCD)3. The same ensemble after filtering by our experimental 
CCS restraints is represented in green with an orange Gaussian fit (The 
frequency axis is scaled in order to enable unbiased comparison, but the actual 
frequencies are approximately 10-fold lower for the filtered ensemble). This result 
reveals that an ensemble filtered by our experimental CCS data is only minimally 
enriched for models akin to the Ligabue-Braun model, indicating only weak agreement 
between our experimental data and the model. Since direct comparison of experimental 
CCS with that calculated from the Ligabue-Braun model is difficult due to the presence 
of the MBP tag in our experimental data, we also compared the CCS values for our 
entire ensemble of experimentally-restrained models with CCS values calculated from 
the Ligabue-Braun model. In figure 5-5 B, we compare CCS values for our 
experimentally restrained models and theoretical CCS values computed from the all-
atom structures proposed by Ligabue-Braun. CCS values for our experimentally 
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Figure 5-5 Comparing IM-MS-derived models with structures from 
molecular docking. A) RMSD distributions of IM-MS derived models 
from a reference model generated using molecular docking and 
integrative modeling. The blue distribution (black Gaussian fit) 
represents an ensemble of structures generated from the 
(UreABC)3(ureD)3 scaffold with no filtering by experimental CCS 
restraints. The green ensemble (orange fit) represents the same 
ensemble filtered by experimental CCS (frequency axis 
normalized). B) Experimental and predicted CCS values for several 
urease complexes. Blue dots indicate IM-MS-derived models where 
the error bars represent two standard deviations, green and red 
dots represent calculated CCS values for the reference structure by 
the trajectory method approximation and scaled projection 
approximation, respectively. C) Qualitative comparison of the kernel 
density function of an IM-MS-derived ensemble with a coarse-
grained representation of the reference structure.  
restrained models are 
shown as blue dots, with 
error bars representing 2 
standard deviations within 
the ensemble. CCS values 
for the Ligabue-Braun 
model were calculated 
using a linearly scaled 
projection approximation 
method (PA*1.15), as well 
as the trajectory method 
estimation (TJM) within 
IMPACT in red and green 
circles, respectively. 
Interestingly, although the 
TJM values agree very well 
with our experimental 
measurements for smaller 
complexes like (ureABC)3 and (ureABC)3(ureD), we also note increasing deviation 
between these values as additional subunits are added. In contrast, the scaled 
projection approximation values for the high-resolution models put forth by Ligabue-
Braun are consistently 12% to 20% lower than the CCS values associated with models 
generated from IM-MS. To understand these deviations from predicted model CCS 
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values, we built a coarse-grained model based on Ligabue-Braun’s structure and 
superimposed it into the density cloud calculated from our IM-MS restrained ensemble. 
(Figure 5-5 C) This representation reveals that the ensemble restrained by our 
experimental CCS generally adopts a more extended conformation than the previously-
reported model. Although a portion of the experimentally-derived models do agree well 
with the Ligabue-Braun model, specifically those in cluster 2 shown within figure 5-4, it 
is clear that our IM-MS experiments sample a somewhat different ensemble of protein 
quaternary structures preferentially. 
 
5.5 Conclusions 
In this study, we characterized the 610 kDa, 18-subunit urease pre-activation complex 
using IM-MS. To our knowledge, this complex, among the largest heterocomplexes to be 
characterized by IM-MS, has not been directly observed by any other method. We used CCS 
values derived from ion mobility drift times of the fully assembled complex, as well as several 
subcomplexes to build coarse-grained models revealing possible gas-phase structures of the 
complex. Our IM-MS data alone was not sufficient for unambiguous structural assignment, but 
when combined with data from chemical crosslinking, SAXS, and molecular modeling, we were 
able to define a narrow population of possible structures falling within our experimental 
restraints.  
Our model shares major structural features with other models proposed by 
computational docking, however it differs in the angle of ureDFG modules relative to the urease 
core structure. By estimating kernel density functions for ensembles of experimentally-
restrained structures, we visualized the discrepancies between our experimental data and the 
previously reported model. These discrepancies may be due to gas-phase rearrangements of 
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the (UreABC)3(MBP-DFG)3 complex, they may also be representative of how the complex may 
alter its structure under different experimental conditions, or related to the scarcity of 
experimental data restraining previous models.  We note that due to the size and putative 
structures of the proteins involved, a scenario that rationalized the above-described differences 
based solely on a gas-phase rearrangement is unlikely, and that the relative flexibility of the 
urease pre-activation complex has been discussed in detail previously. 
In summary, the model of the urease pre-activation complex presented in this report represents 
the most restrained structure of the assembly to date, representing a consensus of datasets 
acquired through IM-MS, chemical cross-linking, and SAXS experiments reported from multiple 
laboratories.  Clearly, urease activation includes additional steps and protein binding events in 
order to load the enzyme with its required dinuclear Ni2+ core, but given the information content 
presented in this report we expect that our model will drive new discussions surrounding the role 
of this activation complex in the context of current urease activation mechanisms.  Furthermore, 
the lability and size of this complex represents a frontier for the IM-MS technique in terms of its 
capabilities to build structural models of such large protein hetero-oligomers, and points to a 
bright future for the tool in similar structural biology efforts. 
5.6 Supporting Information 
Supporting Information can be found in Appendix III 
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Chapter 6: Applications of IM-MS for Studying 
the Self-Assembly of both Natural and 
Engineered Protein Complexes 
6.1 Abstract 
The ability of proteins to assemble into higher-order structures is fundamental to 
many biological processes.1 Additionally, this phenomenon presents intriguing 
opportunities for engineering macromolecular structures or machines from rationally 
designed proteins.2,3  The study of protein interfaces has shown that these interfaces 
are incredibly diverse, and feature hydrophobic and polar interactions that are highly 
tuned for modulating the strength and specificity of the interaction.4 In some cases, 
unstructured interaction domains facilitate highly regulated protein-protein interactions 
based on allostery or solution conditions.5 As discussed in previous chapters, methods 
for accurately measuring the stoichiometric and conformational equilibrium of protein 
complexes are limited, and IM-MS methods provide can provide unique insight into 
equilibrium and structure simultaneously.6-8 In the first sections of this chapter, work is 
presented where the equilibrium stoichiometry of several engineered protein complexes 
is assessed.  In the last section, I discuss the use of the IM-MS modeling techniques 
developed in the previous chapters to elucidate gas-phase structures of ApoE tetramers
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6.2 IM-MS Evaluates de novo -designed coiled coils as off-the-shelf components 
for protein assembly 
Protein engineering seeks to build amino acid sequences either from scratch or 
as derivatives of existing sequences to access new structures and functions.9 Control of 
protein-protein interactions is a longstanding goal within this field, as it may allow for 
modulation of enzymatic or regulatory activities of proteins, or directed assembly into 
macromolecular protein structures.2 Although the composition of protein interfaces 
throughout nature is well understood, rational design of existing interfaces, and 
especially de novo design of interfaces remains extremely difficult.10 One emerging 
technique for driving oligomerization of proteins leverages α-helical coiled-coil domains 
inserted at the ends of polypeptide chains.11 The self-assembly of coiled-coil domains is 
one of the most well-studied protein-protein interaction types, where the sequence of 
the repeating canonical heptad of amino acids in the coil governs the interactions 
between the coils. Indeed, many sequence variants of coiled coils have been shown by 
crystallography to self-assemble into various oligomer numbers,12 and software tools are 
also available for prediction of self-assembly based on variations to canonical sequences.13 
Despite the wealth of knowledge in this area, the oligomerization of coiled coils has not 
been examined in detail under the conditions commonly used for protein engineering.14  
In this study, we use ion mobility mass spectrometry to evaluate protein 
complexes engineered to self-assemble using coiled coils. In the first experiments, we 
used green fluorescent protein as a monomeric model system to provide proof of 
concept for the use of coiled coils to form GFP oligomers. IM-MS is capable of 
assigning both the oligomerization states and the integrity of protein folds for samples 
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like these, as has been reported previously.15 Next, we leveraged the symmetry of 
protein interactions within native esterase trimers to direct self-assembly into protein 
cages using coiled-coils. The resulting complexes are macromolecules between 400 
and 800 kDa, consisting of at least 12 subunits. Some of the work presented here is 
previously published1614 
6.1.1 Methods 
All protein constructs were designed by the Marsh group (University of Michigan, 
Department of Chemistry) and expressed and purified using standard protocols [14] 
including SEC as the last step before IM-MS sample preparation. For green 
fluorescence protein constructs and tetrahedron constructs, samples were prepared for 
mass spectrometry concentrated to 40 μL. The minimum concentration of protein 
required for analysis was 1 μM. Samples were then loaded into gold plated needles 
prepared in house as previously described.15 Nano-electrospray-ion-mobility-TOF mass 
spectrometry was performed using a Synapt G2 Traveling-Wave instrument (Waters 
Corp, Manchester, U.K.). Ions were generated by applying a voltage of 1.5 kV between 
the needle and the instrument source, with further voltage drops aiding in acceleration 
and desolvation as ions passed through the skimmer region of the instrument. The 
quadrupole region was set to RF-only mode for collection of complete mass spectra, 
and in some cases was tuned to isolate selected peaks for MS/MS analysis. A range of 
collision energies was tested for enhanced transmission and desolvation of the ions, 
and in some cases dissociation of the ion into its component subunits. The base values 
for collision energies were 20–50 V; however, energies up to 150 V were utilized for 
dissociation experiments. The IMS region of the instrument was operated at 4 mBar of 
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nitrogen, with wave heights and wave velocities of 15 V and 150 m s−1, respectively. 
The instrument time of flight mass analyzer was operated in sensitivity mode, and mass 
spectra were collected from 1000 to 15 000 m/z. Data analysis was performed using the 
manufacturer-provided Masslynx software.  
 In order to analyze octahedral structures, after SEC, samples were concentrated 
to ∼5 mg/mL and then buffer-exchanged into 200 mM ammonium acetate, pH 7.0, using 
a Bio-spin P30 column (Bio-Rad, Inc.); 2–3 μL of the sample was loaded into glass 
capillary (approximate o.d. of 1.5–1.8 mm and wall thickness of 0.2 mm) before 
mounting to the source of an Exactive Plus EMR mass spectrometer (Thermo Fisher 
Scientific, housed in the Ohio State University Campus Chemical Instrument Center). 
An electrospray voltage of 1.2 kV was applied to the sample using a platinum wire 
inserted into the capillary, the source temperature was set to 175 °C, in-source CID was 
minimized to 1 V or 2 V, HCD was 20 V, the resolution was set to 17,500, and other 
instrument parameters were set as described previously. Data processing was 
preformed using MMass.17 
6.2 Results and Discussion 
6.2.1 Evaluation of GFP-coiled-coil oligomerization states To evaluate the 
propensity of coiled coils to drive the oligomerization of monomeric GFP, we analyzed 
the native MS spectra of several constructs coupling specific coiled coil sequences to 
the c-terminus of GFP (Figure 6.2.1 A) using the Q-ToF analyzer platform. Accurate 
mass measurements were obtained for the WT GFP monomer  at 29,053 +/- 5 Da, and 
no oligomers were observed, indicating that effects from artifactual concentration-
dependant ESI oligomers were neglible.18 (Figure 6.2.1 B) When coiled-coils were 
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added to GFP at the C-terminus, however, clear signs of oligomerization were 
observed. New signals with masses around 65,000 and 98,000 Da are clearly 
observable in these spectra, indicating an 
 
Figure 6- 1 Evaluation of Coiled Coils for Oligomerization of GFP monomers. A) Schematic of the amino 
acid sequences for the C-terminal fusion proteins screened in this study. B)  Characterization of the 
Oligomerization of Fusion proteins containing Heptad Repeat Coiled Coils. The heptad oligermization 
state is the predicted oligomerization for coiled coils in isolation, whereas the multiprotein oligomerization 
state is the observed state from our experiments. The mass is column represents the mass of the most 
abundant oligomer in the sample.  
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equilibrium of monomer, dimer, and trimer populations exist when coiled coils are 
implemented. Generally, the oligomerization states observed GFP constructs 
correspond to those predicted from X-ray and computational analysis of the coiled coil 
sequences.  Conversely, analysis of the LAAIKQE sequence by native MS revealed 
tetramers for the coiled coils alone but signals only up to trimer were for GFP constructs 
incoreprating this sequence. Overall, these results indicate that although most coiled 
coils operate as expected when assembling large protein complexes, steric effects may 
inhibit the formation of some higher order structures (e.g. tetramers).  
 
6.2.2 Evaluation of the effects of coil position on GFP structure 
 Preservation of protein tertiary structure following sequence manipulation is a key 
factor in the success of protein engineering efforts, as the disruption of major structural 
components can lead to misfolding and uncontrolled aggregation.  To further 
understand the effects of coiled coil domains on the native structure of GFP, we 
analyzed the transposition of the IAAIKQE GFP construct shown in the previous section 
to successfully form trimers. This transposition constructs were structured with the 
IAAIKQE heptad repeat domain now on the N-terminus of the GFP, as opposed to C-
terminal coiled coils from Figure 6.2.1 A in the previous section. Surprisingly, we found 
that that placement of the coiled coil on the N-terminus greatly disrupts the GFP 
structure. Figure 6.2.2 A shows native state ion mobility and MS-only data for the N-
terminal construct II4, which correlates directly to the transposition of IAAIKQE. Here, 
we observe that the transposition of the oligomerization domain to the N-terminus 
removes the assembly potential for these proteins, resulting in signal for only 
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monomeric subunits.  We then characterized the effects of strengthening the interaction 
of the IAAIKQE n-terminal oligomerization domain by adding another heptad repeat. 
These studies showed that the addition of extra repeating units to these helices 
increased their  ability to form larger oligmers substantially.12 In figure 6.2.2 B we show 
that in this N-terminal construct the integrity of the GFP monomer structure appears to 
be affected, as evidenced by large amounts of highly charged, low m/z signals that 
indicate the increased surface area of the GFP monomers and are symptomatic of 
protein  
Figure 6- 2 Evaluation of the effects of coiled-coil fusion on protein structure. A) 
Transposition of the IAAIKQE 4-heptad repeat from the  previous section to the N-terminus 
of GFP was evaluated, IM-MS data and standard MS data is provided to show oligomer 
distributions and relative signal intensities. B) A strengthened oligomerization domain 
featuring a 5-heptad repeat is evaluated. 
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unfolding.19,20 Additionally, the IM-MS spectra for these constructs revealed increased 
drift times for these highly charged signals, providing further evidence of protein 
unfolding. Despite the predominance of signals associated with unfolded proteins in 
these spectra, we do observe evidence of assembled oligomers, including the targeted 
trimers. We take this result with caution, however, as we also observe hexameric 
complexes that indicate the presence of nonspecific aggregation in this sample.  
 
6.2.3 Symmetry-directed Assembly of Protein Cages using Coiled Coils 
 After evaluating the fidelity of coiled coils for engineering the self-assembly of 
monomeric proteins, we set out to develop protein cages by leveraging the natural 
symmetry of a trimeric esterase. In this esterase, the c-terminus of each monomer is 
oriented toward the apex of the trigonal structure formed by the protein complex, 
making it a strong candidate for potential self-assembly into a protein cage with the 
addition of c-terminal coiled coils. We introduced the IAAIKQE coiled coil into the c-
terminus with an 8-glycine linker and to introduce a C3 oligomerization element at the 
apex of each esterase trimer. The predicted geometry for the resulting self-assembled 
structure would be a tetrahedron, as shown in figure 6.2.3 A. Indeed, comparison of 
native MS spectra for a control fusion protein with non-oligomerizing coils (figure 6.2.3 
B) and those with the IAAIKQE, coiled coils reveals high propensity for oligomerization 
into a monodisperse population of complexes with N = 12 subunits. Within the resulting 
native MS data, we observe a smaller population of esterase trimers with N = 3 subunits 
that did not oligomerize. We attribute this behavior to the solution-phase equilibrium for 
these interactions, however due to differences in ionization and transmission efficiency 
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in native MS analysis between N =3 and 
N =12, we predict the efficiency of the 
self-assembly process is higher than 
what is indicated in our data.21,22  
 Next, we undertook a similar 
study utilizing tetramer-forming 
LAAIKQE coiled coils to drive C4 
symmetry around the c-termini of the 
esterase trimer, which we predict would 
result in an octahedral protein cage. Due 
to the size of this complex, we were not 
able to obtain charge-state resolution 
using the Synapt G2 IM-MS platform, 
making determination of m/z ratios for 
the signals observed impossible. The 
Orbitrap Exactive EMR platform is in 
some cases able to obtain better 
resolution for large complexes, due 
largely to its heated-capillary inlet that 
allows for more efficient desolvation of 
large ions. Using this platform, we 
observed signals corresponding to two 
Gaussian-like distributions in m/z, one 
Figure 6- 3 Symmetry-directed Assembly of Protein 
Cages. A) Schematic of the symmetry directed 
approach. B) Control native MS data for the esterase 
trimer with “dummy” coiled coil fusions. C) Native MS 
data for the trimeric esterase fusion with XXX coiled 
coils. C) Native MS data for the trimeric esterase 
fusion with LAAIKQE coiled coils. 
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centered around 11,000 m/z and the other around 13,000 m/z. By increasing the in-
source CID energy from 1V to 2V, we increased the observed intensity for  the signals 
observed at 11,000 m/z substantially, indicating some amount of disruption for the intact 
assembly. However these settings also allowed for charge-state resolution of both 
distributions at around 90% of the max intensity. Deconvolution of the m/z peaks 
revealed the masses of the two distributions 757 ± 7 kDa and 887 ± 5kDa, 
corresponding to N = 21 and N = 24 subunits, respectively. With the help of cryo-
electron microscopy, we verified that the N= 24 subunit structure did in fact form an 
octahedral geometry. SEC and ultracentrifugation data for these samples revealed a 
homogenous population, with masses corresponding to N =24, so we attribute our 
observation of N = 21 species to dissociation events occurring during the buffer 
exchange process for native MS, or perhaps an non-canonical gas-phase dissociation 
event, as the relative populations of these species were highly dependent on the in-
source CID energies (data not shown). 
6.2.4 Conclusions 
 In this section, we demonstrated the utility of native IM-MS for aiding in the study 
of protein self-assembly, specifically in the context of protein engineering. IM-MS 
provides sequence analysis to confirm the identity of an engineered construct, a 
snapshot of the equilibrium distribution of stoichiometries the sample, and information 
regarding the integrity of protein tertiary structures in a single experiment.  Using this 
technology, dozens of engineered GFP protein variants were screened in a matter of a 
few hours, providing robust information to guide the next round of engineering. In the 
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future, higher throughput analyses may be possible using automated screening 
workflows.  
6.3.0 Elucidating the Structure of Gas-Phase ApoE Tetramers 
 Apoplipoprtoein E (apoE) is the primary cholesterol transporter in the brain, and 
is implicated in both Alzheimer’s and cardiovascular disease.23 Genetic sequencing has 
correlated the presence of ApoE isoforms with these diseases, although at the chemical 
level, apoE isoforms only differ by amino acid substitutions at two sites.24 The ε4 allele 
produces an apoE proteoform with arginines at sites 112 and 158, and has the 
strongest risk for Alzheimer’s disease associated with it compared with ε3 and ε2 which 
replace arginine with cysteine at one or both sites, respectively.  Lipid-free apoE is 
known to assemble into a homotetramer at physiological concentrations in the low 
micromolar range, and these associations are believed to be important in apoE 
pathogenesis due to the potential sequestration of lipid binding sites  within the protein 
complex.25 High resolution structural information on near-native apoE is limited to an 
NMR structure of a monomeric mutant in which 5 C-terminal residues were deleted to 
inhibit oligomerization.26 In this structure, the C-terminal domain  is revealed to be a 
helix that wraps around the largely globular N-terminal domain.  Other studies, however, 
have provided evidence for more extended apoE structures, where the C-terminal 
domain is proposed to generate a new conformation that is independent of the N-
terminus.27-29 
 In this study, we integrated IM-MS with molecular modeling, ECD and CIU to 
provide the first structural characterization of the ApoE tetramer.  Here, we relied on IM-
MS datasets collected by collaborators at Washington University in St. Louis to build a 
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coarse-grained model of apoE. As discussed in chapter 4, coarse-graining can 
introduce errors into a molecular model, and care must be taken to ensure that all 
structural elements are represented properly. In this case, we encountered a system 
where coarse-graining errors made it impossible to find models consistent with all of the 
input data, guiding us toward a higher-resolution depictation of the protein complex and 
a more informative result. 
6.3.1 Materials and Methods 
Coarse-grained modeling was performed using IM-MS_Modeller, a  Monte-carlo 
annealing algorithm built within the Integrative Modeling Platform library in Python 
described in Chapter 4.Experimental data was input in the form of spherical radii 
corresponding to measured collision cross sections, and in some cases distance 
restraints between multiple spheres that optimized agreement with experimental cross 
sections. Ensembles of 10,000 models were generated according to scoring functions 
with and without C4 symmetry constraints, and models with tetrahedral symmetry were 
generated by applying the appropriate transformation to the C4 models. For each 
ensemble, we calculated CCS values using the IMPACT projection approximation and 
considered only models within +/- 3% of the experimental cross section. Models 
agreeing with all CCS datasets were then clustered into an average-linkage hierarchy 
using a pairwise RMSD matrix, and the probability density function of each cluster was 
estimated using gaussian kernels.  
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6.3.2 Results and Discussion 
 A typical IM-MS modeling workflow involves representation of protein subunits as 
spheres with radii corresponding to experimental CCS.7 Additionally, common restraints 
on the interactions between subunits include rigidly defined distances, or connectivity 
restraints that are more ambiguous in terms of their absolute geometry.  Moreover, 
symmetry may be incorporated in some models to increase sampling efficiency where 
symmetric elements are hypothesized. In the case of apoE, native IM-MS was 
performed for all variants and a population of species was observed, with tetramers as 
the dominant oligomer, accounting for at least 60% of the total signal. Monomers were 
observed at appreciable levels around 20-30% total intensity, with small amounts of 
dimer and trimer accounting for the remaining signals. Interestingly, we found no 
significant differences between the apoE isoforms in terms of oligomerization potential. 
The similarities between isoforms extended into the ion-mobility dimension, with each 
isoform giving rise to CCS values within 2% of the mean value of 2420 Å2 and 7540 Å2 
for the monomer and tetramer, respectively.   
A simple model of the apoE tetramer was build using spheres corresponding to 
monomeric CCS that employed only basic connectivity restraints, requiring that each 
subunit was connected to at least two other subunits. The rationale for this connectivity 
restraint was that a linear connectivity was unlikely given that oligomerization did not 
extend indefinitely through pentamers, hexamers, and other larger stoichiometry 
assemblies. After generating 1,000 putative structures using this set of restraints, we 
filtered these structures based on the tetrameric CCS as measured by the IMPACT 
projection approximation. Surprisingly, only 5 structures out of the ensemble of 1,000 
 129 
 
were within 3% of our 
experimental CCS. Further 
analysis of the ensemble of 
structures reveals that 
distribution of CCS values falls 
well below the experimental 
dataset, and only the most 
extreme CCS values approach 
our experimental result.(Figure 
6.4)  Analysis of the distances 
between each subunit in the 
group of structures agreeing with our experimental CCS revealed that although the 
connectivity restraint had been satisfied, connecting subunits only had a spherical 
overlap value of about 5%, well under the threshold for biologically relevant interactions, 
which is generally a minimum of 15%. From this result, we hypothesized that the 
assumption of sphericity, which holds for many globular, single domain proteins, is not 
appropriate for the dynamic two-domain structure of apoE.29 That tetrameric apoE 
cannot be calibrated as a globular protein based on size-exclusion chromatography has 
also been reported earlier.29 Therefore, we developed a two-domain model for the 
monomer subunit, which agrees well with our experimental CCSs, based on the 
proposed structures for WT.27,29 We used a computational model27 that has two distinct 
domains, in contrast to the NMR structure where the domains are intermeshed. Residue 
183 was used to "cut" the domains to make a two-body structure. We then assembled 
Figure 6- 4 CCS Distribution of apoE tetramers modeled at 
subunit resolution. The CCS distribution reveals that models 
generated from sbunit-level representations of the apoE 
monomer are significantly more compact than our experimental 
measurements suggest. An example of a high scoring model 
reveals that the inter-subunit distances within the most 
extended models in this ensemble do not agree with 
biophysical restraints on interprotein distances.  
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four copies of this two-domain monomer via connectivity restraints applied to the C-
terminal domain for the generation of tetramer models. Modeling conducted with and 
without C4 symmetry enforced on the complex yielded similar structural ensembles that 
agreed with the recorded experimental CCS values. For simplicity, we present the 
results that possess C4 symmetry, and consider tetrahedral symmetry separately as a 
control. Through analyzing the dendrogram that represents hierarchical clustering of the 
 
Figure 6- 5 Figure 6- 6 Modeling the apoE tetramer at domain resolution from IM-
MS data. A.) Hierarchical clustering of models satisfying all experimental and 
biophysical restraints represented as a dendrogram with two structural families 
identified. B.) CCS values for median structures in each cluster agree with 
experimental results (relative error in parenthesis), with the exception of 
tetrahedral structures. C.) Median structures for each cluster (plus an example 
tetrahedral structure) are plotted within their kernel density functions to visualize 
the most probable structures and the ambiguity within each cluster. 
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ensemble of C4-symmetric structures that exhibit good agreement with all 
experimental data, two distinct families of structures are revealed, with each having a 
median structure which falls within 1% of the experimental CCS for the tetramer (Figure 
6.5A and B). Visualizing the kernel density function and median structures of each 
family reveals the presence of planar and non-planar families. The most common 
family, the non-planar structure pictured as cluster 1 within Figure 6.5 C represents over 
80% of the possible solutions as compared to the planar structure which represents the 
other 20%. To avoid biasing our modeling approach toward C4-symmetric structures, 
we transformed a selection of the C4 models into tetrahedral structural to measure the 
impact of such a step on the eventual model CCS values. For these tetrahedral 
structures, we observe that the resultant CCS increases to values on average 30% 
larger than our experimental result, strongly indicating that apoE does not produce 
tetrahedral symmetry.  
6.3.3 Conclusions 
Combined with evidence from other targeted structural biology techniques, IM-
MS has provided the first structural model for the apoE tetramer. ECD datasets (data 
not shown) also complement our IM-MS-based models, where data indicates that the C-
terminal regions of apoE undergo significant amounts of electron capture and 
dissociation, indicative of their relatively large exposed surface area. The IM-MS and 
ECD data discussed above are at odds with a previously-hypothesized tetrahedral 
geometry for the apoE tetramer, and point more strongly to parallel association along a 
C4 axis. Our analysis highlights the importance of properly representing protein domain 
structure within IM-MS derived models . Our inability to generate physical models that 
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matched our experimental data at the subunit-level of coarse graining  led us to develop 
a two-domain model for the apoE monomer that was consistent with both the literature 
and our experimental results. Importantly, IM-MS based modeling of apoE tetramers did 
not lead to anunambiguous structural determination. In our analysis, two putative 
structures emerged as well-defined structural families within an ensemble of possible 
structures. We hope that reporting the ambiguity present in our data results in future 
hypothesis-driven structural studies using other experimental methods capable of 
properly annotating such uncertainty.  
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Chapter 7: Conclusions and Future Directions 
 This dissertation has focused on new contributions to gas-phase structural 
biology and drug discovery by way of two major techniques: Multiprotein complex 
modeling via IM-MS datasets and the study of proteins and protein-ligand complexes by 
CIU. In both of these areas, significant progress has been made in designing 
experimental workflows as well as informatics tools for  extracting maximal information 
from complex systems and processes. 
7.1 Findings and Future Directions for Integrative Modeling of Multiprotein 
Complexes 
 Our studies of multiprotein complexes have focused on the utility of IM-MS 
datasets in restraining the connectivity and structure of heterogeneous protein 
complexes. Although previous work in this area has provided proof-of-concept for such 
studies,1-3 we were unable to confidently model some reference complexes based on 
simulated IM-MS data using current approaches, indicating that more development had 
to take place before IM-MS data could be widely used for protein topology assignment. 
The studies in this dissertation highlight the power of IM-MS to restrain models of 
multiprotein complexes; however, we are also approaching a clearer definition of the 
limitations of the technique. Although we envisage IM-MS being used in conjunction 
with other datasets as part of a much broader integrative modeling workflow,4-6 the 
details of IM-MS-only datasets must first be worked out before
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understanding how this data can complement other types of information. In Chapter 4, 
we undertook a series of bioinformatics experiments focused on the ability of IM-derived 
CCS restraints to accurately restrain the topology of multiprotein complexes. We found 
that one limitation is the use of heavily coarse-grained models at the subunit resolution 
leads to the introduction of CCS errors in model structures. On the other hand, we find 
that only modest increases in resolution, where subunits are modeled at the domain 
level, can nearly eliminate coarse-graining errors in the context of protein complexes. In 
Chapter 6, we outlined a method for generating domain-level coarse grained models 
from partial high-resolution structures 
and bioinformatics. When this 
information is not available, however, 
CIU may be a powerful tool for 
assignment of domain structure, and 
even the sizes of such domains. 
Previous work in the lab, and work 
from chapter 2 and 3 in this 
dissertation has found high correlation 
between CIU and protein domain 
structure,7 and as we continue to gain 
understanding of the mechanism of 
CIU, we believe this data could be 
directly integrated into domain-level 
models of protein subunits.8  
Figure 7- 1 Challenges in Integrative Modeling of Protein 
Complexes From MS datasets.  
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 In order to sample structures that fit experimental datasets with more confidence, 
we developed a novel Monte Carlo algorithm9 that efficiently samples the entirety of 
structural spaced defined by the input restraints. Using this tool, we defined the 
information content of CCS measurements in terms of their effects on the positive 
predictive power when modeling known complexes. Moreover, the effects of symmetry 
and modularity were explored, pointing toward new directions for the integrative 
modeling field. We envisage a platform for facile integration of MS-based datasets to 
understand protein complex structure. In Figure 7-1, we outline current workflows, 
challenges, and potential solutions for such a platform.  The studies in this dissertation 
have focused on predicting the resolution and accuracy of models based on the 
completeness of the input restraints, as well as utilizing a probabilistic approach for 
assigning confidence to models. In the immediate future, multiresolution objects must 
be integrated into this workflow in order to harness the power of covalent labeling 
experiments such as HDX,10 FPOP,11 and CXL.12 Once these multiresolution objects 
are implemented and restrained by experimental data, the structural landscape to 
explore will become much more complex, and so we also see the need for more 
rigorous investigation of optimization algorithms incorporating replica exchange13,14 or 
dynamic weighting of restraints.15   
7.2 Conclusions and Future Directions for CIU as a Structural and Drug Discovery 
Tool 
 Work in this dissertation focused on understanding the CIU process and 
importantly, developing robust data analysis tools to help bring CIU measurements 
toward the mainstream of structural biology tools.16 In chapter 2, we demonstrate our 
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software package CIUSuite that allows users from many IM-MS groups worldwide to 
batch process large amounts of data, and draw quantitative comparisons between the 
unfolding processes of different analytes. Although the principles of CIU used in the 
context of drug screening have been demonstrated,17-19 widespread adaptation the 
technology is hindered by a lack of understanding of the physical process of CIU, and 
specifically how it relates to solution-phase structure.  
 In Chapter 3, we investigated the mechanism of unfolding for a series of 
multidomain serum albumins.8 In our studies we found that the stability of unfolded 
intermediates of protein ions is sensitive to subtle changes in primary structure, but the 
overall CIU pathway is dependent on the tertiary structure and specifically the domain 
organization of the protein. Additionally, we found that the ejection of small molecules 
during the CIU process was highly correlated with specific structural transitions, which 
allowed us to develop a model of albumin unfolding based on CID of small molecules of 
known binding locations. These studies not only shed light on the unfolding processes 
of multidomain proteins, but indicated new applications of CIU and CID for studying 
localized changes in stability or ligand binding.  
 To fully understand CIU processes at the mechanistic level, more detailed case 
studies of proteins of different tertiary structures must be conducted. Importantly, it is 
extremely difficult for these studies to provide information at the atomic level, and 
therefore it is necessary to develop molecular dynamics tools to that capture complex 
ion heating and charge migration processes in the gas-phase.20 Although the effects of 
charge state on the CIU of proteins is understood broadly,21-24 it is still difficult to predict 
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how the presence or absence of charge may affect the information content of the 
experiment.  
 Future directions for the analytical side of this experiment include development of 
new technologies for increasing the throughput and information content of the 
experiment. A major limitation for CIU is the requirement that single charge states be 
isolated and unfolded to avoid convolution of signals from charge stripped products. 
Although this workflow increases the confidence in the observed unfolding fingerprints, 
it either throws out useful information from other charge states, or vastly increases the 
time of the experiment if CIU for more charge states is required. To obviate these 
problems, an algorithm for deconvolution of signals from charge-stripped ions should be 
Figure 7- 2 Adaptation of the Agilent 6560 IM-MS platform for high throughput, charge multiplexed CIU 
experiments. We envision integration of instrument control software with data analysis tools, allowing for 
maximum acquisition efficiency. Further improvements in ion activation and IMS resolution will also be 
required for maximizing the potential for high throughput CIU.  
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developed that allows CIU fingerprints for all observable charge states to be collected 
simultaneously. Moreover, automated sample handling and online signal-to-noise 
detection are key improvements to the CIU workflow that may lead to truly high 
throughput applications.  
 Recent work has focused on developing CIU workflows for the Agilent 6560 IM-
MS platform.25 This platform has the potential for high-throughput CIU experiments, 
although many parts of the process require further development. Figure 7-2 provides a 
schematic of the platform, annotated with several necessary advancements that are 
required for reaching maximum throughput and CIU information content. The first 
consideration is integrating automated sample handling and instrument control with 
online data processing, allowing for great reductions in acquisition time. This 
improvement will allow the signal-to-noise ratio of the acquired data to dictate the 
actions of the instrument: when sufficient signal-to-noise is achieved, the instrument will 
automatically move to a new collision energy or to the next sample; if the signal drops to 
minimal levels, the instrument can automatically reload the sample. Other challenges for 
this instrument will include engineering of the capillary region of the instrument to 
maximize the collision energies achieved, as they are currently not capable of fully 
activating large ions. Additionally, optimal conditions need to be found for separating 
unfolded ions across multiple charge states simultaneously.  
 All of these engineering advances will be coupled with new features within 
CIUSuite. These features will include novel data mining techniques that may expand 
into the areas of Gaussian modeling and even machine learning. In the near term, 
however, the field should focus on identifying regions of maximal heterogeneity within 
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CIU fingerprints to decrease the time spent acquiring signal at less informative collision 
energies. With a combination of the tools mentioned in this section, we feel that the time 
requirements for CIU experiments can be decreased from hours to seconds per sample.  
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Appendix I: Supporting information for Chapter 3  
 
Table I-1. Comparison of Albumins used in this study 
Species Sequence Mass Experimental Mass(Da) Experimental CCS(A2) 
Bovine 66432 66453 4060* 
Human 66472 66460 4060 
Sheep 66327 66384 4050 
Goat 66313 66361 3940 
Pig 66797 67045 4170 
Rabbit 66015 66150 4020 
Rat 65916 66024 3940 
*Literature CCS 4100 A2 
Table I-2. Protein Calibrants used for CCS Calculation1 
Calibrant Protein Mass Charge m/z Lit CCS 
avidin 64000 16 4001.01 3640 
avidin 64000 17 3765.71 3640 
Concanavalin A 103000 20 5151.01 5550 
Concanavalin A 103000 21 4905.77 5550 
Concanavalin A 103000 22 4682.83 5480 
Concanavalin A 103000 23 4479.27 5450 
Alcohol Dehydrogenase 143000 25 5721.01 6830 
Alcohol Dehydrogenase 143000 26 5501.01 6720 
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Figure I-1. CIU Fingerprints of All Homologues for 14+, 15+ and 16+ charge states 
Supplementary Discussion: CIU Feature Assignments 
For our analysis of the CCS and stability of folded and unfolded features observed in our CIU 
fingerprints, we used qualitative and quantitative (CIUSuite) metrics for deciding what was counted and 
not counted as a feature. Feature 1 is L shaped, and we have chosen not to treat the tail as a separate 
feature because it is not always differentiated from the base of feature 1, it does not remain stable for 
more than 10V in any of our datasets, and presents as a contiguous feature in drift time/energy space. 
While this feature represents more than one conformational family, we have constructed our analysis 
paradigm so that all elements of this L-shaped signal are counted as a single, unresolved feature. 
In our Human Albumin dataset, we also note a reappearance of signal in the drift time range of feature 2 
around 120V. This signal is artificially amplified due to the normalization procedures we use in CIUSuite 
to project our fingerprint plots. As collision energy is increased, the signal intensity for all ions decreases 
due to CID pathways.  Thus, we attribute this signal as an fragmented structural population related to 
feature 2. We note that the in other homologues, e.g. BSA, this anomalous feature occupies a similar 
range.  
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Figure I-2. Quantitative analysis of CIU Differences across Homologues 
 
 
Table I-3. Pairwise RMSD matrix for Albumin Homologues Generated by CIUSuite_compare 
 Bovine  Bovidian  Hominian  Porcine  Leporine  Murine Ovine 
Bovine 0  -  -  -  -  - - 
Bovidian 11.7  0  -  -  -  - - 
Hominian 14.1  16.9  0  -  -  - - 
Porcine 17.5  20.3  12.6  0  -  - - 
Leporine 14.9  13.1  13.6  13.9  0  - - 
Murine 17.9  18.1  14.1  14.1  11.2  0 - 
Ovine 8.5  7.2  15.5  18.4  12.3  18.3 0 
 
 
A.  Pairwise Comparison of CIU Fingerprints. We 
calculated  pairwise RMSD values for all CIU 
fingerprints, and plotted these values against 
differences in albumin primary structure, as 
measured by sequence identity and similarity.  
B. Regions of the Fingerprint Enriched for 
Sequence-Dependent Variation. Comparing all 
pairwise RMSD values revealed that the area from 
120 to 140V showed higher incidence of 
significant deviations in the fingerprint.  
C. Differences in Stability for Individual 
Conformers Drive Sequence-Dependent Variation 
in CIU. After quantitative measurement of drift 
times, centroid voltages, and stabilities of each 
feature, we found that feature-specific stability 
drove the vast majority of deviations in CIU. Most 
ablumins studied underwent near-identical 
unfolding pathways, achieving the same set of 
intermediate conformers, as defined by centroid 
voltage (V) and Drift Time (ms), as evidenced by 
the coefficient of variation for these two metrics.  
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Table I-4. Pairwise Sequence Identities for Albumin Homologues 
 Bovine Hominian Ovine Porcine Murine Leporine Bovidian 
Bovine 1 - - - - - - 
Hominian 0.758 1 - - - - - 
Ovine 0.922 0.75 1 - - - - 
Porcine 0.792 0.759 0.775 1 - - - 
Murine 0.702 0.734 0.695 0.723 1 - - 
Leporine 0.714 0.743 0.722 0.739 0.724 1 - 
Bovidian 0.921 0.748 0.985 0.777 0.697 0.723 1 
 
Table I-5. Pairwise Sequence Similarities for Albumin Homologues 
 Bovine Hominian Ovine Porcine Murine Leporine Bovidian 
Bovine 1 - - - - - - 
Hominian 92.8 1 - - - - - 
Ovine 99 92.3 1 - - - - 
Porcine 93 91.1 92.8 1 - - - 
Murine 91.8 93.5 91.4 91.6 1 - - 
Leporine 93 94.5 92.8 91.9 92.6 1 - 
Bovidian 98.5 92.5 99.7 92.5 91.7 93 1 
 
Table I-6. Raw numerical output from CIUSuite_Detect 
 Feature1 
Centroid 
Feature1 
Stability 
Feature1 dt 
Bovine 38 24 15.85 
Goat 37 22 15.196 
Human 38 24 16.83 
Pig 35 18 16.38 
Rabbit 37 22 15.56 
Rat 34 18 16.29 
Sheep 37 22 15.743 
Avg. 36.57142857 21.42857143 15.97842857 
Std. 1.399708424 2.32115383 0.513073054 
 0.038273277 0.108320512 0.032110358 
 Feature2 
Centroid 
Feature2 
Stability 
Featuer2 dt 
Bovine 76 36 23.3 
Goat 69 22 22.566 
Human 72 32 22.93 
 145 
 
Pig 89 54 24.297 
Rabbit 72 20 22.839 
Rat 72 32 23.387 
Sheep 70 20 23.114 
Avg. 74.28571429 30.85714286 23.20471429 
Std. 6.340668863 11.20495517 0.515585025 
 0.085355158 0.363123547 0.022218978 
 Feature3 
Centroid 
Feature3 
Stability 
Featuer3 dt 
Bovine 132 84 27.2 
Goat 134 108 27.6 
Human 113 50 27.2 
Rabbit 102 36 26.3 
Rat 94 12 26.2 
Sheep 134 108 27.8 
Pig    
Avg. 118.1666667 66.33333333 27.05 
Std. 16.1494754 36.33944903 0.604841577 
 0.136666929 0.54783089 0.022360132 
 Feature4 
Centroid 
Feature4 
Stability 
Featuer4 dt 
Bovine 179 18 30 
Human 159 58 30 
Rabbit 155 66 29.2 
Rat 152 72 29.7 
Pig 155 66 29.8 
Sheep    
Goat    
Avg. 160 56 29.74 
Std. 9.757048734 19.51409747 0.293938769 
 0.060981555 0.348466026 0.009883617 
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Figure I-3. Correlations between a BSA-based evolutionary distance and the CIU RMSD for all albumin 
homologues. 
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Figure I-4. Raw output from CIUSuite_compare, comparing Bovine and Human Albumins to other 
species 
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Figure I-5. Quantitation of BSA:HSA Ratio Using Peak Ratio of Unfolded States Present at 120V 
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Section 2: Supporting Information for Albumin-Ligand complexes and dissociation curves 
 
Figure I-6. A CIU difference plot from CIUSuite, showing that HSA bound to diazepam (blue) stabilizes 
late transitions relative to apo HSA (red). 
 
Figure I-7. CIU and CID Datasets for HAS bound to selected Ligands at 14+ and 16+ charge state 
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Figure I-8. A graph of fraction bound versus collision voltage in the ion trap prior to IM separation, 
reveals that Iodipamide and Thyroxine form multiply bound, cooperatively stabilized Albumin 
Complexes. 
  
Supporting Text for Figure S8.  CID curves for all observed species of Thyroxine and Iodipamide. Crystal 
structures for Thyroxine bound to HSA reveal two binding sites embedded in D2, and two binding sites 
on the perifiery of D3.2 Our data suggests all of these ligands dissociate in rapid succession upon 
collisional activation, before, during, and after the first structural transition from C1 to C2. Considering 
the disparate positions of the ligands and relatively low CID transition energy, it is difficult to interpret 
this data in terms of individual dissociation events for each binding location. (PDB ID 1HK1) Likewise, 
Iodipamide is a large ligand that has multiple binding locations within HSA.3 Crystallographic analysis 
reveals iodipamide binding at the D2 drug site, and also shows some electron density for the ligand in 
the cleft formed between all three domains. We utilized our individual domain constructs to further 
localize this binding, finding that Iodipamide binds to both D2 as well as D3. Due to the size of this 
ligand, we assume the electron density from the crystal structure is a tail of the D3-Bound ligand 
protruding into the interdomain cleft.  Despite the ambiguity in assigning binding locations, our CID 
analysis shows that Iodipamide behaves similarly to thyroxine, releasing ligands within a narrow range 
of collision voltages, and thus providing evidence for cooperative effects during dissociation. Further CIU 
analysis also reveals conformational stabilization of the protein (Figure S9, see below).  
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Figure I-9. Iodipamide binding causes significant conformational shifts in HSA, exaggerated at larger 
stoichiometries. CIU Difference plots between apo HSA and one (left plot) and two (right plot) 
iodipamide bound species reveal signficant  increases in drift time for the bound forms, as well as large 
degree of stabilization for the final CIU transition observed.  
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Figure I-10. We observe a lack of any correlation between the CID energy required to eject ligands from 
HSA and the total polar surface area (A), the total number of polar interactiosn in the binding pocket (B), 
or the number of total interactions in the binding pocket (C).4  Correation coefficients (R2 values) for a 
linear fit are shown on each graph.   
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Section 3 IM-MS Data related to Noncovalent Albumin Constructs 
 
10V      100V 
 
Figure I-11. IM-MS spectra for HSA domain 1 constructs at 10V (left) and 100V (right) collisional 
activation in the ion trap prior to IM separation, having a measured mass of 22,167.  In both spectra, 
signals for monomers, dimers and trimers of the domain are observed.   More CIU is observed at 100V, 
as expected.   
 
10V       100V 
 
Figure I-12. IM-MS spectra for HSA domain 2 constructs at 10V (left) and 100V (right) collisional 
activation in the ion trap prior to IM separation, having a measured masses of 21,968 and 22,501.  In the 
10V spectra, signals for monomers, dimers and trimers of the domain are observed.   In the 100V 
spectrum, significant fragmentation of the covalent domain 2 backbone is observed.   
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10V      100V 
 
Figure I-13. IM-MS spectra for HSA domain 3 constructs at 10V (left) and 100V (right) collisional 
activation in the ion trap prior to IM separation, having measured masses of 23,365 and 23569.  In the 
10V spectrum, signals for monomers, dimers, trimers, tetramers and pentamers of the domain are 
observed.   Signal associated with domain 3 monomer dominates the 100V spectrum.    
 
10V      100V 
 
 
Figure I-14. IM-MS spectra for HSA domains 1 and 2, covalently linked, at 10V (left) and 100V (right) 
collisional activation in the ion trap prior to IM separation, having a measured mass of 45,266.  In the 
10V spectrum, signals for monomers, dimers and trimers of the construct are observed.   Signal 
associated with domain 1-2 monomer dominates the 100V spectrum.    
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10V      100V 
 
Figure I-15. IM-MS spectra for HSA domain 1-2 construct, mixed with domain 3, at 10V (left) and 100V 
(right) collisional activation in the ion trap prior to IM separation. The D12-D3 dimer has an expected 
mass of 68,835 Da, whereas the domain 3 trimer has an expected mass of 70707 Da.  Based on the 
identifications made in the 10V spectrum, we observe both a species at 68409 and one at 70793, which 
we assign to D12-D3 and D3 trimer respectively.  Monomer signal for both D3 and D12 dominates the 
100V spectrum, and some traveling wave IM roll-over is observed at low drift time and high m/z values.    
 
10V      100V 
 
Figure I-16. MS/MS data, acquired using a quadrupole selection window centered on m/z 4560, 
acquired at a voltage of 10V (left) and 100V (right), for the signal putatively assigned as the D12-D3 
dimer from Supplementary Figure 25.    Two CID products are observed, corresponding to 23,359 (D3, at 
low m/z) and 45266 (D12, charge stripped at higher m/z), confirming our D12-D3 dimer assignment.  
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Figure I-17. IM-MS and MS/MS data for samples where D12 and D1 were mixed in solution. The left 
spectrum was acquired using 10V activation voltage in the ion trap, and we observe strong evidence of 
D12-D1 dimer complexes (as indicated), having a measured mass of 67,288 Da.  D1 and D12 multimers 
are also observed. The right hand spectrum was acquired using a quadrupole selection window centered 
on the m/z value highlighted in the left hand spectrum.    Two CID products are observed, corresponding 
to D1 (at low m/z) and D12 (at higher m/z), confirming our D12-D1 dimer assignment. See figures above 
for individual monomer masses.       
 
Figure I-18. IM-MS and MS/MS data for samples where D12 and D2 were mixed in solution. The left 
spectrum was acquired using 10V activation voltage in the ion trap, and we observe strong evidence of 
D12-D1 dimer complexes (as indicated), having a measured mass of 67,288 Da.  D1 and D12 multimers 
are also observed. The right hand spectrum was acquired using a quadrupole selection window centered 
on the m/z value highlighted in the left hand spectrum.    Two CID products are observed, corresponding 
to D1 (at low m/z) and D12 (at higher m/z), confirming our D12-D1 dimer assignment. See figures above 
for individual monomer masses.   
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Figure I-19. IM-MS and MS/MS data for samples where D1, D2 and D3 were mixed in solution. The left 
spectrum was acquired using 10V activation voltage in the ion trap, and we observe strong evidence of 
D1-D2-D3 trimer complexes (as indicated), having a measured mass of 67,767 Da.  Other D1, D2 and D3 
multimers are also observed. The right hand spectrum was acquired using a quadrupole selection 
window centered on the m/z value highlighted in the left hand spectrum.    Two CID products are 
observed, corresponding to D3 (at low m/z) and the noncovalent D12 dimer (at higher m/z), confirming 
our D1-D2-D3 dimer assignment. In addition to the MS/MS results, we can identify the signal at m/z of 
4450 is 15+ because it shows near-identical CIU behavior to all other 15+ ions studied at <50 V. (shown 
below).  See figure captions above for individual monomer masses.  
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Figure I-20. CIU data for WT HSA (A), compared with CIU data for D12-D3 (B), D12-D1 (C) and D12-D2 
(D), overlaid with CID breakdown curves (white) for the ejection of the smaller bound monomer within 
each dimer. A detailed comparison of native HSA with noncovalent reconstructions thereof highlights 
interesting mechanistic changes to the unfolding pathway that effect observed CID trends. D12-D3 
appears to follow a near-sigmoidal curve coinciding with the appearance of confrmer family 3 (see main 
paper text). When this conformer family can no longer be efficiently accessed, the CID breakdown curve 
clearly changes. Likewise, D12-D1 and D12-D2 are unable to access this conformational family, and thus 
can only proceed through a frustrated CID mechanism that accesses alternative conformational states.  
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Figure I-21. CIU fingerprint data for reconstituted noncovalent HSA constructs for (A) the D1 trimer, (B) 
the D1-D2-D3 trimer, and (C) the D3 trimer.  A complete CIU fingerprint for the D2 trimer could not be 
acquired due to its low stability.  
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Table I-7. Experimental and Calculated Cross Section Values for Albumin Domains and Multidomain 
Constructs 
 
calculated exp unfolded 
2nd 
Unfolded 
%ERROR 
UNFOLDED-
FOLDED 
% 
CHANGE 
D1 7+ 2081 1484 1916 2354 -40.2 432 29 
D1 8+ 2081 1838 2341   -13.2 503 27 
D1 9+ 2081 1816 2636   -14.5 820 45 
D1 10+ 2081 2071 2595 2905 -0.48 524 25 
D2 6+ 2119 1361 1496  -55.6 135 10 
D2 6+ 2119 1361 2002  -55.6 641 47 
D2 7+  2119 1626 1916  -30.3 290 17 
D2 8+ 2119 1634 2379  -29.6 745 45 
D2 9+ 2119 1874 2710  -13.0 836 44 
D2 10+ 2119 1903 2811  -11.3 908 47 
D3 8+ 2068 1840 2096  -11.0 228 12 
D3 9+ 2068 1900 2814    -8.1 914  
D12 13+ 3410 3150 3901   -8.2 751 23 
D12 13+ 3410 3150 4136   -8.2 986 31 
D12 15+ 3410 3265 5036   -4.4 1771 54 
D12 16+ 3410 3367 5538   -1.2 2171 64 
WT 15+ 4388 4136 6132   -6.0 1996 48 
 
Table I-8. Measured CCS values for Unfolded Albumin Conformations at 15+ 
 
 Calculated Observed CCS %Change 
Ground 
State 
4388* 4136 - - 
Unfld 1  5153 1017 24.6 
Unfld 2  5740 587 11.4 
Unfld 3  6107 367 6 
*From 4K2C using PA*1.15 
 
References: 
(1) Bush, M. F.; Hall, Z.; Giles, K.; Hoyes, J.; Robinson, C. V.; Ruotolo, B. T. Analytical 
Chemistry 2010, 82, 9557. 
(2) Petitpas, I.; Petersen, C. E.; Ha, C.-E.; Bhattacharya, A. A.; Zunszain, P. A.; Ghuman, J.; 
Bhagavan, N. V.; Curry, S. Proc. Natl. Acad. Sci. U. S. A.   2003, 100, 6440. 
(3) Ghuman, J.; Zunszain, P. A.; Petitpas, I.; Bhattacharya, A. A.; Otagiri, M.; Curry, S. J. of 
Mol. Biology 2005, 353, 38. 
 (4) Wallace, A. C.; Laskowski, R. A.; Thornton, J. M. Protein Engineering 1995, 8, 127. 
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Appendix II: Supporting information for  Chapter 
4: Coming to Grips with Ambiguity: Ion Mobility-
Mass Spectrometry for Protein Quaternary 
Structure Assignment 
 
Generating coarse-grained structures at variable resolution.  
To estimate the contributions of multidomain and other non-globular protein subunits to coarse-
graining errors, we developed a fast, online method for adding resolution to our coarse grained models. 
For any protein subunit greater than 500 residues, we invoked k-means clustering of its coordinates to 
determine if it contained clusters of greater than 100 residues that were resolved in space. If multiple 
clusters did exist within a single subunit, we developed a coarse-grained model using our standard 
workflow, albeit assigning a sphere to each cluster rather than each subunit. By applying this method 
against many known multiprotein topologies and varying the thresholds for cluster assignment, we 
assessed the coarse-graining error as a function of the residues per sphere in the coarse-grained model.  
 
Figure II-1. Coarse-graining CCS error as a function of Subunit Residues/Sphere 
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Generation of Coarse-Grained Multiprotein Models based on IM-MS datasets. 
 
Restraint file. Although previous methods have been published for generating structural models from 
IM-MS datasets, these have generally relied on custom scripts that are difficult to implement for those 
not well-versed in computational modeling or coding. Building on this work and integrating many 
aspects already developed, we sought to build a general method for translation of IM-MS restraints into 
structural models that does not require any changes to the source code, but instead relies on simple 
input files that are read by the program and translated into an ensemble of putative structures. Input 
files allow for facile input of CCS information for subunits, subcomplexes, and complexes; connectivity 
information at varying levels of ambiguity; explicit protein-protein distance information, and symmetry 
information. These four types of information represent all levels of information derived from IM-MS 
experiments, and can also represent data from other experiments, especially crosslinking-MS. For more 
information, we refer the reader to our website where annotated input files as well as the MS modeler 
source code and data analysis scripts are available: 
 
 https://sites.lsa.umich.edu/ruotolo/software/IMMS_Modeler 
 
Interpretation of Restraints. IMMS-Modeler integrates information from the input file into a model 
system with a scoring function that is later optimized many times to generate an ensemble of putative 
structures. The model consists of multiple spheres representing each protein (or domain) with radii 
derived from the collision cross section. Each sphere is initially positioned randomly within a bounding 
box. The size of the bounding box scales with the expected CCS of the target complex in order to reduce 
biases related to the initial coordinates of the subunits and to reduce the need for unnecessary 
optimization of coordinates placed too far apart in space.  
 After generation of the geometric system, a scoring function is built by combining the 
connectivity, distance, and symmetry restraints into a single optimizable function. Connectivity 
restraints are expressed as a tree structure that allows for varying levels of ambiguity: explicit subunit-
subunit contacts are scored by a square function that allows the two spheres to interpenetrate to 
varying degrees within biophysical thresholds for interacting proteins, previously established at 15% to 
45%.37 Interacting subunits that interpenetrate by greater or less than these values will not be accepted. 
For more ambiguous connectivity inputs, only a single connectivity restraint between a pair of subunits 
must be satisfied. For example, if subcomplex [A,B] has connectivity to subcomplex [C,D], any pairwise 
connectivity within the set ([A,C],[A,D],[B,C],[B,D]) would satisfy the restraint. 
 Explicit subunit-subunit distances can also be implemented into the scoring function. For 
instance, the CCS of a dimeric protein complex, where the CCS of both monomers are known, restrains 
the distance between those subunits explicitly within the model. The same is true for trimeric proteins 
where CCS information is known for all subcomplexes. When this information is known, it is often useful 
to input it directly into the model to increase sampling efficiency. Additionally, high resolution models 
may be available for some subcomplexes, in which case all the pairwise distances between subunits can 
be easily extracted and used to define the subunit structure explicitly within the model. Since pairwise 
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distances generated from IM-MS restraints have some error associated with them, they are 
implemented as a harmonic restraint for which the force constant can be scaled appropriately.  
 In order to increase sampling efficiency when symmetry is expected within the protein complex, 
we also implemented symmetry constraints on the system. These constraints enforce a given symmetry 
operation on a group of particles which forces them to maintain symmetry throughout the optimization 
cycle. When the exact symmetry is unknown, we have had success at comparing ensembles generated in 
parallel with different putative symmetries.  
 
Unbiased Sampling with a Monte Carlo / Monte Carlo Search 
 
Our program optimizes the scoring function of the system while attempting to sample as much 
structural space as possible. First, starting from the random initial coordinates of the system, an 
annealing-type Monte Carlo (MC) search is utilized to locate a local minimum within the energy 
landscape. The annealing type MC proposes moves for each subunit randomly, and accepts or rejects 
those moves based on their effect on the scoring function relative to the temperature of the system. 
After the annealing-type MC has found a local minimum within energy landscape, that structure is 
recorded before the temperature of the system is then raised in order to allow for less biased 
exploration of nearby structures. In this way, each local minima within the system is not characterized 
by a single structure, but an ensemble of structures. This process can then be repeated, starting with 
new, randomized initial coordinates, to characterize many local minima within the system. We have 
found that 100-1000 optimization cycles, which each output an ensemble of 10-100 structures within a 
family, is generally sufficient to characterize all possible geometries that satisfy common IM-MS-based 
restraint sets.  
Filtering and Characterizing the Ensemble 
After an ensemble of putative structures is generated, it is necessary to filter the dataset based on 
biophysical parameters as well as experimental cross section results. Filtering the dataset to ensure no 
non-physical interactions exist is important because we have chosen not to penalize subunits not 
restrained by the connectivity restraint for interpenetrating beyond physical norms. The reason for this 
is that it allows our sampling algorithm more freedom in exploring new areas of conformational space, 
albeit with some sacrifice of sampling efficiency. Similarly, we have not included the experimental CCS of 
the target complex into the optimization function. Until recently, calculation of the CCS for a candidate 
model on the timescale of a MC optimization would have been intractable, even for the relatively fast 
projection approximation method. The development of IMPACT, however, has changed this paradigm 
and brought projection approximation to molecular dynamics timescales. Despite these advances, we 
still have some concern about the potential for a CCS restraint within the optimization function to create 
high barriers to exploring conformational space, and hence we have chosen to filter the ensemble after 
optimization, at the expense of some sampling efficiency. Our filtering procedures remove models that 
feature unphysical interactions, and those that have absolute deviations from the experimental CCS of 
greater than 3%. Once a filtered ensemble is obtained that satisfies both the optimization function 
parameters and post-optimization parameters, characterization of the ensemble is of paramount 
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importance for generating new hypotheses about the complex structure and planning further 
experiments to resolve ambiguities. As previously proposed, we implemented average-linkage 
hierarchical clustering as a tool for determining the structural families present within an ensemble. This 
algorithm utilizes pairwise structural distances, in the form of RMSD values, to generate clusters of 
similar complex structures; and provides quantitative relationships between clusters. 
Figure II-2. CCS restraints increase in selectivity when subunits are similar in size. In our analysis of the PPVs for 
trimeric protein complexes from the 3D complex set, we found one outlier in the dataset (PDB ID 2INC) showing 
extremely low PPV even when restrained by a set of 2 internal CCS restraints and a global CCS restraint. We 
observed that in this protein complex, one subunit was approximately 75% smaller than the other proteins in the 
system. In order to determine the impact of this size disparity on the observed PPV, we artificially inflated the CCS 
of the small subunit until it was in parity with the others. Indeed, as the CCS of the small subunit was increased, 
the corresponding restraint set yielded a higher PPV.  
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Appendix III: Supporting information for Chapter 
5: Structural Models of the Urease Activation 
Complex Derived from Ion Mobility-Mass 
Spectrometry and Integrative Modeling 
 
Joseph D. Eschweiler, Mark. A. Farrugia, Robert P. Hausinger, Brandon T. Ruotolo 
 
 
Figure III-1. Solution-phase disruption reveals the (UreA)3 subcomplex of urease. We sprayed the urease 
core complex from a solution of 50% isopropanol and 50% 200mM ammonium acetate. The IM-MS 
spectrum under these conditions reveals the presence of a modular ureA trimer at 10+ and 11+. Also 
observed in the spectra are various losses of ureB from the urease core complex. Expected mass of 
(UreA)3: 33254 Da 
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Figure III-2. Expression of urease with a ureB gene knockout yields a homogenous population of 
(UreAC)3 hexamers at 215,000 Da. Expected mass : 215:024 Da 
 Figure III-3. IM-MS of the urease holoenzyme (ureABC)3 reveals predominant signals with a mass in 
close agreement with the expected mass of 250,308 Da.  
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Figure III-4. IM-MS of a sample containing all urease accessory components including MBP-ureD. Key 
complexes are annotated. Although higher order complexes were identified, it was impossible to assign 
configurations to these different stoichiometries, and thus they were not included in the model.   
 
Figure III-5. Fully annotated IM-MS spectrum of the (ureDFG)2 complex and its subcomplexes. 
